
<html lang="en"     class="pb-page"  data-request-id="169f86ad-de1f-41e1-8fa9-a590dbc8380e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-15;article:article:10.1021/acs.jmedchem.7b00298;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth" /></meta><meta name="dc.Creator" content="Samantha  Kendrick" /></meta><meta name="dc.Creator" content="Andrea  Muranyi" /></meta><meta name="dc.Creator" content="Vijay  Gokhale" /></meta><meta name="dc.Creator" content="Laurence H.  Hurley" /></meta><meta name="dc.Creator" content="Lisa M.  Rimsza" /></meta><meta name="dc.Description" content="Secondary DNA structures are uniquely poised as therapeutic targets due to their molecular switch function in turning gene expression on or off and scaffold-like properties for protein and small mo..." /></meta><meta name="Description" content="Secondary DNA structures are uniquely poised as therapeutic targets due to their molecular switch function in turning gene expression on or off and scaffold-like properties for protein and small mo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 25, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00298" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00298" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00298" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00298" /></link>
        
    
    

<title>Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00298" /></meta><meta property="og:title" content="Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0005.jpeg" /></meta><meta property="og:description" content="Secondary DNA structures are uniquely poised as therapeutic targets due to their molecular switch function in turning gene expression on or off and scaffold-like properties for protein and small molecule interaction. Strategies to alter gene transcription through these structures thus far involve targeting single DNA conformations. Here we investigate the feasibility of simultaneously targeting different secondary DNA structures to modulate two key oncogenes, cellular-myelocytomatosis (MYC) and B-cell lymphoma gene-2 (BCL2), in diffuse large B-cell lymphoma (DLBCL). Cotreatment with previously identified ellipticine and pregnanol derivatives that recognize the MYC G-quadruplex and BCL2 i-motif promoter DNA structures lowered mRNA levels and subsequently enhanced sensitivity to a standard chemotherapy drug, cyclophosphamide, in DLBCL cell lines. In vivo repression of MYC and BCL2 in combination with cyclophosphamide also significantly slowed tumor growth in DLBCL xenograft mice. Our findings demonstrate concurrent targeting of different DNA secondary structures offers an effective, precise, medicine-based approach to directly impede transcription and overcome aberrant pathways in aggressive malignancies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00298"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00298">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00298&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00298&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00298&amp;href=/doi/10.1021/acs.jmedchem.7b00298" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6587-6597</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00285" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00283" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Simultaneous Drug Targeting of the Promoter <i>MYC</i> G-Quadruplex and <i>BCL2</i> i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Kendrick">Samantha Kendrick</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7782-7415" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Muranyi">Andrea Muranyi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Gokhale">Vijay Gokhale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurence+H.++Hurley">Laurence H. Hurley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-8522-450X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+M.++Rimsza">Lisa M. Rimsza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Pathology, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Ventana Medical Systems, Inc., 1910 Innovation Park Drive, Tucson, Arizona 85755, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, Arizona 85721, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">BIO5 Institute, University of Arizona, 1657 East Helen Street, Tucson, Arizona 85721, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: (520) 626-9884. E-mail: <a href="/cdn-cgi/l/email-protection#5e323f3d2c3137262d1e3b333f3732703f2c372431303f703b3a2b"><span class="__cf_email__" data-cfemail="75191416071a1c0d06351018141c195b14071c0f1a1b145b101100">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00298&amp;href=/doi/10.1021%2Facs.jmedchem.7b00298" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6587â6597</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 12, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 February 2017</li><li><span class="item_label"><b>Published</b> online</span>25 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 August 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00298</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6587%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSamantha%2BKendrick%252C%2BAndrea%2BMuranyi%252C%2BVijay%2BGokhale%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D15%26contentID%3Dacs.jmedchem.7b00298%26title%3DSimultaneous%2BDrug%2BTargeting%2Bof%2Bthe%2BPromoter%2BMYC%2BG-Quadruplex%2Band%2BBCL2%2Bi-Motif%2Bin%2BDiffuse%2BLarge%2BB-Cell%2BLymphoma%2BDelays%2BTumor%2BGrowth%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6597%26publicationDate%3DAugust%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00298"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1812</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00298" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Kendrick&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Muranyi&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Gokhale&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;H. Hurley&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;M. Rimsza&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6587-6597&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00298&quot;},&quot;abstract&quot;:&quot;Secondary DNA structures are uniquely poised as therapeutic targets due to their molecular switch function in turning gene expression on or off and scaffold-like properties for protein and small molecule interaction. Strategies to alter gene transcription through these structures thus far involve targeting single DNA conformations. Here we investigate the feasibility of simultaneously targeting different secondary DNA structures to modulate two key oncogenes, cellular-myelocytomatosis (MYC) and B-cell lymphoma gene-2 (BCL2), in diffuse large B-cell lymphoma (DLBCL). Cotreatment with previously identified ellipticine and pregnanol derivatives that recognize the MYC G-quadruplex and BCL2 i-motif promoter DNA structures lowered mRNA levels and subsequently enhanced sensitivity to a standard chemotherapy drug, cyclophosphamide, in DLBCL cell lines. In vivo repression of MYC and BCL2 in combination with cyclophosphamide also significantly slowed tumor growth in DLBCL xenograft mice. Our findings demonstrate concur&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00298&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00298" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00298&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00298" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00298&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00298" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00298&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00298&amp;href=/doi/10.1021/acs.jmedchem.7b00298" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00298" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00298" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00298%26sid%3Dliteratum%253Aachs%26pmid%3D28605593%26genre%3Darticle%26aulast%3DKendrick%26date%3D2017%26atitle%3DSimultaneous%2BDrug%2BTargeting%2Bof%2Bthe%2BPromoter%2BMYC%2BG-Quadruplex%2Band%2BBCL2%2Bi-Motif%2Bin%2BDiffuse%2BLarge%2BB-Cell%2BLymphoma%2BDelays%2BTumor%2BGrowth%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D15%26spage%3D6587%26epage%3D6597%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291048" title="G-Quadruplex">G-Quadruplex</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/jmcmar.2017.60.issue-15/20170810/jmcmar.2017.60.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Secondary DNA structures are uniquely poised as therapeutic targets due to their molecular switch function in turning gene expression on or off and scaffold-like properties for protein and small molecule interaction. Strategies to alter gene transcription through these structures thus far involve targeting single DNA conformations. Here we investigate the feasibility of simultaneously targeting different secondary DNA structures to modulate two key oncogenes, cellular-myelocytomatosis (<i>MYC</i>) and B-cell lymphoma gene-2 (<i>BCL2</i>), in diffuse large B-cell lymphoma (DLBCL). Cotreatment with previously identified ellipticine and pregnanol derivatives that recognize the <i>MYC</i> G-quadruplex and <i>BCL2</i> i-motif promoter DNA structures lowered mRNA levels and subsequently enhanced sensitivity to a standard chemotherapy drug, cyclophosphamide, in DLBCL cell lines. In vivo repression of <i>MYC</i> and <i>BCL2</i> in combination with cyclophosphamide also significantly slowed tumor growth in DLBCL xenograft mice. Our findings demonstrate concurrent targeting of different DNA secondary structures offers an effective, precise, medicine-based approach to directly impede transcription and overcome aberrant pathways in aggressive malignancies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Duplex DNA is capable of adopting noncanonical secondary structures that arise from guanine-rich and cytosine-rich sequences: the G-quadruplex and the i-motif, respectively.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> These secondary DNA structures act as molecular switches, turning gene expression on or off. Consistent with this function, genome-wide analyses have detected DNA secondary structure-forming sequences within close proximity to transcription start sites in 43% of promoter regions, which are mostly oncogene promoters, including cellular myelocytomatosis (<i>MYC</i>) and B-cell lymphoma gene-2 (<i>BCL2</i>).<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3-7)</a> Our group, along with others, characterized the <i>MYC</i> G-quadruplex and <i>BCL2</i> i-motif structures that form within each promoter region (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A,B) and the interplay of these structures with nuclear proteins (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C,D).<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15">(8-15)</a> In addition, we recently discovered small molecules from a high-throughput screen of the NCI Diversity Set I (1990 compounds) that specifically modulate either <i>MYC</i> or <i>BCL2</i> expression, i.e., ellipticine [9-(dimethylaminoethoxy)-dihydrochloride (NSC-338258, GQC-05,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><b>05</b>)] or (3<i>S</i>,5<i>S</i>,8<i>R</i>,9<i>S</i>,10<i>S</i>,13<i>S</i>,14<i>S</i>)-17-(1-(6-methoxy-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-3(4<i>H</i>)-yl)ethyl)-10,13-dimethylhexadecahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthren-3-ol (NSC-59276, IMC-76,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a><b>76</b>), respectively, through interaction with their respective promoter region DNA secondary structure (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E,F). The ellipticine derivative <b>05</b> stabilizes the <i>MYC</i> G-quadruplex and maintains an âoff-switchâ DNA conformation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In contrast, <b>76</b>, a pregnanol derivative, stabilizes the <i>BCL2</i> flexible hairpin, which is in equilibrium with the i-motif structure located on the DNA strand complementary to the <i>BCL2</i> G-quadruplex and thereby selects for an alternative DNA conformation from the âon-switchâ.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> In both cases, we used ChIP analysis to show the expected effects on the occupancy of the G-quadruplex- or i-motif-binding proteins at the promoter elements and, in the case of <b>05</b>, demonstrated using an exon-specific assay that the <i>MYC</i> G-quadruplex is required for drug action.<a onclick="showRef(event, 'ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref15">(13, 15)</a> These DNA secondary structure-targeting agents led to the repression of <i>MYC</i> or <i>BCL2</i> transcription and an increased etoposide sensitivity of chemotherapy-resistant Burkittâs and mantle lymphoma cell lines and a mantle cell lymphoma xenograft mouse model.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> It is likely that targeting DNA secondary structures offers a strategy to minimize resistance because mutations within coding regions that alter protein conformation or post-translational modifications and confer resistance do not affect these structures within oncogene promoter regions. Thus, these structures potentially provide an advantage over protein-directed therapeutic approaches.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed model for targeting the DNA secondary structure formation within the <i>MYC</i> and <i>BCL2</i> gene promoter regions with <b>05</b> and <b>76</b>. (A) The <i>MYC</i> promoter region consists of a G-rich element that forms a G-quadruplex structure from three stacked G-tetrads composed of four G-Hoogsteen base pairs.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> (B) The C-rich sequence upstream of the <i>BCL2</i> promoter region is capable of adopting an i-motif structure with three and one-half sets of two intercalated hemiprotonated C<sup>+</sup>âC base pairs.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (C) During transcription NM23-H2 can unfold the <i>MYC</i> G-quadruplex, resulting in single-stranded DNA to which CNBP can bind and activate <i>MYC</i> transcription. (D) The nuclear protein hnRNP LL can initiate conformational changes in the <i>BCL2</i> i-motif, leading to transcription activation. (E) Binding of <b>05</b> stabilizes the <i>MYC</i> G-quadruplex, resulting in transcription repression.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> (F) <b>76</b> sequesters the flexible hairpin form of this dynamic element and inhibits transcription.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkinâs lymphoma, there is a particularly aggressive form of the disease characterized by concurrent overexpression of <i>MYC</i> and <i>BCL2</i> oncogenes that occurs in at least 30% of patients. Patients with dual MYC and BCL2 protein-positive DLBCL experience a rapid disease progression that is often refractory to the current immunochemotherapy regimen consisting of rituximab monoclonal antibody, cyclophosphamide (CPA), doxorubicin, vincristine, and prednisone. The majority of patients survive less than five years due to the lethal combination of resistance to cell death and high cell proliferation.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a> Currently there are no effective strategies to treat these patients. Even preclinically there is no approach to directly and specifically modulate MYC expression, although the broad bromodomain and extra-terminal domain inhibitor <i>tert</i>-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6<i>H</i>-thieno[3,2-<i>f</i>][1,2,4]triazolo[4,3-<i>a</i>][1,4]diazepin-6-yl)acetate (JQ1, <b>1</b>) has been shown to indirectly lower MYC expression.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Similarly, most anti-BCL2 therapies have not been clinically useful except for the BH-3 mimetic 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-<i>N</i>-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yloxy)benzamide (ABT-199, venetoclax, <b>199</b>) found to inhibit BCL2 protein activity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, resistance to compounds <b>1</b> and <b>199</b> and other BH-3 mimetics has been observed in patients and anticipated in preclinical models.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26 ref27">(22-27)</a> Thus far, investigations have focused on individually targeting these potent oncogenes, but this may not be clinically relevant for DLBCL patients with double-positive tumors and may be less effective in circumventing drug resistance and relapse. Despite the presently available pharmacologic inhibitors of <i>MYC</i> and <i>BCL2</i> in preclinical and clinical studies, issues with resistance and specificity demand continued, active research focused on promising new approaches to target these critical oncogenes in this aggressive disease.</div><div class="NLM_p last">We sought to directly and simultaneously target <i>MYC</i> and <i>BCL2</i> transcription through DNA secondary structures to induce chemosensitization using DLBCL as a model. Herein we apply our novel therapeutic strategy of inhibiting oncogenes at the transcriptional level to address the coincident expression of MYC and BCL2 known to confer an aggressive tumor cell phenotype and chemotherapy resistance in DLBCL. For the first time, we demonstrate that concurrent targeting of the <i>MYC</i> and <i>BCL2</i> DNA secondary structures inhibits gene expression and subsequently protein expression and sensitizes dual-expressing DLBCL cell lines to CPA. CPA was selected for this proof-of-concept because it is a major component of the DLBCL standard chemotherapy regimen that induces DNA damage via nonspecific interaction with DNA as an alkylating agent, leads to mitochondrial BCL2-dependent apoptotic cell death, and is highly toxic. This chemosensitization resulted in a reduced concentration of CPA required to lower viability and to induce apoptosis in lymphoma cells, as well as to inhibit tumor growth in xenograft mice. With the increasing appreciation for the genetic complexity of lymphoma, targeted therapy in conjunction with existing chemotoxic drugs may be important in management of these aggressive lymphomas that depend on specific oncogenic pathways for survival.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previous work from our group identified compounds that target the structures within the <i>MYC</i> and <i>BCL2</i> promoter regions independently, defined the mechanism for these drug-like molecules to silence <i>MYC</i> and <i>BCL2</i> gene expression, and demonstrated their potential to increase chemotherapy sensitivity in non-Hodgkinâs lymphoma cells.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> In order to assess the efficacy of our novel approach to simultaneously target the <i>MYC</i> G-quadruplex and <i>BCL2</i> i-motif for dual transcription repression, we utilized DLBCL as a model due to the frequent concurrent overexpression and clinical significance of both oncogenes. DLBCL cell lines were characterized for <i>MYC</i> and <i>BCL2</i> translocation and amplification status, and four cell lines were selected to represent the varying molecular mechanisms of <i>MYC</i> and <i>BCL2</i> deregulation observed within patient tumors (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S1). The SUDHL4 (<i>BCL2</i> translocation-positive), VAL (<i>BCL2</i> and <i>MYC</i> translocation-positive), and U2932 (<i>MYC</i> translocation-positive; <i>BCL2</i> amplification-positive) cells display different levels of MYC and BCL2 expression at the mRNA and protein levels (<a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a>A and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The HT cell line with no <i>MYC</i> or <i>BCL2</i> genomic abnormalities, no detectable levels of BCL2, and little MYC (<a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a>A and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) was used for comparison to the dual-expressing cell lines. Our initial studies confirmed the inhibition of <i>MYC</i> and <i>BCL2</i> in vitro using the DNA secondary structure-interactive small molecules <b>05</b> and <b>76</b> within these DLBCL cells.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>MYC</i> targeting with <b>05</b> in DLBCL in vitro and in vivo models. (A) <i>MYC</i> mRNA (left panel) and protein (right panel) expression in DLBCL cell lines as detected by qPCR and Western blot. (B) Effect of 24 h treatment with <b>05</b> on <i>MYC</i> mRNA and protein expression. (C) Tumor burden of mice treated with CPA alone or cotreated with <b>05</b> as measured by tumor volume. Arrows indicate the 5 days of drug administration. <i>MYC</i> mRNA expression is relative to TBP and compared to levels in either the HT or untreated cells. Western blots are representative, with actin as a loading control and DMSO used as vehicle/diluent control. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.0001 for triplicate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>BCL2</i> targeting with <b>76</b> in DLBCL cell lines. (A) <i>BCL2</i> mRNA (left panel) and protein (right panel) expression in DLBCL cell lines as detected by qPCR and Western blot. (B) Effect of 24 h treatment with <b>76</b> on <i>BCL2</i> mRNA and protein expression. <i>BCL2</i> mRNA expression is relative to TBP and compared to levels in either the HT or untreated cells. Western blots are representative, with actin as a loading control and DMSO used as vehicle control. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.0001 for triplicate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Targeting the <i>MYC</i> G-Quadruplex Inhibits Gene Expression in Vitro and in Vivo</h3><div class="NLM_p">We previously demonstrated that <b>05</b> effectively down-regulates <i>MYC</i> in a Burkittâs lymphoma cell line, RAJI, after 24 h of treatment using concentrations below the cell viability IC<sub>50</sub> so as not to inhibit â¥50% of cell growth.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Here we also performed cell viability assays with <b>05</b> and treated our DLBCL cell lines with increasing concentrations based on the IC<sub>50</sub> values for 24 h (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S2 and Table S1). Treatment with <b>05</b> resulted in a substantial knock-down of up to 90% of <i>MYC</i> mRNA that was dose-dependent in the SUDHL4 and U2932 cells and occurred at the highest concentration of 3 Î¼M in the VAL and HT cells, with corresponding decreases at the protein level as shown by Western blot (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). Since the repression of <i>MYC</i> by <b>05</b> can occur as early as 6 h in the RAJI cell line,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> we tested whether this immediate effect would be present in the DLBCL cell lines and found that a similar, potent lowering of <i>MYC</i> occurred in all cell lines (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S3). Compound <b>05</b> exhibits a considerable specificity for the <i>MYC</i> G-quadruplex and transcription inhibition relative to other oncogenes with promoters consisting of potential DNA secondary structures.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> While not a comprehensive transcriptome analysis, these data included both competition binding and expression assays with duplex DNA and <i>VEGF</i>, <i>Hif1Î±</i>, <i>hTERT</i>, <i>PDGFRÎ²</i>, <i>PDGF-A</i>, <i>BCL2</i>, and <i>MYC</i> G-quadruplex-forming DNA. In the present study we also observed significant <i>MYC</i> repression with little to no effect on <i>BCL2</i> mRNA levels within the same cell lysates (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S4A). Albeit, at the highest concentration <b>05</b> decreased <i>BCL2</i> mRNA in SUDHL4 cells, presumably due to the slight interaction with the <i>BCL2</i> G-quadruplex shown in a competition assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The ultimate goal of the current work is to simultaneously down-regulate both <i>BCL2</i> and <i>MYC</i>; thus, this only strengthens the likelihood for a combined effect and the advantage of using these compounds.</div><div class="NLM_p last">Compound <b>05</b> was never tested in a xenograft mouse model, unlike the <i>BCL2</i> i-motif-interactive small molecule <b>76</b>. Therefore, our first in vivo study involved <b>05</b> alone in combination with CPA, a component of the multichemotherapy DLBCL regimen, to determine the maximum tolerated dose (MTD) and the independent effects on tumor growth and <i>MYC</i> levels prior to combining with <b>76</b>. As indicated in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C, both 2.5 and 5 mg/kg <b>05</b> with 50 mg/kg CPA significantly reduced tumor burden in comparison to diluent-treated severe combined immunodeficient (SCID) mice with U2932 DLBCL xenografts. In contrast, there was a trend for slowed tumor growth with CPA alone (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). However, at these doses, the addition of <b>05</b> potentiated CPA for only up to 10 days after the first day of treatment. Importantly, tumors from mice treated with <b>05</b> and CPA were compared to diluent-treated mice or mice treated with CPA alone for <i>MYC</i> mRNA level and found to have significantly less <i>MYC</i> expression (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). As expected, there was no effect on <i>BCL2</i> mRNA levels (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5A). There was no effect on mean mouse weight, and LD<sub>50</sub> was not reached at either concentration of <b>05</b> in combination with CPA (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5B,C).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Targeting the <i>BCL2</i> i-Motif Down-Regulates <i>BCL2</i> in DLBCL Cell Lines</h3><div class="NLM_p">Compound <b>76</b> specifically targets the <i>BCL2</i> i-motif when examined in parallel with mutant, <i>MYC</i>, and <i>VEGF</i> i-motif, <i>BCL2</i> G-quadruplex, and duplex-forming sequences and does not affect <i>MYC</i> or <i>VEGF</i> mRNA levels in Burkittâs lymphoma, mantle cell lymphoma, and breast carcinoma cell lines.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Consistent with these findings, <b>76</b> did not alter <i>MYC</i> expression in the DLBCL cell lines (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S4B) and significantly decreased <i>BCL2</i> mRNA levels by 11â37% in SUDHL4, VAL, and U2932 cells following 24 h treatment with 1 and 3 Î¼M (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). There was no effect in the non-BCL2-expressing HT cell line. The targeting of <i>BCL2</i> gene expression also resulted in a concomitant decrease in protein expression (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><div class="NLM_p last">Although the down-regulation of <i>BCL2</i> expression by <b>76</b> is less than that observed for <i>MYC</i> in response to <b>05</b>, the average 20% loss of <i>BCL2</i> is most likely sufficient to facilitate chemosensitization and to a similar level as achieved by the protein inhibitor 4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-<i>N</i>-[4-[[(2<i>R</i>)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide (ABT-737), as previously noted in other non-Hodgkinâs lymphoma cell lines.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The dependence of cancer cells on <i>BCL2</i> is known to âprimeâ the cells for death such that even small levels of inhibition skew the pro- and anti-apoptotic ratio. With the balance tipped toward pro-apoptotic proteins, cells then require less stimuli to induce cell death and allow for chemosensitivity when coupled with a chemotherapeutic agent.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Concurrent Treatment with <i>MYC</i> and <i>BCL2</i> Transcription Inhibitors Enhances the Cytotoxicity of CPA in Vitro</h3><div class="NLM_p">We then sought to determine whether simultaneous knock-down of <i>MYC</i> and <i>BCL2</i> with both <b>05</b> and <b>76</b> would lead to an increased potency of CPA by cotreating DLBCL cells. We determined the effects of <b>05</b> and <b>76</b> combined treatment on cell viability and CPA IC<sub>50</sub> using the MTS cytotoxicity assay as previously described.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(29-31)</a> Initially, we conducted the cell viability assay with increasing concentrations of CPA to determine the IC<sub>50</sub> of CPA alone relative to untreated cells [<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A (black bars) and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>]. A CPA concentration above the IC<sub>50</sub> (5 mM for SUDHL4 and VAL, 10 mM for HT and U2932) was then selected to combine with known concentrations of both inhibitors that repress MYC and BCL2 expression (1â3 Î¼M). We observed in all four DLBCL cell lines that the addition of <b>05</b> and <b>76</b> at 3 Î¼M to CPA at sub-IC<sub>50</sub> significantly (<i>P</i> < 0.01) decreased cell viability by more than 50% (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, red bars). Specifically, the SUDHL4, VAL, and U2932 MYC/BCL2-expressing cell lines exhibited a 30â46% decrease in cell viability compared to CPA alone, with a concomitant 1.6â2-fold lowering of CPA IC<sub>50</sub> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The HT cells, which express MYC only, also displayed lower cell viability (27%); however, there was no measurable reduction in IC<sub>50</sub> of CPA (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dual-targeting of <i>BCL2</i> and <i>MYC</i> increases the efficacy of CPA in DLBCL cell lines. (A) Percent cell viability determined by an MTS cytotoxicity assay following 96 h treatment with CPA alone, with <b>76</b> or <b>05</b>, and with both <b>76</b> and <b>05</b>. CPA concentration for the combination treatments were 5 mM for SUDHL4 and VAL and 10 mM for HT and U2932 cells. Significance considered at <i>P</i> â¤ 0.006 for CPA only comparisons to the nine possible combination treatments and <i>P</i> â¤ 0.03 for the CPA+<b>76</b> or CPA+<b>05</b> compared to the triple combination. (B) Percent caspase-3 activity following 24 h treatment with 1.25 mM CPA alone or in combination with <b>76</b> and/or <b>05</b>. Significance considered at <i>P</i> â¤ 0.02 for CPA only comparisons to the three possible combination treatments. Data represent three replicates, with the exception of HT and SUDHL4 in panel B, which represent four replicates. Comparisons were conducted using the Studentâs <i>t</i> test with the Å Ã­dÃ¡kâBonferroni multiple test correction applied. *<i>P</i> < 0.05 and **<i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cyclophosphamide (CPA) IC<sub>50</sub> in the Absence and Presence of the <i>BCL2</i> Inhibitor (<b>76</b>) and/or the <i>MYC</i> Inhibitor (<b>05</b>)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center" char="Â±">CPA IC<sub>50</sub> (mM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char="Â±">CPA</th><th class="colsep0 rowsep0" align="center" char="Â±">CPA+<b>76</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">CPA+<b>05</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">CPA+<b>76</b>+<b>05</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HT</td><td class="colsep0 rowsep0" align="char" char="Â±">10.5Â Â±Â 1.6</td><td class="colsep0 rowsep0" align="char" char="Â±">5.9Â Â±Â 1.6</td><td class="colsep0 rowsep0" align="char" char="Â±">6.2Â Â±Â 1.2</td><td class="colsep0 rowsep0" align="char" char="Â±">7.3Â Â±Â 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SUDHL4</td><td class="colsep0 rowsep0" align="char" char="Â±">5.9Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">4.9Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char="Â±">5.1Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="char" char="Â±">3.6Â Â±Â 0.2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VAL</td><td class="colsep0 rowsep0" align="char" char="Â±">5.9Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">3.5Â Â±Â 0.4<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="Â±">5.2Â Â±Â 0.8</td><td class="colsep0 rowsep0" align="char" char="Â±">2.9Â Â±Â 0.7<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">U2932</td><td class="colsep0 rowsep0" align="char" char="Â±">12.2Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">8.7Â Â±Â 0.7<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="Â±">9.6Â Â±Â 1.5</td><td class="colsep0 rowsep0" align="char" char="Â±">6.7Â Â±Â 0.8<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Concentrations of <b>76</b> and <b>05</b> are 3 Î¼M.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>P</i> < 0.01 for comparison with CPA alone IC<sub>50</sub>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last"><i>P</i> < 0.001 for comparison with CPA alone IC<sub>50</sub>.</p></div></div></div><div class="NLM_p">In further support, when the dual inhibition of <i>MYC</i> and <i>BCL2</i> was compared to the independent targeting with <b>05</b> or <b>76</b> as single combinations to enhance CPA cytotoxicity, there was a notable and moderately synergistic reduction in cell viability in the SUDHL4 and U2932 cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Synergy was determined by calculating the relative risk ratio, where any value less than 1.0 indicates synergy.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(32)</a> The relative risk ratio values for SUDHL4 and U2932 cells were 0.86 and 0.82, respectively. Synergy for dual inhibition was not observed for the VAL double-hit (<i>BCL2</i> and <i>MYC</i> translocation-positive) lymphoma cell line, as these cells displayed more of an effect after <i>BCL2</i> inhibition alone, which may indicate a greater dependence on the <i>BCL2</i> oncogenic and/or apoptotic pathways. The <i>BCL2</i> inhibitor <b>76</b> at 2 and 3 Î¼M was able to potentiate the toxicity of 5 mM CPA up to 45% with a corresponding 1.7-fold decrease in CPA IC<sub>50</sub> [<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A (blue bars) and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>]. However, we still observed that a lower concentration of CPA could reduce cell viability and increase apoptosis with <b>76</b> and <b>05</b> cotreatment [<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A (red bars) and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B]. Although the HT cells responded to the combined treatment of <b>76</b> at the highest concentration and 10 mM CPA by a 22% decrease in cell viability, there was no effect on CPA IC<sub>50</sub> [<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A (blue bars) and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>]. Inhibition of <i>MYC</i> alone did not sensitize any of the DLBCL cells to CPA [<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A (green bars)]. These findings suggest that <i>MYC</i> and <i>BCL2</i> repression together at sub-IC<sub>50</sub> concentrations leads to maximum chemosensitization.</div><div class="NLM_p last">The observed lowering of cell viability in the presence of both inhibitors in combination with CPA is most likely due to an increase in apoptosis, as evidenced by the increase in caspase-3 activity (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). With the exception of <b>05</b> with CPA in the VAL cell line, treatment of each inhibitor alone with CPA did not result in a significant increase in caspase-3 activity in comparison to cells treated with CPA only. However, in all dual-expressing cell lines, cotreatment of both <b>05</b> and <b>76</b> with CPA induced caspase-3 activity by 30% to almost 100% from the activity with CPA alone (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Dual Repression of <i>BCL2</i> and <i>MYC</i> Leads to Chemosensitization of in Vivo Tumors</h3><div class="NLM_p">For utility in sensitizing aggressive lymphoid tumors that dual-express MYC and BCL2, we examined the efficacy of <b>05</b> and <b>76</b> combination therapy to inhibit tumor growth in an in vivo model of SCID U2932 DLBCL xenograft mice. We carried over the 5 mg/kg <b>05</b> from the initial in vivo study (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C) to a subsequent experiment where we also tested a 10 mg/kg <b>05</b> dose and included <b>76</b> at 10 mg/kg, a previously established efficacious dose.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> While the mice were able to tolerate the 5 mg/kg <b>05</b> dose when <b>76</b> was added, with or without CPA, to the treatment regimen, the LD<sub>50</sub> was reached and surpassed in mice treated with the 10 mg/kg <b>05</b> combinations (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5D,E). The lowered LD<sub>50</sub> at the higher dose of <b>05</b> suggests alternative mechanisms may be elicited at this high concentration that negatively impact mouse survival in addition to the on-target effect of <i>MYC</i> G-quadruplex stabilization and <i>MYC</i> inhibition. However, the 10 mg/kg concentration of <b>05</b> when cotreated with <b>76</b> and CPA resulted in a notable decrease of tumor <i>MYC</i> expression relative to untreated mice and those treated with CPA only as well as a detectable inhibition of <i>BCL2</i> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5F).</div><div class="NLM_p">We then conducted a follow-up study to evaluate effects on tumor burden using concentrations of <b>05</b> below the LD<sub>50</sub>, 5 and 7.5 mg/kg, and also reduced the dose of CPA from 50 to 30 mg/kg. The cotreatment of mice with <b>05</b> (7.5 mg/kg) and <b>76</b> (10 mg/kg) in combination with CPA delayed tumor growth and decreased tumor size by 50%, 46%, and 37% at 9, 12, and 15 days after the first day of drug administration compared to the diluent-treated mice and 50%, 67%, and 44% smaller tumors relative to those treated with CPA only (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). Overall, there was a prominent decrease in tumor burden in these mice as determined by area under the curve (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B), and the tumors displayed a lower mRNA expression of <i>MYC</i> and <i>BCL2</i> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). The corresponding protein levels from representative mouse tumors are provided in Figure S6 of the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>. Interestingly, knock-down of <i>MYC</i> and <i>BCL2</i> with <b>05</b> and <b>76</b> resulted in no effect on tumor burden unless CPA was present (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) indicating the two transcription inhibitors act as chemosensitizing agents at these concentrations. The tumor burden curves for all treatment groups are shown in Figure 7A of the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>. None of the various drug regimens resulted in a significant loss of mouse weight, and while survival for mice treated with 7.5 mg/kg <b>05</b> was reduced, LD<sub>50</sub> was not reached (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figure 7B,C).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Simultaneous <i>BCL2</i> and <i>MYC</i> repression sensitizes DLBCL tumor cells to CPA and inhibits tumor growth in mice. (A) Tumor burden of U2932 xenograft mice treated with CPA alone, <b>76</b> and <b>05</b>, or CPA with <b>76</b> and <b>05</b> as measured by tumor volume (<i>n</i> = 5â8). Arrows indicate the 5 days of drug administration. (B) Comparison of the area under the curve for the tumor burden of each treatment combination or control (<i>n</i> = 5â8; solid black bars represent alternative treatment combinations for which curves are shown in Figure S6A of the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>). (C) qPCR analysis for <i>BCL2</i> (top) or <i>MYC</i> (bottom) mRNA expression relative to TBP compared to levels in diluent-treated tumors (<i>n</i> = 2â3). *<i>P</i> < 0.05 and **<i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">These are the first studies to demonstrate that two different promoter DNA secondary structures can be targeted at the same time for direct transcription inhibition that leads to a change in a cellular phenotype. Analogous to the varied folding patterns exhibited by proteins and similar conformational features within families of proteins, there are certain structural characteristics conserved among G-quadruplexes and i-motifs and features that confer diversity. The loop regions and the number of stacked G-tetrads or cytosine<sup>+</sup>âcytosine base pairs provide a complexity of structures based on the specific nucleotide sequence and allow for selective recognition by nuclear proteins and small molecules. For example, the unique feature of a broken tetrad at the 3â²-end of the <i>PDGFRÎ²</i> promoter G-quadruplex<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(33)</a> and the cooperative folding mechanism that leads to distinct kinetic properties of the <i>hTERT</i> secondary structure<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(34)</a> allow for additional selectivity. Furthermore, the development of specific antibodies that demonstrate selectivity for the c-KIT2 or telomeric G-quadruplex structures over other G-quadruplexes and duplex DNA, along with several lines of evidence that show protein recognition for specific G-quadruplex folding patterns such as nucleolin, supports that these structures have the potential to serve as selective therapeutic targets.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Here, small compounds shown to have high affinity for the <i>MYC</i> G-quadruplex and the <i>BCL2</i> i-motif lower <i>MYC</i> and <i>BCL2</i> gene and consequent protein expression. Following the concurrent knock-down, we found similar levels of chemosensitization with a notable enhancement of CPA efficacy on cell viability and apoptosis in different DLBCL cell lines, regardless of the mechanism underlying the high levels of MYC and BCL2, including gene translocation or amplification. The ability of the DNA secondary structure-targeting molecules to also exhibit a concerted effect in delaying tumor growth in an animal model demonstrates the potential for this novel approach to repress oncogene expression and sensitize this type of exceedingly difficult-to-treat lymphoma. In using these compounds as chemosensitizing agents at concentrations below their cytotoxic levels, lowering <i>MYC</i> and <i>BCL2</i> expression could serve as an effective adjunct therapy to enhance the existing treatment regimen for dose-reduction, limit toxicity, and overcome first-line resistance. Cooperation of MYC and BCL2 deregulation is necessary for nearly full penetrance of lymphoma development and mortality in transgenic mice when compared to the overexpression of either oncogene alone.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(35)</a> Not surprisingly, dual expression of MYC and BCL2 in DLBCL patients confers an aggressive clinical course with poor prognosis relative to patients with MYC- or BCL2-only tumors. In cells where the intrinsic apoptotic pathway is unperturbed, CPA, an alkylating agent, triggers cell death via DNA damage. However, in cells with elevated MYC and BCL2, this cell death signal is overcome because cell cycle checkpoints are bypassed and pro-apoptotic factors are blocked. This creates a phenomenon referred to as oncogene addiction, in which MYC inactivation causes preferential tumor cell death.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(36, 37)</a> Thus, inhibiting BCL2 alongside MYC has the potential to synergistically reduce the threshold for initiating the apoptotic pathway and to sensitize malignant cells to lower concentrations of DNA damaging agents such as CPA. However, it is important to also consider that while not fully understood, hyperelevated MYC expression can paradoxically induce apoptosis through regulation of p53, in which BCL2 inhibition and apoptosis is a downstream consequence. Therefore, dual inhibition may minimize this MYC pro-apoptotic function and dampen synergistic effects.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(38-41)</a> The synergy observed in the SUDHL4 and U2932 cell lines, which harbor p53 mutations, but not in cells such as VAL with wild-type p53 supports this hypothesis and suggests that dual inhibition can chemosensitize tumors when MYC cannot exert is pro-apoptotic activity and BCL2 inhibition is then sufficient to induce sensitization when the MYC p53-induced apoptotic pathway is intact.</div><div class="NLM_p last">Our findings provide insight into future studies aimed at developing DNA secondary structure therapeutic agents. On the basis of these favorable proof-of-principle studies, optimization of the preclinical activity and chemical development of the <b>05</b> and <b>76</b> lead compounds for testing with other drug combinations to determine an optimal multitargeted therapeutic strategy for selection of a clinical candidate is ongoing.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compounds</h3><div class="NLM_p last">Compounds <b>05</b> and <b>76</b> were obtained from the National Cancer Institute (NCI) Developmental Therapeutics Program (DTP). The purity of these compounds was confirmed by HPLC to be â¥95% (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Figures S8 and S9). CPA was used in the monohydrate form (Sigma, C7068), which has proven in vitro cytotoxic activity despite the prodrug form.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(29-31)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cell Line Maintenance and Authentication</h3><div class="NLM_p last">The SUDHL4 and VAL cell lines were previously obtained from Dr. Staudt (NCI) and Dr. Rossi (University of Rochester), respectively. The U2932 and HT cells were purchased from the DSMZ (ACC633) and the American Type Culture Collection (CRL2260), respectively. All cells were cultured in 10% FBS, 5% penicillin/streptomycin-supplemented RPMI, except the SUDHL4 cells, which were cultured in 15% FBS according to ATCC recommendations. Cell lines were tested for mycoplasma every 6 months (data not shown) and authenticated by the University of Arizona Genetics Core (Tucson, AZ) using the PowerPlex 16 System (Promega), which consists of forensic-style 15 autosomal STR loci, including 13 CODIS DNA markers (nine of the standard loci collected by ATCC and DSMZ), amelogenin, and a mouse-specific locus, every 6â10 months (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>, Table S2).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Western Blot</h3><div class="NLM_p last">Expression of MYC and BCL2 proteins was evaluated in cell line or tumor lysates at basal levels or following treatment with <b>05</b> and/or <b>76</b>. Protein lysates were obtained and assayed for the presence of MYC or BCL2 as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Exceptions include the use of 20 Î¼g of total protein and the antibodies used for BCL2 (mouse, 610538, BD Laboratories) and MYC (rabbit, ab32072, Abcam) detection at 1:1000. Actin (mouse, MAB1501 from Millipore, and rabbit, PA1-183 from Thermo Fisher Scientific) was used as a loading control. Untreated and DMSO-treated cells or tumors were used as experimental controls for comparison.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Real-Time Quantitative PCR</h3><div class="NLM_p last">Total RNA was isolated from the same cell line or tumor preparations as for protein lysates with the Roche High Pure RNA isolation kit. Reverse transcription and real-time quantitative PCR (qPCR) were performed using the Bio-Rad iScript kit and the Bio-Rad Probe Supermix, respectively, on the Bio-Rad CFX1000 Touch thermal cycler. All kits were used according to the manufacturerâs protocol. The <i>C</i><sub>t</sub> values obtained were normalized to TBP (TATA-binding protein) and compared to the untreated controls. TaqMan probes were used for <i>BCL2</i> (Hs00608023_m1), <i>MYC</i> (Hs00153408_m1), and <i>TBP</i> (Hs00427620_m1).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Dual ISH Assays</h3><div class="NLM_p last">The <i>BCL2</i> and <i>MYC</i> dual ISH probes were previously designed by Ventana Medical Systems, Inc. (VMSI) (Tucson, AZ). The dual ISH assays were performed on a VENTANA BenchMark ULTRA automated staining system in collaboration with VMSI as previously described.<a onclick="showRef(event, 'ref20 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref28">(20, 42)</a> Cell lines were pelleted and placed into a paraffin block (Tissue Acquisition and Cellular/Molecular Analysis Shared Resource, University of Arizona), and 4 Î¼m cuts were subjected to either the <i>BCL2</i> break-apart, <i>BCL2</i> amplification, or <i>MYC</i> amplification assay. Stained sections were viewed using an Olympus BX-61 microscope system (Olympus America Inc., Center Valley, PA) at 60Ã magnification (Plan Fluor, Nikon Instruments Inc., Melville, NY). Images were captured with a Nikon DS-Fil digital CCD camera and DS-L2 imaging controller (Nikon). On the basis of previously published guidelines, cell lines were scored translocation positive (+) if at least 15% of cells within a 20-informative-cell count displayed distinctly separate black (DNP, 5â²-end of <i>BCL2</i>) and red (DIG, 3â²-end of <i>BCL2</i>) signals.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The FISH assays to detect <i>MYC</i> translocation were performed at the Mayo Cytogenetics Core, as a <i>MYC</i> translocation CISH probe set is unavailable at this time (Rochester, MN).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Immunohistochemistry Staining and Evaluation</h3><div class="NLM_p last">Paraffin slides were prepared from blocks cut at 4 Î¼m and stained using a VENTANA BenchMark XT instrument. The primary antibodies VMSI Clone SP66 (rabbit, 790-4604) and Epitomics Clone Y69 (rabbit, 1472-1) were used to detect BCL2 and MYC following previous protocols.<a onclick="showRef(event, 'ref20 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref28">(20, 42)</a> Briefly, the BCL2 antibody was used as supplied and incubated for 32 min at 37 Â°C while the MYC antibody was used at a 1:50 dilution and incubated for 36 min. Protein was detected with an OptiView DAB Detection Kit (760-700, VMSI). All slides were counterstained with hematoxylin for 4 min. Cut-offs for positivity were at least 30% of cells (within a 100 cell count) with moderate to strong DAB brown staining for BCL2 and 40% of cells with any DAB brown staining for MYC, as previously described.<a onclick="showRef(event, 'ref20 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref28">(20, 42)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cytotoxicity Assay</h3><div class="NLM_p last">The percent cell viability of the cell lines was determined by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) colorimetric assay as per the manufacturerâs protocol (Promega). In brief, 100â¯000 cells were set and incubated with the compounds alone or in combination for 96 h. The IC<sub>50</sub> values were calculated using the Boltzmann-sigmoidal equation with variable slope in the GraphPad Prism software version 6 (GraphPad Software).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Caspase-3 Activity Assay</h3><div class="NLM_p last">Caspase-3 activity was measured by the ApoAlert Caspase-3 plate-based or reagent-based assay (Clontech) as per the manufacturerâs specifications.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Xenograft SCID Mouse Study</h3><div class="NLM_p last">The in vivo studies were performed by The University of Arizona Cancer Center Experimental Mouse Shared Resource according to the American Association for Laboratory Animal Care guidelines under protocols approved by the University of Arizona Institutional Animal Care and Use Committee and those published by the National Institutes of Health (NIH publication no. 85-23, revised 1985). Mice were housed in microisolater cages (Allentown Caging Equipment Co.) and maintained under specific pathogen-free conditions. The mice ate NIH31 irradiated pellets (Tekland Premier) and drank autoclaved water. Mice were screened each month by ELISA serology for mycoplasma, mouse hepatitis virus, pinworms, and Sendai virus. In-house female or male mice 6â8 weeks of age were bled (50 Î¼L) by cheek pouch puncture to determine mice immunoglobulin levels using ELISA, and mice with levels â¤20 Î¼g/mL were used. SCID mice (<i>n</i> = 8 per treatment group) were injected with U2932 diffuse large B-cell lymphoma cells (10 Ã 10<sup>6</sup> cells/100 Î¼L sterile saline, mycoplasma free, viability >91%) subcutaneously in the left flank. <b>76</b> and/or <b>05</b> in the absence or presence of CPA was administered by intraperitoneal injection every day for a total of 5 days. The control group received all three compound diluents, and the groups receiving two compounds concurrently also were administered the diluent of the absent compound. As tumors developed, subcutaneous tumors were measured for tumor volume estimation (cm<sup>3</sup> or mm<sup>3</sup>) in accordance with the formula <i>a</i>2 Ã <i>b</i>/2, where <i>a</i> equals the smallest diameter and <i>b</i> is the largest diameter. The mice were pair-matched into the different control and drug groups by sorting the mice evenly based on tumor volume measurement. The Grubbsâ (maximum normed residual test) was used to detect outliers in each treatment group. Two outliers from the initial study with <b>05</b> and CPA only were found and excluded (<i>n</i> = 1 per group; CPA+<b>05</b> 2.5 mg/kg and CPA+<b>05</b> 5.0 mg/kg).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Statistical Analysis</h3><div class="NLM_p last">Statistical analyses were performed with GraphPad Prism software version 6 (GraphPad Software). Significance (<i>P</i> < 0.05) was evaluated using a two-tailed Studentâs <i>t</i> test unless multiple testing occurred, and then the Å Ã­dÃ¡kâBonferroni correction for multiple comparisons was applied. Significance was considered at <i>P</i> â¤ 0.006 for CPA only comparisons to the nine possible combination treatments or <i>P</i> â¤ 0.03 for the CPA+<b>76</b> or CPA+<b>05</b> to the triple combination in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, and at <i>P</i> â¤ 0.02 for CPA only comparisons to the three possible combination treatments in <a class="ref internalNav" href="#fig4" aria-label="Figures 4">Figures 4</a>B and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Data are represented as mean Â± standard error from at least three independent experiments.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00298">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00298" class="ext-link">10.1021/acs.jmedchem.7b00298</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures showing in situ hybridization characterization of the DLBCL cells for <i>MYC</i> and <i>BCL2</i> translocations and gene amplification; cell viability MTS curves; qPCR data for <i>MYC</i> expression following 6 h treatment with <b>05</b>; qPCR data for <i>MYC</i> and <i>BCL2</i>; mean mouse weight, survival curves, qPCR, Western blot data from in vivo studies; and purity determination of the compunds and tables summarizing the IC<sub>50</sub> of <b>05</b> and <b>76</b> and STR data for authentication of DLBCL cell lines (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf">jm7b00298_si_001.pdf (5.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_002.csv">jm7b00298_si_002.csv (0.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00298" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Kendrick</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7782-7415" title="Orcid link">http://orcid.org/0000-0002-7782-7415</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#15797476677a7c6d66557078747c793b74677c6f7a7b743b707160"><span class="__cf_email__" data-cfemail="e78b868495888e9f94a7828a868e8bc986958e9d888986c9828392">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Muranyi</span> - <span class="hlFld-Affiliation affiliation">Ventana
Medical Systems, Inc., 1910 Innovation Park Drive, Tucson, Arizona 85755, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Gokhale</span> - <span class="hlFld-Affiliation affiliation">BIO5
Institute, University of Arizona, 1657 East Helen Street, Tucson, Arizona 85721, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence H. Hurley</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, Arizona 85721, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8522-450X" title="Orcid link">http://orcid.org/0000-0002-8522-450X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa M. Rimsza</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.K. designed and performed all the experiments, except for the dual-chromogenic ISH and FISH assays, analyzed and interpreted data, and drafted the manuscript. A.M. performed the dual-chromogenic ISH assays and edited the manuscript. V.G. and L.H.H. synthesized compound 05, contributed to data interpretation, and edited the manuscript. L.M.R. supervised the research, contributed to data interpretation, and edited the manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A.M. is an employee of Ventana Medical Systems, V.G. and L.H.H. have equity ownership in Reglagene. All other authors declare no potential conflicts of interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d264e2009-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">S.K. was supported by a Lymphoma Research Foundation Post-Doctoral Fellowship (2558183). The University of Arizona Experimental Mouse Shared Resource is supported by the National Institutes of Health (NIH) Cancer Center Support Grant (P30 CA023074). We thank the Mayo Cytogenetics Core, Director Patricia T. Greipp, D.O., and the individual technologists Darlene Knutson, Sara Kloft-Nelson, and Ryan Knudson for performing the FISH analysis. We thank David Bishop, Project Coordinator for L.H.H., for proofreading and editing the final version of the manuscript and figures.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">BCL2</td><td class="NLM_def"><p class="first last">B-cell lymphoma gene-2</p></td></tr><tr><td class="NLM_term">ChIP</td><td class="NLM_def"><p class="first last">chromatin immunoprecipitation</p></td></tr><tr><td class="NLM_term">CPA</td><td class="NLM_def"><p class="first last">cyclophosphamide</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">FISH</td><td class="NLM_def"><p class="first last">fluorescent in situ hybridization</p></td></tr><tr><td class="NLM_term">ISH</td><td class="NLM_def"><p class="first last">in situ hybridization</p></td></tr><tr><td class="NLM_term">MTS</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium</p></td></tr><tr><td class="NLM_term">MYC</td><td class="NLM_def"><p class="first last">cellular myelocytomatosis</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficient</p></td></tr><tr><td class="NLM_term">TBP</td><td class="NLM_def"><p class="first last">TATA-binding protein</p></td></tr><tr><td class="NLM_term">qPCR</td><td class="NLM_def"><p class="first last">quantitative PCR</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Williamson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghuraman, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cech, T. R.</span><span> </span><span class="NLM_article-title">Monovalent cation-induced structure of telomeric DNA: the G-quartet model</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">â</span> <span class="NLM_lpage">880</span><span class="refDoi">Â DOI: 10.1016/0092-8674(89)90610-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2F0092-8674%2889%2990610-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=2590943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFCgsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1989&pages=871-880&author=J.+R.+Williamsonauthor=M.+K.+Raghuramanauthor=T.+R.+Cech&title=Monovalent+cation-induced+structure+of+telomeric+DNA%3A+the+G-quartet+model&doi=10.1016%2F0092-8674%2889%2990610-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Monovalent cation-induced structure of telomeric DNA:  the G-quartet model</span></div><div class="casAuthors">Williamson, James R.; Raghuraman, M. K.; Cech, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">871-80</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Structures formed by oligonucleotides composed of 2 or 4 repeats of the telomeric sequences from Oxytricha and Tetrahymena were investigated.  The Oxytricha 4-repeat mol. [d(T4G4)4 = Oxy-4] forms structures with increased electrophoretic mobility in nondenaturing gels contg. Na+, K+, or Cs+, but not in gels contg. Li+ or no added salt.  Formation of the folded structure results in protection of a set of dG's from methylation by di-Me sulfate.  Efficient UV-induced crosslinks are obsd. in Oxy-4 and the related sequence from Tetrahymena [d(T2G4)4 = Tet-4], and join thymidines in different repeats.  Models proposed to account for these data involve G-quartets, H-bonded structures formed from 4 guanosines in a square-planar array.  It is proposed that the G-quartet structure must be dealt with in vivo by the telomere replication machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogp-GTQAD5FbVg90H21EOLACvtfcHk0lgT9QOIdn90PQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFCgsLo%253D&md5=6a86541fc934bcd72b517b75e2dda57b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2889%2990610-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252889%252990610-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%2BR.%26aulast%3DRaghuraman%26aufirst%3DM.%2BK.%26aulast%3DCech%26aufirst%3DT.%2BR.%26atitle%3DMonovalent%2520cation-induced%2520structure%2520of%2520telomeric%2520DNA%253A%2520the%2520G-quartet%2520model%26jtitle%3DCell%26date%3D1989%26volume%3D59%26spage%3D871%26epage%3D880%26doi%3D10.1016%2F0092-8674%2889%2990610-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Leroy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueron, M.</span><span> </span><span class="NLM_article-title">Acid multimers of oligodeoxycytidine strands: stoichiometry, base-pair characterization, and proton exchange properties</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">6019</span><span class="NLM_x">â</span> <span class="NLM_lpage">6031</span><span class="refDoi">Â DOI: 10.1021/bi00074a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00074a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADyaK3sXkvV2itr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=6019-6031&author=J.+L.+Leroyauthor=K.+Gehringauthor=A.+Kettaniauthor=M.+Gueron&title=Acid+multimers+of+oligodeoxycytidine+strands%3A+stoichiometry%2C+base-pair+characterization%2C+and+proton+exchange+properties&doi=10.1021%2Fbi00074a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Acid multimers of oligodeoxycytidine strands: Stoichiometry, base-pair characterization, and proton exchange properties</span></div><div class="casAuthors">Leroy, Jean Louis; Gehring, Kalle; Kettani, Abdelali; Gueron, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6019-31</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The structure recently proposed for the acid form of the oligonucleotide 5'-d(TC5) is a four-strand tetrad in which two parallel-stranded, base-paired duplexes are intimately assocd., with their hemiprotonated CÂ·C+ base pairs face-to-face and fully intercalated, in a so-called i-motif (K. Gehring et al., 1993).  The amino and imino proton spectra were used to establish the structure and symmetry of the base pairs, properties which are a primary element in the resoln. of the acid form described above.  The amino proton spectrum gives the best lower limit (8 Ã 104 s-1) on the rate of the imino proton jumping process which is responsible for the base-pair symmetry.  The stoichiometry of the acid form of other deoxycytidine sequences is studied by gel filtration chromatog. and in one case by an NMR equil. titrn.  In all cases, i.e., d(C12), d(T2C8T2), d(C4TC4), d(TC5), d(C5), d(C4), d(TC4), d(TC3T), and d(TC3), the acid form elutes as a tetramer.  A single-strand component is also present in some cases.  But no dimer is obsd., except for some samples prepd. by quenching from high temps.  The characteristic H1'-H' interresidue NOESY cross-peaks of the d(TC5) structure (K. Gerhring et al., 1992) are also found in all the tetramers where they have been searched for, i.e., those of d(T2C8T2), d(C4TC4), d(TC3T), and d(TC3) (not shown), suggesting that these tetramers also are built on the i-motif and that such structures may be formed generally by strands contg. a stretch of as little as three deoxycytidines.  From the NMR titrn. of d(TC3), a free energy of -7.6 kJ/mol per cytidine base pair was derived for the formation of the tetramer from single strands.  The free energy released by packing a base pair into the i-motif is comparable to that released in forming the base pair itself.  Imino proton exchange is limited by base-pair opening, thanks to efficient intrinsic exchange catalysis: this explains the lack of effect of added catalysts.  The base-pair lifetime is hundreds of times longer than in any DNA duplex, presumably due to the base-pair intercalation geometry.  The variation of the lifetime along the sequence of the d(TC5) tetramer provides support for the recently proposed structure.  The internal amino proton exchanges from the open state of the CÂ·C+ pair, at a rate compatible with a pK of 9 appropriate for C+.  But the external proton exchanges from the closed state, as with a pK of 17!  Comparable pK shifts occur upon transfer of org. acids from an aq. to an org. solvent.  It is also shown that exchange of the internal amino proton is opening-limited, even though it is eight times slower than imino proton exchange.  The lifetime of the open state is at least 1 Î¼s, 100 times longer than in duplexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwdkqnUe73bVg90H21EOLACvtfcHk0lh38DhVO5fx9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvV2itr0%253D&md5=37cfaa5a5b354831bbe34f06e27defbc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fbi00074a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00074a013%26sid%3Dliteratum%253Aachs%26aulast%3DLeroy%26aufirst%3DJ.%2BL.%26aulast%3DGehring%26aufirst%3DK.%26aulast%3DKettani%26aufirst%3DA.%26aulast%3DGueron%26aufirst%3DM.%26atitle%3DAcid%2520multimers%2520of%2520oligodeoxycytidine%2520strands%253A%2520stoichiometry%252C%2520base-pair%2520characterization%252C%2520and%2520proton%2520exchange%2520properties%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D6019%26epage%3D6031%26doi%3D10.1021%2Fbi00074a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Huppert, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span> </span><span class="NLM_article-title">G-quadruplexes in promoters throughout the human genome</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">â</span> <span class="NLM_lpage">413</span><span class="refDoi">Â DOI: 10.1093/nar/gkl1057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1093%2Fnar%2Fgkl1057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=17169996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=406-413&author=J.+L.+Huppertauthor=S.+Balasubramanian&title=G-quadruplexes+in+promoters+throughout+the+human+genome&doi=10.1093%2Fnar%2Fgkl1057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes in promoters throughout the human genome</span></div><div class="casAuthors">Huppert, Julian L.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Certain G-rich DNA sequences readily form four-stranded structures called G-quadruplexes.  These sequence motifs are located in telomeres as a repeated unit, and elsewhere in the genome, where their function is currently unknown.  It has been proposed that G-quadruplexes may be directly involved in gene regulation at the level of transcription.  In support of this hypothesis, we show that the promoter regions (1 kb upstream of the transcription start site TSS) of genes are significantly enriched in quadruplex motifs relative to the rest of the genome, with >40% of human gene promoters contg. one or more quadruplex motif.  Furthermore, these promoter quadruplexes strongly assoc. with nuclease hypersensitive sites identified throughout the genome via biochem. measurement.  Regions of the human genome that are both nuclease hypersensitive and within promoters show a remarkable (230-fold) enrichment of quadruplex elements, compared to the rest of the genome.  These quadruplex motifs identified in promoter regions also show an interesting structural bias towards more stable forms.  These observations support the proposal that promoter G-quadruplexes are directly involved in the regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaKOSq_qjKrVg90H21EOLACvtfcHk0lh38DhVO5fx9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D&md5=626903207653e1c97d568b9b50c093bd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl1057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl1057%26sid%3Dliteratum%253Aachs%26aulast%3DHuppert%26aufirst%3DJ.%2BL.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplexes%2520in%2520promoters%2520throughout%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D406%26epage%3D413%26doi%3D10.1093%2Fnar%2Fgkl1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Eddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maizels, N.</span><span> </span><span class="NLM_article-title">Gene function correlates with potential for G4 DNA formation in the human genome</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3887</span><span class="NLM_x">â</span> <span class="NLM_lpage">3896</span><span class="refDoi">Â DOI: 10.1093/nar/gkl529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1093%2Fnar%2Fgkl529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=16914419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1yis7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=3887-3896&author=J.+Eddyauthor=N.+Maizels&title=Gene+function+correlates+with+potential+for+G4+DNA+formation+in+the+human+genome&doi=10.1093%2Fnar%2Fgkl529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Gene function correlates with potential for G4 DNA formation in the human genome</span></div><div class="casAuthors">Eddy, Johanna; Maizels, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3887-3896</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">G-rich genomic regions can form G4 DNA upon transcription or replication.  We have quantified the potential for G4 DNA formation (G4P) of the 16 654 genes in the human RefSeq database, and then correlated gene function with G4P.  We have found that very low and very high G4P correlates with specific functional classes of genes.  Notably, tumor suppressor genes have very low G4P and proto-oncogenes have very high G4P.  G4P of these genes is evenly distributed between exons and introns, and it does not reflect enrichment for CpG islands or local chromosomal environment.  These results show that genomic structure undergoes selection based on gene function.  Selection based on G4P could promote genomic stability (or instability) of specific classes of genes; or reflect mechanisms for global regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPf7ajy8A2MLVg90H21EOLACvtfcHk0lh38DhVO5fx9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1yis7o%253D&md5=c5da07ec9e667a0fbb1843159e773eb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl529%26sid%3Dliteratum%253Aachs%26aulast%3DEddy%26aufirst%3DJ.%26aulast%3DMaizels%26aufirst%3DN.%26atitle%3DGene%2520function%2520correlates%2520with%2520potential%2520for%2520G4%2520DNA%2520formation%2520in%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D3887%26epage%3D3896%26doi%3D10.1093%2Fnar%2Fgkl529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span> </span><span class="NLM_article-title">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span><span class="refDoi">Â DOI: 10.1038/nrd3428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnrd3428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=21455236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=261-275&author=S.+Balasubramanianauthor=L.+H.+Hurleyauthor=S.+Neidle&title=Targeting+G-quadruplexes+in+gene+promoters%3A+a+novel+anticancer+strategy%3F&doi=10.1038%2Fnrd3428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span></div><div class="casAuthors">Balasubramanian, Shankar; Hurley, Laurence H.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-275</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-quadruplexes are four-stranded DNA structures that are over-represented in gene promoter regions and are viewed as emerging therapeutic targets in oncol., as transcriptional repression of oncogenes through stabilization of these structures could be a novel anticancer strategy.  Many gene promoter G-quadruplexes have physicochem. properties and structural characteristics that might make them druggable, and their structural diversity suggests that a high degree of selectivity might be possible.  Here, we describe the evidence for G-quadruplexes in gene promoters and discuss their potential as therapeutic targets, as well as progress in the development of strategies to harness this potential through intervention with small-mol. ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk0ePjfQEBk7Vg90H21EOLACvtfcHk0lh38DhVO5fx9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D&md5=b3ea27635da9d1ff72d60228f1ef6d76</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3428%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520G-quadruplexes%2520in%2520gene%2520promoters%253A%2520a%2520novel%2520anticancer%2520strategy%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D261%26epage%3D275%26doi%3D10.1038%2Fnrd3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hansel-Hertsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Antonio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span> </span><span class="NLM_article-title">DNA G-quadruplexes in the human genome: detection, functions, and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">â</span> <span class="NLM_lpage">284</span><span class="refDoi">Â DOI: 10.1038/nrm.2017.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnrm.2017.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=28225080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1agsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=279-284&author=R.+Hansel-Hertschauthor=M.+Di+Antonioauthor=S.+Balasubramanian&title=DNA+G-quadruplexes+in+the+human+genome%3A+detection%2C+functions%2C+and+therapeutic+potential&doi=10.1038%2Fnrm.2017.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential</span></div><div class="casAuthors">Hansel-Hertsch, Robert; Di Antonio, Marco; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">279-284</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Single-stranded guanine-rich DNA sequences can fold into four-stranded DNA structures called G-quadruplexes (G4s) that arise from the self-stacking of two or more guanine quartets.  There has been considerable recent progress in the detection and mapping of G4 structures in the human genome and in biol. relevant contexts.  These advancements, many of which align with predictions made previously in computational studies, provide important new insights into the functions of G4 structures in, for example, the regulation of transcription and genome stability, and uncover their potential relevance for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojysTqYKqZi7Vg90H21EOLACvtfcHk0liLVvUWXjb8WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1agsr0%253D&md5=452d13815a3284a4ca51607d1522fb5f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2017.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2017.3%26sid%3Dliteratum%253Aachs%26aulast%3DHansel-Hertsch%26aufirst%3DR.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DDNA%2520G-quadruplexes%2520in%2520the%2520human%2520genome%253A%2520detection%252C%2520functions%252C%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D18%26spage%3D279%26epage%3D284%26doi%3D10.1038%2Fnrm.2017.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hansel-Hertsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beraldi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensing, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zyner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Antonio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannahill, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span> </span><span class="NLM_article-title">G-quadruplex structures mark human regulatory chromatin</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">â</span> <span class="NLM_lpage">1272</span><span class="refDoi">Â DOI: 10.1038/ng.3662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fng.3662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=27618450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=1267-1272&author=R.+Hansel-Hertschauthor=D.+Beraldiauthor=S.+V.+Lensingauthor=G.+Marsicoauthor=K.+Zynerauthor=A.+Parryauthor=M.+Di+Antonioauthor=J.+Pikeauthor=H.+Kimuraauthor=M.+Naritaauthor=D.+Tannahillauthor=S.+Balasubramanian&title=G-quadruplex+structures+mark+human+regulatory+chromatin&doi=10.1038%2Fng.3662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplex structures mark human regulatory chromatin</span></div><div class="casAuthors">Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Di Antonio, Marco; Pike, Jeremy; Kimura, Hiroshi; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1267-1272</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G-quadruplex (G4) structural motifs have been linked to transcription, replication and genome instability and are implicated in cancer and other diseases.  However, it is crucial to demonstrate the bona fide formation of G4 structures within an endogenous chromatin context.  Herein we address this through the development of G4 ChIP-seq, an antibody-based G4 chromatin immunopptn. and high-throughput sequencing approach.  We find â¼10,000 G4 structures in human chromatin, predominantly in regulatory, nucleosome-depleted regions.  G4 structures are enriched in the promoters and 5' UTRs of highly transcribed genes, particularly in genes related to cancer and in somatic copy no. amplifications, such as MYC.  Strikingly, de novo and enhanced G4 formation are assocd. with increased transcriptional activity, as shown by HDAC inhibitor-induced chromatin relaxation and obsd. in immortalized as compared to normal cellular states.  Our findings show that regulatory, nucleosome-depleted chromatin and elevated transcription shape the endogenous human G4 DNA landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo8vsZd_UZLVg90H21EOLACvtfcHk0liLVvUWXjb8WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP&md5=898d19559a9ccbc0ff468558a653fc43</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng.3662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3662%26sid%3Dliteratum%253Aachs%26aulast%3DHansel-Hertsch%26aufirst%3DR.%26aulast%3DBeraldi%26aufirst%3DD.%26aulast%3DLensing%26aufirst%3DS.%2BV.%26aulast%3DMarsico%26aufirst%3DG.%26aulast%3DZyner%26aufirst%3DK.%26aulast%3DParry%26aufirst%3DA.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DPike%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplex%2520structures%2520mark%2520human%2520regulatory%2520chromatin%26jtitle%3DNat.%2520Genet.%26date%3D2016%26volume%3D48%26spage%3D1267%26epage%3D1272%26doi%3D10.1038%2Fng.3662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The i-motif in the <i>bcl-2</i> P1 promoter forms an unexpectedly stable structure with a unique 8:6:7 loop folding pattern</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">17667</span><span class="NLM_x">â</span> <span class="NLM_lpage">17676</span><span class="refDoi">Â DOI: 10.1021/ja9076292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9076292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17667-17676&author=S.+Kendrickauthor=Y.+Akiyamaauthor=S.+M.+Hechtauthor=L.+H.+Hurley&title=The+i-motif+in+the+bcl-2+P1+promoter+forms+an+unexpectedly+stable+structure+with+a+unique+8%3A6%3A7+loop+folding+pattern&doi=10.1021%2Fja9076292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fja9076292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9076292%26sid%3Dliteratum%253Aachs%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DY.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520i-motif%2520in%2520the%2520bcl-2%2520P1%2520promoter%2520forms%2520an%2520unexpectedly%2520stable%2520structure%2520with%2520a%2520unique%25208%253A6%253A7%2520loop%2520folding%2520pattern%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17667%26epage%3D17676%26doi%3D10.1021%2Fja9076292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11593</span><span class="NLM_x">â</span> <span class="NLM_lpage">11598</span><span class="refDoi">Â DOI: 10.1073/pnas.182256799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1073%2Fpnas.182256799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=12195017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11593-11598&author=A.+Siddiqui-Jainauthor=C.+L.+Grandauthor=D.+J.+Bearssauthor=L.+H.+Hurley&title=Direct+evidence+for+a+G-quadruplex+in+a+promoter+region+and+its+targeting+with+a+small+molecule+to+repress+c-MYC+transcription&doi=10.1073%2Fpnas.182256799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Grand, Cory L.; Bearss, David J.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11593-11598</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The nuclease hypersensitivity element III1 upstream of the P1 promoter of c-MYC controls 85-90% of the transcriptional activation of this gene.  We have demonstrated that the purine-rich strand of the DNA in this region can form two different intramol. G-quadruplex structures, only one of which seems to be biol. relevant.  This biol. relevant structure is the kinetically favored chairform G-quadruplex, which is destabilized when mutated with a single G â A transition, resulting in a 3-fold increase in basal transcriptional activity of the c-MYC promoter.  The cationic porphyrin TMPyP4, which has been shown to stabilize this G-quadruplex structure, is able to suppress further c-MYC transcriptional activation.  These results provide compelling evidence that a specific G-quadruplex structure formed in the c-MYC promoter region functions as a transcriptional repressor element.  Furthermore, we establish the principle that c-MYC transcription can be controlled by ligand-mediated G-quadruplex stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMKd0v3rpM7Vg90H21EOLACvtfcHk0lht1Zomtkwq1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D&md5=5f2767891816e2364405e1a4b37eba48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.182256799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.182256799%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DGrand%26aufirst%3DC.%2BL.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DDirect%2520evidence%2520for%2520a%2520G-quadruplex%2520in%2520a%2520promoter%2520region%2520and%2520its%2520targeting%2520with%2520a%2520small%2520molecule%2520to%2520repress%2520c-MYC%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11593%26epage%3D11598%26doi%3D10.1073%2Fpnas.182256799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Phan, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span> </span><span class="NLM_article-title">Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">8710</span><span class="NLM_x">â</span> <span class="NLM_lpage">8716</span><span class="refDoi">Â DOI: 10.1021/ja048805k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja048805k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFKrsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=8710-8716&author=A.+T.+Phanauthor=Y.+S.+Modiauthor=D.+J.+Patel&title=Propeller-type+parallel-stranded+G-quadruplexes+in+the+human+c-myc+promoter&doi=10.1021%2Fja048805k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Propeller-Type Parallel-Stranded G-Quadruplexes in the Human c-myc Promoter</span></div><div class="casAuthors">Phan, Anh Tuan; Modi, Yasha S.; Patel, Dinshaw J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8710-8716</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nuclease-hypersensitivity element III1 in the c-myc promoter is a good anticancer target since it largely controls transcriptional activation of the important c-myc oncogene.  Recently, the guanine-rich strand of this element has been shown to form an equil. between G-quadruplex structures built from two different sets of G-stretches; two models of intramol. fold-back antiparallel-stranded G-quadruplexes, called "basket" and "chair" forms, were proposed.  Here, the authors show by NMR that two sequences contg. these two sets of G-stretches form intramol. propeller-type parallel-stranded G-quadruplexes in K+-contg. soln.  The two structures involve a core of three stacked G-tetrads formed by four parallel G-stretches with all anti guanines and three double-chain-reversal loops bridging three G-tetrad layers.  The central loop contains two or six residues, while the two other loops contain only one residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6kPTTc-vQbVg90H21EOLACvtfcHk0lht1Zomtkwq1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFKrsrs%253D&md5=715526a31f0807bfd3698cb89b5d0861</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fja048805k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja048805k%26sid%3Dliteratum%253Aachs%26aulast%3DPhan%26aufirst%3DA.%2BT.%26aulast%3DModi%26aufirst%3DY.%2BS.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DPropeller-type%2520parallel-stranded%2520G-quadruplexes%2520in%2520the%2520human%2520c-myc%2520promoter%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D8710%26epage%3D8716%26doi%3D10.1021%2Fja048805k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ambrus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span> </span><span class="NLM_article-title">Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2048</span><span class="NLM_x">â</span> <span class="NLM_lpage">2058</span><span class="refDoi">Â DOI: 10.1021/bi048242p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi048242p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFaitQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=2048-2058&author=A.+Ambrusauthor=D.+Chenauthor=J.+Daiauthor=R.+A.+Jonesauthor=D.+Yang&title=Solution+structure+of+the+biologically+relevant+G-quadruplex+element+in+the+human+c-MYC+promoter.+Implications+for+G-quadruplex+stabilization&doi=10.1021%2Fbi048242p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Solution Structure of the Biologically Relevant G-Quadruplex Element in the Human c-MYC Promoter. Implications for G-Quadruplex Stabilization</span></div><div class="casAuthors">Ambrus, Attila; Chen, Ding; Dai, Jixun; Jones, Roger A.; Yang, Danzhou</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2048-2058</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nuclease hypersensitivity element III1 (NHE III1) of the c-MYC promoter strongly controls the transcriptional activity of the c-MYC oncogene.  The purine-rich strand of the NHE III1 element has been shown to be a silencer element for c-MYC transcription upon formation of a G-quadruplex structure.  We have detd. the predominant G-quadruplex structure of this silencer element in potassium soln. by NMR.  The G-quadruplex structure adopts an intramol. parallel-stranded quadruplex conformation with three guanine tetrads and three side loops, including two single-nucleotide side loops and one double-nucleotide side loop, that connect the four guanine strands.  The three side loops are very stable and well-defined.  The 3'-flanking sequence forms a stable fold-back stacking conformation capping the top end of the G-quadruplex structure.  The 5'-flanking A and G bases cap the bottom end of the G-quadruplex, with the adenine stacking very well with the bottom tetrad.  This paper reports the first soln. structure of a G-quadruplex found to form in the promoter region of an oncogene (c-MYC).  This G-quadruplex structure is extremely stable, with a similar melting temp. (>85Â°) to that of the wild-type 27-mer purine-rich NHE III1 sequence of the c-MYC promoter.  This predominant quadruplex structure has been shown to be biol. relevant, and the structural information revealed in this research provides an important basis for the design of new drug candidates that specifically target the c-MYC G-quadruplex structure and modulate gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgsHMKbDZc7Vg90H21EOLACvtfcHk0lht1Zomtkwq1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFaitQ%253D%253D&md5=98bed86094bf0d91e5cceb01d1d38304</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi048242p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048242p%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrus%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BA.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DSolution%2520structure%2520of%2520the%2520biologically%2520relevant%2520G-quadruplex%2520element%2520in%2520the%2520human%2520c-MYC%2520promoter.%2520Implications%2520for%2520G-quadruplex%2520stabilization%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D2048%26epage%3D2058%26doi%3D10.1021%2Fbi048242p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuohe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichsel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuillet, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montfort, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III<sub>1</sub></span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">â</span> <span class="NLM_lpage">1377</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-08-1093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1158%2F1535-7163.MCT-08-1093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=19435876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1363-1377&author=T.+S.+Dexheimerauthor=S.+S.+Careyauthor=S.+Zuoheauthor=V.+M.+Gokhaleauthor=X.+Huauthor=L.+B.+Murataauthor=E.+M.+Maesauthor=A.+Weichselauthor=D.+Sunauthor=E.+J.+Meuilletauthor=W.+R.+Montfortauthor=L.+H.+Hurley&title=NM23-H2+may+play+an+indirect+role+in+transcriptional+activation+of+c-myc+gene+expression+but+does+not+cleave+the+nuclease+hypersensitive+element+III1&doi=10.1158%2F1535-7163.MCT-08-1093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1</span></div><div class="casAuthors">Dexheimer, Thomas S.; Carey, Steven S.; Song, Zuohe; Gokhale, Vijay M.; Hu, Xiaohui; Murata, Lauren B.; Maes, Estelle M.; Weichsel, Andrzej; Sun, Daekyu; Meuillet, Emmanuelle J.; Montfort, William R.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1363-1377</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The formation of G-quadruplex structures within the nuclease hypersensitive element (NHE) III1 region of the c-myc promoter and the ability of these structures to repress c-myc transcription have been well established.  However, just how these extremely stable DNA secondary structures are transformed to activate c-myc transcription is still unknown.  NM23-H2/nucleoside disphosphate kinase B has been recognized as an activator of c-myc transcription via interactions with the NHE III1 region of the c-myc gene promoter.  Through the use of RNA interference, we confirmed the transcriptional regulatory role of NM23-H2.  In addn., we find that further purifn. of NM23-H2 results in loss of the previously identified DNA strand cleavage activity, but retention of its DNA binding activity.  NM23-H2 binds to both single-stranded guanine- and cytosine-rich strands of the c-myc NHE III1 and, to a lesser extent, to a random single-stranded DNA template.  However, it does not bind to or cleave the NHE III1 in duplex form.  Significantly, potassium ions and compds. that stabilize the G-quadruplex and i-motif structures have an inhibitory effect on NM23-H2 DNA-binding activity.  Mutation of Arg88 to Ala88 (R88A) reduced both DNA and nucleotide binding but had minimal effect on the NM23-H2 crystal structure.  On the basis of these data and mol. modeling studies, we have proposed a stepwise trapping-out of the NHE III1 region in a single-stranded form, thus allowing single-stranded transcription factors to bind and activate c-myc transcription.  Furthermore, this model provides a rationale for how the stabilization of the G-quadruplex or i-motif structures formed within the c-myc gene promoter region can inhibit NM23-H2 from activating c-myc gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorcY4x6T96eLVg90H21EOLACvtfcHk0ljdysifNZ_Aag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7o%253D&md5=d167d3f600b446c016db741a571abf13</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1093%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DCarey%26aufirst%3DS.%2BS.%26aulast%3DZuohe%26aufirst%3DS.%26aulast%3DGokhale%26aufirst%3DV.%2BM.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DMurata%26aufirst%3DL.%2BB.%26aulast%3DMaes%26aufirst%3DE.%2BM.%26aulast%3DWeichsel%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26aulast%3DMontfort%26aufirst%3DW.%2BR.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DNM23-H2%2520may%2520play%2520an%2520indirect%2520role%2520in%2520transcriptional%2520activation%2520of%2520c-myc%2520gene%2520expression%2520but%2520does%2520not%2520cleave%2520the%2520nuclease%2520hypersensitive%2520element%2520III1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1363%26epage%3D1377%26doi%3D10.1158%2F1535-7163.MCT-08-1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Brown, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danford, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, T. A.</span><span> </span><span class="NLM_article-title">Demonstration that drug-targeted downregulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">41018</span><span class="NLM_x">â</span> <span class="NLM_lpage">41027</span><span class="refDoi">Â DOI: 10.1074/jbc.M111.274720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1074%2Fjbc.M111.274720" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=41018-41027&author=R.+V.+Brownauthor=V.+Gokhaleauthor=L.+H.+Hurleyauthor=F.+L.+Danfordauthor=T.+A.+Brooks&title=Demonstration+that+drug-targeted+downregulation+of+MYC+in+non-Hodgkins+lymphoma+is+directly+mediated+through+the+promoter+G-quadruplex&doi=10.1074%2Fjbc.M111.274720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.274720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.274720%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BV.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DDanford%26aufirst%3DF.%2BL.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26atitle%3DDemonstration%2520that%2520drug-targeted%2520downregulation%2520of%2520MYC%2520in%2520non-Hodgkins%2520lymphoma%2520is%2520directly%2520mediated%2520through%2520the%2520promoter%2520G-quadruplex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D41018%26epage%3D41027%26doi%3D10.1074%2Fjbc.M111.274720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madathil, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">4161</span><span class="NLM_x">â</span> <span class="NLM_lpage">4171</span><span class="refDoi">Â DOI: 10.1021/ja410934b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja410934b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFOhtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4161-4171&author=S.+Kendrickauthor=H.+J.+Kangauthor=M.+P.+Alamauthor=M.+M.+Madathilauthor=P.+Agrawalauthor=V.+Gokhaleauthor=D.+Yangauthor=S.+M.+Hechtauthor=L.+H.+Hurley&title=The+dynamic+character+of+the+BCL2+promoter+i-motif+provides+a+mechanism+for+modulation+of+gene+expression+by+compounds+that+bind+selectively+to+the+alternative+DNA+hairpin+structure&doi=10.1021%2Fja410934b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure</span></div><div class="casAuthors">Kendrick, Samantha; Kang, Hyun-Jin; Alam, Mohammad P.; Madathil, Manikandadas M.; Agrawal, Prashansa; Gokhale, Vijay; Yang, Danzhou; Hecht, Sidney M.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4161-4171</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is generally accepted that DNA predominantly exists in duplex form in cells.  However, under torsional stress imposed by active transcription, DNA can assume nonduplex structures.  The BCL2 promoter region forms two different secondary DNA structures on opposite strands called the G-quadruplex and the i-motif.  The i-motif is a highly dynamic structure that exists in equil. with a flexible hairpin species.  Here we identify a pregnanol deriv. and a class of piperidine derivs. that differentially modulate gene expression by stabilizing either the i-motif or the flexible hairpin species.  Stabilization of the i-motif structure results in significant upregulation of the BCL2 gene and assocd. protein expression; in contrast, stabilization of the flexible hairpin species lowers BCL2 levels.  The BCL2 levels reduced by the hairpin-binding compd. led to chemosensitization to etoposide in both in vitro and in vivo models.  Furthermore, we show antagonism between the two classes of compds. in soln. and in cells.  For the first time, our results demonstrate the principle of small mol. targeting of i-motif structures in vitro and in vivo to modulate gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvtwX3W1cNTbVg90H21EOLACvtfcHk0ljdysifNZ_Aag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFOhtLg%253D&md5=fa217ef832b60ab09959c0ca9eb72983</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja410934b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja410934b%26sid%3Dliteratum%253Aachs%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DAlam%26aufirst%3DM.%2BP.%26aulast%3DMadathil%26aufirst%3DM.%2BM.%26aulast%3DAgrawal%26aufirst%3DP.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520dynamic%2520character%2520of%2520the%2520BCL2%2520promoter%2520i-motif%2520provides%2520a%2520mechanism%2520for%2520modulation%2520of%2520gene%2520expression%2520by%2520compounds%2520that%2520bind%2520selectively%2520to%2520the%2520alternative%2520DNA%2520hairpin%2520structure%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4161%26epage%3D4171%26doi%3D10.1021%2Fja410934b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">4172</span><span class="NLM_x">â</span> <span class="NLM_lpage">4185</span><span class="refDoi">Â DOI: 10.1021/ja4109352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4109352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFOgsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4172-4185&author=H.+J.+Kangauthor=S.+Kendrickauthor=S.+M.+Hechtauthor=L.+H.+Hurley&title=The+transcriptional+complex+between+the+BCL2+i-motif+and+hnRNP+LL+is+a+molecular+switch+for+control+of+gene+expression+that+can+be+modulated+by+small+molecules&doi=10.1021%2Fja4109352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Transcriptional Complex Between the BCL2 i-Motif and hnRNP LL Is a Molecular Switch for Control of Gene Expression That Can Be Modulated by Small Molecules</span></div><div class="casAuthors">Kang, Hyun-Jin; Kendrick, Samantha; Hecht, Sidney M.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4172-4185</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a companion paper (DOI: 10.021/ja410934b) we demonstrate that the C-rich strand of the cis-regulatory element in the BCL2 promoter element is highly dynamic in nature and can form either an i-motif or a flexible hairpin.  Under physiol. conditions these two secondary DNA structures are found in an equil. mixt., which can be shifted by the addn. of small mols. that trap out either the i-motif (IMC-48) or the flexible hairpin (IMC-76).  In cellular expts. we demonstrate that the addn. of these mols. has opposite effects on BCL2 gene expression and furthermore that these effects are antagonistic.  In this contribution we have identified a transcriptional factor that recognizes and binds to the BCL2 i-motif to activate transcription.  The mol. basis for the recognition of the i-motif by hnRNP LL is detd., and we demonstrate that the protein unfolds the i-motif structure to form a stable single-stranded complex.  In subsequent expts. we show that IMC-48 and IMC-76 have opposite, antagonistic effects on the formation of the hnRNP LL-i-motif complex as well as on the transcription factor occupancy at the BCL2 promoter.  For the first time we propose that the i-motif acts as a mol. switch that controls gene expression and that small mols. that target the dynamic equil. of the i-motif and the flexible hairpin can differentially modulate gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCm1zTboqYrVg90H21EOLACvtfcHk0ljliiPXxhr7DA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFOgsLs%253D&md5=6da68941b5392461c7fd2491d538c287</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja4109352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4109352%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520transcriptional%2520complex%2520between%2520the%2520BCL2%2520i-motif%2520and%2520hnRNP%2520LL%2520is%2520a%2520molecular%2520switch%2520for%2520control%2520of%2520gene%2520expression%2520that%2520can%2520be%2520modulated%2520by%2520small%2520molecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4172%26epage%3D4185%26doi%3D10.1021%2Fja4109352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Green, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu-Monette, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadeberg, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourits-Andersen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¸ller, M. B.</span><span> </span><span class="NLM_article-title">Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3460</span><span class="NLM_x">â</span> <span class="NLM_lpage">3467</span><span class="refDoi">Â DOI: 10.1200/JCO.2011.41.4342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1200%2FJCO.2011.41.4342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=22665537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSksrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=3460-3467&author=T.+M.+Greenauthor=K.+H.+Youngauthor=C.+Viscoauthor=Z.+Y.+Xu-Monetteauthor=A.+Oraziauthor=R.+S.+Goauthor=O.+Nielsenauthor=O.+V.+Gadebergauthor=T.+Mourits-Andersenauthor=M.+Frederiksenauthor=L.+M.+Pedersenauthor=M.+B.+M%C3%B8ller&title=Immunohistochemical+double-hit+score+is+a+strong+predictor+of+outcome+in+patients+with+diffuse+large+B-cell+lymphoma+treated+with+rituximab+plus+cyclophosphamide%2C+doxorubicin%2C+vincristine%2C+and+prednisone&doi=10.1200%2FJCO.2011.41.4342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cydophosphamide, doxombicin, vincristine, and prednisone</span></div><div class="casAuthors">Green, Tina Marie; Young, Ken H.; Visco, Carlo; Xu-Monette, Zijun Y.; Orazi, Attilio; Go, Ronald S.; Nielsen, Ole; Gadeberg, Ole V.; Mourits-Andersen, Torben; Frederiksen, Mikael; Pedersen, Lars Moeller; Moeller, Michael Boe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3460-3467</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Approx. 5% of diffuse large B-cell lymphomas (DLBCLs) are double-hit lymphomas (DHLs) with translocations of both MYC and BCL2.  DHLs are characterized by poor outcome.  We tested whether DLBCLs with high expression of MYC protein and BCL2 protein share the clin. features and poor prognosis of DHLs.  Patients and Methods: Paraffin-embedded lymphoma samples from 193 patients with de novo DLBCL who were uniformly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) were studied using immunohistochem. for MYC, BCL2, CD10, BCL6, and MUM1/interferon regulatory factor 4, and fluorescent in situ hybridization (FISH) for MYC and BCL2.  Results: FISH anal. identified DHL in 6% of patients, who showed the expected poor overall survival (OS; P = .002).  On the basis of immunohistochem. MYC and BCL2 expression, a double-hit score (DHS) was assigned to all patients with DLBCL.  The DHS-2 group, defined by high expression of both MYC and BCL2 protein, comprised 29% of the patients.  DHS 2 was significantly assocd. with lower complete response rate (P = .004), shorter OS (P < .001), and shorter progression-free survival (PFS; P < .001).  The highly significant correlation with OS and PFS was maintained in multivariate models that controlled for the International Prognostic Index and the cell-of-origin subtype (OS, P < .001; PFS, P < .001).  DHS was validated in an independent cohort of 116 patients who were treated with R-CHOP.  Conclusion The immunohistochem. DHS defined a large subset of DLBCLs with double-hit biol. and was strongly assocd. with poor outcome in patients treated with R-CHOP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTVpHFuf5h2rVg90H21EOLACvtfcHk0ljliiPXxhr7DA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSksrfJ&md5=16187bdcf5721376a943c7242916c8e2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.41.4342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.41.4342%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DT.%2BM.%26aulast%3DYoung%26aufirst%3DK.%2BH.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DXu-Monette%26aufirst%3DZ.%2BY.%26aulast%3DOrazi%26aufirst%3DA.%26aulast%3DGo%26aufirst%3DR.%2BS.%26aulast%3DNielsen%26aufirst%3DO.%26aulast%3DGadeberg%26aufirst%3DO.%2BV.%26aulast%3DMourits-Andersen%26aufirst%3DT.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DPedersen%26aufirst%3DL.%2BM.%26aulast%3DM%25C3%25B8ller%26aufirst%3DM.%2BB.%26atitle%3DImmunohistochemical%2520double-hit%2520score%2520is%2520a%2520strong%2520predictor%2520of%2520outcome%2520in%2520patients%2520with%2520diffuse%2520large%2520B-cell%2520lymphoma%2520treated%2520with%2520rituximab%2520plus%2520cyclophosphamide%252C%2520doxorubicin%252C%2520vincristine%252C%2520and%2520prednisone%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26spage%3D3460%26epage%3D3467%26doi%3D10.1200%2FJCO.2011.41.4342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Johnson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Neriah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehn, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimsza, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunhoeber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braziel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubbs, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holcroft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span> </span><span class="NLM_article-title">Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3452</span><span class="NLM_x">â</span> <span class="NLM_lpage">3459</span><span class="refDoi">Â DOI: 10.1200/JCO.2011.41.0985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1200%2FJCO.2011.41.0985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=22851565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSksrfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=3452-3459&author=N.+A.+Johnsonauthor=G.+W.+Slackauthor=K.+J.+Savageauthor=J.+M.+Connorsauthor=S.+Ben-Neriahauthor=S.+Rogicauthor=D.+W.+Scottauthor=K.+L.+Tanauthor=C.+Steidlauthor=L.+H.+Sehnauthor=W.+C.+Chanauthor=J.+Iqbalauthor=P.+N.+Meyerauthor=G.+Lenzauthor=G.+Wrightauthor=L.+M.+Rimszaauthor=C.+Valentinoauthor=P.+Brunhoeberauthor=T.+M.+Groganauthor=R.+M.+Brazielauthor=J.+R.+Cookauthor=R.+R.+Tubbsauthor=D.+D.+Weisenburgerauthor=E.+Campoauthor=A.+Rosenwaldauthor=G.+Ottauthor=J.+Delabieauthor=C.+Holcroftauthor=E.+S.+Jaffeauthor=L.+M.+Staudtauthor=R.+D.+Gascoyne&title=Concurrent+expression+of+MYC+and+BCL2+in+diffuse+large+B-cell+lymphoma+treated+with+rituximab+plus+cyclophosphamide%2C+doxorubicin%2C+vincristine%2C+and+prednisone&doi=10.1200%2FJCO.2011.41.0985"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone</span></div><div class="casAuthors">Johnson, Nathalie A.; Slack, Graham W.; Savage, Kerry J.; Connors, Joseph M.; Ben-Neriah, Susana; Rogic, Sanja; Scott, David W.; Tan, King L.; Steidl, Christian; Sehn, Laurie H.; Chan, Wing C.; Iqbal, Javeed; Meyer, Paul N.; Lenz, Georg; Wright, George; Rimsza, Lisa M.; Valentino, Carlo; Brunhoeber, Patrick; Grogan, Thomas M.; Braziel, Rita M.; Cook, James R.; Tubbs, Raymond R.; Weisenburger, Dennis D.; Campo, Elias; Rosenwald, Andreas; Ott, German; Delabie, Jan; Holcroft, Christina; Jaffe, Elaine S.; Staudt, Louis M.; Gascoyne, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3452-3459</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Diffuse large B-cell lymphoma (DLBCL) is curable in 60% of patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).  MYC translocations, with or without BCL2 translocations, have been assocd. with inferior survival in DLBCL.  We investigated whether expression of MYC protein, with or without BCL2 protein expression, could risk-stratify patients at diagnosis.  Patients and Methods We detd. the correlation between presence of MYC and BCL2 proteins by immunohistochem. (IHC) with survival in two independent cohorts of patients with DLBCL treated with R-CHOP.  We further detd. if MYC protein expression correlated with high MYC mRNA and/or presence of MYC translocation.  Results: In the training cohort (n = 167), MYC and BCL2 proteins were detected in 29% and 44% of patients, resp.  Concurrent expression (MYC pos./BCL2 pos.) was present in 21% of patients.  MYC protein correlated with presence of high MYC mRNA and MYC translocation (both P < .001), but the latter was less frequent (both 11%).  MYC protein expression was only assocd. with inferior overall and progression-free survival when BCL2 protein was coexpressed (P < .001).  Importantly, the poor prognostic effect of MYC pos./BCL2 pos. was validated in an independent cohort of 140 patients with DLBCL and remained significant (P < .05) after adjusting for presence of high-risk features in a multivariable model that included elevated international prognostic index score, activated B-cell mol. subtype, and presence of concurrent MYC and BCL2 translocations.  Conclusion: Assessment of MYC and BCL2 expression by IHC represents a robust, rapid, and inexpensive approach to risk-stratify patients with DLBCL at diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQqYAo5rAoXLVg90H21EOLACvtfcHk0ljliiPXxhr7DA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSksrfI&md5=1aa99c2dc3506531c1273d170f0cce56</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.41.0985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.41.0985%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DSlack%26aufirst%3DG.%2BW.%26aulast%3DSavage%26aufirst%3DK.%2BJ.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DBen-Neriah%26aufirst%3DS.%26aulast%3DRogic%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DD.%2BW.%26aulast%3DTan%26aufirst%3DK.%2BL.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DP.%2BN.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DValentino%26aufirst%3DC.%26aulast%3DBrunhoeber%26aufirst%3DP.%26aulast%3DGrogan%26aufirst%3DT.%2BM.%26aulast%3DBraziel%26aufirst%3DR.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BR.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DHolcroft%26aufirst%3DC.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26atitle%3DConcurrent%2520expression%2520of%2520MYC%2520and%2520BCL2%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%2520treated%2520with%2520rituximab%2520plus%2520cyclophosphamide%252C%2520doxorubicin%252C%2520vincristine%252C%2520and%2520prednisone%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26spage%3D3452%26epage%3D3459%26doi%3D10.1200%2FJCO.2011.41.0985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu-Monette, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzankov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanyam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes-Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybkaer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsi, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Krieken, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreri, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Variakojis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piris, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¸ller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. H.</span><span> </span><span class="NLM_article-title">MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from the International DLBCL Rituximab-CHOP Consortium Program</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">4021</span><span class="NLM_x">â</span> <span class="NLM_lpage">4031</span><span class="refDoi">Â DOI: 10.1182/blood-2012-10-460063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1182%2Fblood-2012-10-460063" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2013&pages=4021-4031&author=S.+Huauthor=Z.+Y.+Xu-Monetteauthor=A.+Tzankovauthor=T.+Greenauthor=L.+Wuauthor=A.+Balasubramanyamauthor=W.+M.+Liuauthor=C.+Viscoauthor=Y.+Liauthor=R.+N.+Mirandaauthor=S.+Montes-Morenoauthor=K.+Dybkaerauthor=A.+Chiuauthor=A.+Oraziauthor=Y.+Zuauthor=G.+Bhagatauthor=K.+L.+Richardsauthor=E.+D.+Hsiauthor=W.+W.+Choiauthor=X.+Zhaoauthor=J.+H.+van+Kriekenauthor=Q.+Huangauthor=J.+Huhauthor=W.+Aiauthor=M.+Ponzoniauthor=A.+J.+Ferreriauthor=F.+Zhouauthor=G.+W.+Slackauthor=R.+D.+Gascoyneauthor=M.+Tuauthor=D.+Variakojisauthor=W.+Chenauthor=R.+S.+Goauthor=M.+A.+Pirisauthor=M.+B.+M%C3%B8llerauthor=L.+J.+Medeirosauthor=K.+H.+Young&title=MYC%2FBCL2+protein+coexpression+contributes+to+the+inferior+survival+of+activated+B-cell+subtype+of+diffuse+large+B-cell+lymphoma+and+demonstrates+high-risk+gene+expression+signatures%3A+a+report+from+the+International+DLBCL+Rituximab-CHOP+Consortium+Program&doi=10.1182%2Fblood-2012-10-460063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-10-460063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-10-460063%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DXu-Monette%26aufirst%3DZ.%2BY.%26aulast%3DTzankov%26aufirst%3DA.%26aulast%3DGreen%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBalasubramanyam%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%2BM.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMiranda%26aufirst%3DR.%2BN.%26aulast%3DMontes-Moreno%26aufirst%3DS.%26aulast%3DDybkaer%26aufirst%3DK.%26aulast%3DChiu%26aufirst%3DA.%26aulast%3DOrazi%26aufirst%3DA.%26aulast%3DZu%26aufirst%3DY.%26aulast%3DBhagat%26aufirst%3DG.%26aulast%3DRichards%26aufirst%3DK.%2BL.%26aulast%3DHsi%26aufirst%3DE.%2BD.%26aulast%3DChoi%26aufirst%3DW.%2BW.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3Dvan%2BKrieken%26aufirst%3DJ.%2BH.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHuh%26aufirst%3DJ.%26aulast%3DAi%26aufirst%3DW.%26aulast%3DPonzoni%26aufirst%3DM.%26aulast%3DFerreri%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DSlack%26aufirst%3DG.%2BW.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVariakojis%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGo%26aufirst%3DR.%2BS.%26aulast%3DPiris%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25B8ller%26aufirst%3DM.%2BB.%26aulast%3DMedeiros%26aufirst%3DL.%2BJ.%26aulast%3DYoung%26aufirst%3DK.%2BH.%26atitle%3DMYC%252FBCL2%2520protein%2520coexpression%2520contributes%2520to%2520the%2520inferior%2520survival%2520of%2520activated%2520B-cell%2520subtype%2520of%2520diffuse%2520large%2520B-cell%2520lymphoma%2520and%2520demonstrates%2520high-risk%2520gene%2520expression%2520signatures%253A%2520a%2520report%2520from%2520the%2520International%2520DLBCL%2520Rituximab-CHOP%2520Consortium%2520Program%26jtitle%3DBlood%26date%3D2013%26volume%3D121%26spage%3D4021%26epage%3D4031%26doi%3D10.1182%2Fblood-2012-10-460063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Perry, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarado-Bernal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehn, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bociek, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armitage, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vose, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span> </span><span class="NLM_article-title">MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">391</span><span class="refDoi">Â DOI: 10.1111/bjh.12763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1111%2Fbjh.12763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=24506200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1Wmuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2014&pages=382-391&author=A.+M.+Perryauthor=Y.+Alvarado-Bernalauthor=J.+A.+Lauriniauthor=L.+M.+Smithauthor=G.+W.+Slackauthor=K.+L.+Tanauthor=L.+H.+Sehnauthor=K.+Fuauthor=P.+Aounauthor=T.+C.+Greinerauthor=W.+C.+Chanauthor=P.+J.+Biermanauthor=R.+G.+Bociekauthor=J.+O.+Armitageauthor=J.+M.+Voseauthor=R.+D.+Gascoyneauthor=D.+D.+Weisenburger&title=MYC+and+BCL2+protein+expression+predicts+survival+in+patients+with+diffuse+large+B-cell+lymphoma+treated+with+rituximab&doi=10.1111%2Fbjh.12763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab</span></div><div class="casAuthors">Perry, Anamarija M.; Alvarado-Bernal, Yuridia; Laurini, Javier A.; Smith, Lynette M.; Slack, Graham W.; Tan, King L.; Sehn, Laurie H.; Fu, Kai; Aoun, Patricia; Greiner, Timothy C.; Chan, Wing C.; Bierman, Philip J.; Bociek, Robert G.; Armitage, James O.; Vose, Julie M.; Gascoyne, Randy D.; Weisenburger, Dennis D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">382-391</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease and "double-hit" DLBCL, with both MYC and BCL2 translocations has a poor prognosis.  In this study, the authors investigated whether MYC and BCL2 protein expression in tissue would predict survival in DLBCL.  The study included 106 cases of de novo DLBCL treated with rituximab and cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) or CHOP-like regimens.  The results were validated on an independent cohort of 205 DLBCL patients.  Patients with low expression of BCL2 (â¤30%) and MYC (â¤50%) had the best prognosis, whereas those with high BCL2 (>30%) and MYC (>50%) had the worst outcome.  In multivariate anal., the combination of the BCL2 and MYC was an independent predictor of overall survival (OS) and event-free survival (EFS) (P = 0Â·015 and P = 0Â·005, resp.).  The risk of death was nine times greater for patients with high BCL2 and MYC compared to those with low expression.  High BCL2 and MYC was a strong predictor of poor OS (P < 0Â·001) and EFS (P = 0Â·0017) in patients with the germinal center B-cell (GCB) type, but not in the non-GCB type.  In DLBCL, high co-expression of MYC and BCL2 was an independent predictor of poor survival, and could be used to stratify patients for risk-adapted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8lt2NpbkldrVg90H21EOLACvtfcHk0lhpzCj8SoFRxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Wmuro%253D&md5=eb376732d51fd5bfa877334f817e1561</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fbjh.12763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjh.12763%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DA.%2BM.%26aulast%3DAlvarado-Bernal%26aufirst%3DY.%26aulast%3DLaurini%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DL.%2BM.%26aulast%3DSlack%26aufirst%3DG.%2BW.%26aulast%3DTan%26aufirst%3DK.%2BL.%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DFu%26aufirst%3DK.%26aulast%3DAoun%26aufirst%3DP.%26aulast%3DGreiner%26aufirst%3DT.%2BC.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DBierman%26aufirst%3DP.%2BJ.%26aulast%3DBociek%26aufirst%3DR.%2BG.%26aulast%3DArmitage%26aufirst%3DJ.%2BO.%26aulast%3DVose%26aufirst%3DJ.%2BM.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26atitle%3DMYC%2520and%2520BCL2%2520protein%2520expression%2520predicts%2520survival%2520in%2520patients%2520with%2520diffuse%2520large%2520B-cell%2520lymphoma%2520treated%2520with%2520rituximab%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2014%26volume%3D165%26spage%3D382%26epage%3D391%26doi%3D10.1111%2Fbjh.12763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kendrick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redd, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muranyi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henricksen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanislaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braziel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubbs, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimsza, L. M.</span><span> </span><span class="NLM_article-title">BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2144</span><span class="NLM_x">â</span> <span class="NLM_lpage">2153</span><span class="refDoi">Â DOI: 10.1016/j.humpath.2014.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2Fj.humpath.2014.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=25090918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7bJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2014&pages=2144-2153&author=S.+L.+Kendrickauthor=L.+Reddauthor=A.+Muranyiauthor=L.+A.+Henricksenauthor=S.+Stanislawauthor=L.+M.+Smithauthor=A.+M.+Perryauthor=K.+Fuauthor=D.+D.+Weisenburgerauthor=A.+Rosenwaldauthor=G.+Ottauthor=R.+D.+Gascoyneauthor=E.+S.+Jaffeauthor=E.+Campoauthor=J.+Delabieauthor=R.+M.+Brazielauthor=J.+R.+Cookauthor=R.+R.+Tubbsauthor=L.+M.+Staudtauthor=W.+C.+Chanauthor=C.+Steidlauthor=T.+M.+Groganauthor=L.+M.+Rimsza&title=BCL2+antibodies+targeted+at+different+epitopes+detect+varying+levels+of+protein+expression+and+correlate+with+frequent+gene+amplification+in+diffuse+large+B-cell+lymphoma&doi=10.1016%2Fj.humpath.2014.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma</span></div><div class="casAuthors">Kendrick, Samantha L.; Redd, Lucas; Muranyi, Andrea; Henricksen, Leigh A.; Stanislaw, Stacey; Smith, Lynette M.; Perry, Anamarija M.; Fu, Kai; Weisenburger, Dennis D.; Rosenwald, Andreas; Ott, German; Gascoyne, Randy D.; Jaffe, Elaine S.; Campo, Elias; Delabie, Jan; Braziel, Rita M.; Cook, James R.; Tubbs, Raymond R.; Staudt, Louis M.; Chan, Wing Chung; Steidl, Christian; Grogan, Thomas M.; Rimsza, Lisa M.</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2144-2153</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Patients with aggressive, BCL2 protein-pos. (+) diffuse large B-cell lymphoma (DLBCL) often experience rapid disease progression that is refractory to std. therapy.  However, there is potential for false-neg. staining of BCL2 using the std. monoclonal mouse 124 antibody that hinders the identification of these high-risk DLBCL patients.  Herein, we compare 2 alternative rabbit monoclonal antibodies (E17 and SP66) to the 124 clone in staining for BCL2 in formalin-fixed, paraffin-embedded DLBCL tissues.  Overall, in 2 independent DLBCL cohorts, E17 and SP66 detected BCL2 expression more frequently than 124.  In the context of MYC expression, cases identified as BCL2 (+) with SP66 demonstrated the strongest correlation with worse overall survival.  The 124 clone failed to detect BCL2 expression in the majority of translocation (+), amplification (+), and activated B-cell DLBCL cases in which high levels of BCL2 protein are expected.  Using dual in situ hybridization as a new tool to detect BCL2 translocation and amplification, we obsd. similar results as previously reported for fluorescence in situ hybridization for translocation but a higher amplification frequency, indicating that BCL2 amplification may be underreported in DLBCL.  Among the discrepant cases, phosphorylation of BCL2 at T69 and/or S70 was more common than in the concordant cases and may contribute to the 124 false negatives, in addn. to previously assocd. mutations within the epitope region.  The accurate detection of BCL2 expression is important in the prognosis and treatment of DLBCL particularly with new anti-BCL2 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpemJhnV44VObVg90H21EOLACvtfcHk0lihDY0X7BXWEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7bJ&md5=dabf4951dd936eb6dc295a11ce89b716</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2014.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2014.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DKendrick%26aufirst%3DS.%2BL.%26aulast%3DRedd%26aufirst%3DL.%26aulast%3DMuranyi%26aufirst%3DA.%26aulast%3DHenricksen%26aufirst%3DL.%2BA.%26aulast%3DStanislaw%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DL.%2BM.%26aulast%3DPerry%26aufirst%3DA.%2BM.%26aulast%3DFu%26aufirst%3DK.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DBraziel%26aufirst%3DR.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BR.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DGrogan%26aufirst%3DT.%2BM.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26atitle%3DBCL2%2520antibodies%2520targeted%2520at%2520different%2520epitopes%2520detect%2520varying%2520levels%2520of%2520protein%2520expression%2520and%2520correlate%2520with%2520frequent%2520gene%2520amplification%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%26jtitle%3DHum.%2520Pathol.%26date%3D2014%26volume%3D45%26spage%3D2144%26epage%3D2153%26doi%3D10.1016%2Fj.humpath.2014.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Delmore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastritis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilpatrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a therapeutic strategy to target c-Myc</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">â</span> <span class="NLM_lpage">917</span><span class="refDoi">Â DOI: 10.1016/j.cell.2011.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2Fj.cell.2011.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=21889194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=904-917&author=J.+E.+Delmoreauthor=G.+C.+Issaauthor=M.+E.+Lemieuxauthor=P.+B.+Rahlauthor=J.+Shiauthor=H.+M.+Jacobsauthor=E.+Kastritisauthor=T.+Gilpatrickauthor=R.+M.+Paranalauthor=J.+Qiauthor=M.+Chesiauthor=A.+C.+Schinzelauthor=M.+R.+McKeownauthor=T.+P.+Heffernanauthor=C.+R.+Vakocauthor=P.+L.+Bergsagelauthor=I.+M.+Ghobrialauthor=P.+G.+Richardsonauthor=R.+A.+Youngauthor=W.+C.+Hahnauthor=K.+C.+Andersonauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=C.+S.+Mitsiades&title=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc&doi=10.1016%2Fj.cell.2011.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc</span></div><div class="casAuthors">Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Jun-Wei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904-917</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist.  Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation.  Using a selective small-mol. bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc.  BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes.  In exptl. models of multiple myeloma, a Myc-dependent hematol. malignancy, JQ1 produces a potent antiproliferative effect assocd. with cell-cycle arrest and cellular senescence.  Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathol. activation of c-Myc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevD1QHKmOhLVg90H21EOLACvtfcHk0lihDY0X7BXWEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF&md5=013674b8224214a9a1c8f0b75583a5a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelmore%26aufirst%3DJ.%2BE.%26aulast%3DIssa%26aufirst%3DG.%2BC.%26aulast%3DLemieux%26aufirst%3DM.%2BE.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DH.%2BM.%26aulast%3DKastritis%26aufirst%3DE.%26aulast%3DGilpatrick%26aufirst%3DT.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520to%2520target%2520c-Myc%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D904%26epage%3D917%26doi%3D10.1016%2Fj.cell.2011.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boghaert, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catron, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enschede, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaw, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecker, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humerickhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">â</span> <span class="NLM_lpage">208</span><span class="refDoi">Â DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0ljiFek3szoYtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davids, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puvvada, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerecitano, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipps, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gressick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitner Enschede, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humerickhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span> </span><span class="NLM_article-title">Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">322</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1513257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1056%2FNEJMoa1513257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26639348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2murrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2016&pages=311-322&author=A.+W.+Robertsauthor=M.+S.+Davidsauthor=J.+M.+Pagelauthor=B.+S.+Kahlauthor=S.+D.+Puvvadaauthor=J.+F.+Gerecitanoauthor=T.+J.+Kippsauthor=M.+A.+Andersonauthor=J.+R.+Brownauthor=L.+Gressickauthor=S.+Wongauthor=M.+Dunbarauthor=M.+Zhuauthor=M.+B.+Desaiauthor=E.+Cerriauthor=S.+Heitner+Enschedeauthor=R.+A.+Humerickhouseauthor=W.+G.+Wierdaauthor=J.+F.+Seymour&title=Targeting+BCL2+with+venetoclax+in+relapsed+chronic+lymphocytic+leukemia&doi=10.1056%2FNEJMoa1513257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Roberts, Andrew W.; Davids, Matthew S.; Pagel, John M.; Kahl, Brad S.; Puvvada, Soham D.; Gerecitano, John F.; Kipps, Thomas J.; Anderson, Mary Ann; Brown, Jennifer R.; Gressick, Lori; Wong, Shekman; Dunbar, Martin; Zhu, Ming; Desai, Monali B.; Cerri, Elisa; Enschede, Sari Heitner; Humerickhouse, Rod A.; Wierda, William G.; Seymour, John F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-322</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND New treatments have improved outcomes for patients with relapsed chronic lymphocytic leukemia (CLL), but complete remissions remain uncommon.  Venetoclax has a distinct mechanism of action; it targets BCL2, a protein central to the survival of CLL cells.  METHODS We conducted a phase 1 dose-escalation study of daily oral venetoclax in patients with relapsed or refractory CLL or small lymphocytic lymphoma (SLL) to assess safety, pharmacokinetic profile, and efficacy.  In the dose-escalation phase, 56 patients received active treatment in one of eight dose groups that ranged from 150 to 1200 mg per day.  In an expansion cohort, 60 addnl. patients were treated with a weekly stepwise ramp-up in doses as high as 400 mg per day.  RESULTS The majority of the study patients had received multiple previous treatments, and 89% had poor prognostic clin. or genetic features.  Venetoclax was active at all dose levels.  Clin. tumor lysis syndrome occurred in 3 of 56 patients in the dose-escalation cohort, with one death.  After adjustments to the dose-escalation schedule, clin. tumor lysis syndrome did not occur in any of the 60 patients in the expansion cohort.  Other toxic effects included mild diarrhea (in 52% of the patients), upper respiratory tract infection (in 48%), nausea (in 47%), and grade 3 or 4 neutropenia (in 41%).  A max. tolerated dose was not identified.  Among the 116 patients who received venetoclax, 92 (79%) had a response.  Response rates ranged from 71 to 79% among patients in subgroups with an adverse prognosis, including those with resistance to fludarabine, those with chromosome 17p deletions (deletion 17p CLL), and those with unmutated IGHV.  Complete remissions occurred in 20% of the patients, including 5% who had no minimal residual disease on flow cytometry.  The 15-mo progression-free survival est. for the 400-mg dose groups was 69%.  CONCLUSIONS Selective targeting of BCL2 with venetoclax had a manageable safety profile and induced substantial responses in patients with relapsed CLL or SLL, including those with poor prognostic features.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQgYgnKl88rVg90H21EOLACvtfcHk0ljiFek3szoYtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2murrP&md5=b371a37b76ee88cfc6ac47ea0eeea0e6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1513257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1513257%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DDavids%26aufirst%3DM.%2BS.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DKahl%26aufirst%3DB.%2BS.%26aulast%3DPuvvada%26aufirst%3DS.%2BD.%26aulast%3DGerecitano%26aufirst%3DJ.%2BF.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DAnderson%26aufirst%3DM.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DGressick%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DDunbar%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DM.%2BB.%26aulast%3DCerri%26aufirst%3DE.%26aulast%3DHeitner%2BEnschede%26aufirst%3DS.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26atitle%3DTargeting%2520BCL2%2520with%2520venetoclax%2520in%2520relapsed%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2016%26volume%3D374%26spage%3D311%26epage%3D322%26doi%3D10.1056%2FNEJMoa1513257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Punnoose, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boghaert, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmont, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingalla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darbonne, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span> </span><span class="NLM_article-title">Expression profile of BCL-2, BCL-XL and MCL-1 predicts pharmacological response to the BCL-2 selective antagonist venetoclax in multiple myeloma models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">â</span> <span class="NLM_lpage">1144</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-15-0730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1158%2F1535-7163.MCT-15-0730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26939706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt12ktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1132-1144&author=E.+Punnooseauthor=J.+D.+Leversonauthor=F.+Pealeauthor=E.+R.+Boghaertauthor=L.+D.+Belmontauthor=N.+Tanauthor=A.+Youngauthor=M.+Mittenauthor=E.+Ingallaauthor=W.+C.+Darbonneauthor=A.+Oleksijewauthor=P.+Tapangauthor=P.+Yueauthor=J.+Oehauthor=L.+Leeauthor=S.+Maigaauthor=W.+J.+Fairbrotherauthor=M.+Amiotauthor=A.+J.+Souersauthor=D.+Sampath&title=Expression+profile+of+BCL-2%2C+BCL-XL+and+MCL-1+predicts+pharmacological+response+to+the+BCL-2+selective+antagonist+venetoclax+in+multiple+myeloma+models&doi=10.1158%2F1535-7163.MCT-15-0730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models</span></div><div class="casAuthors">Punnoose, Elizabeth A.; Leverson, Joel D.; Peale, Franklin; Boghaert, Erwin R.; Belmont, Lisa D.; Tan, Nguyen; Young, Amy; Mitten, Michael; Ingalla, Ellen; Darbonne, Walter C.; Oleksijew, Anatol; Tapang, Paul; Yue, Peng; Oeh, Jason; Lee, Leslie; Maiga, Sophie; Fairbrother, Wayne J.; Amiot, Martine; Souers, Andrew J.; Sampath, Deepak</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1132-1144</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BCL-2 family proteins dictate survival of human multiple myeloma cells, making them attractive drug targets.  Indeed, multiple myeloma cells are sensitive to antagonists that selectively target prosurvival proteins such as BCL-2/BCL-XL (ABT-737 and ABT-263/navitoclax) or BCL-2 only (ABT-199/GDC-0199/venetoclax).  Resistance to these three drugs is mediated by expression of MCL-1.  However, given the selectivity profile of venetoclax it is unclear whether coexpression of BCL-XL also affects antitumor responses to venetoclax in multiple myeloma.  In multiple myeloma cell lines (n = 21), BCL-2 is expressed but sensitivity to venetoclax correlated with high BCL-2 and low BCL-XL or MCL-1 expression.  Multiple myeloma cells that coexpress BCL-2 and BCL-XL were resistant to venetoclax but sensitive to a BCL-XL-selective inhibitor (A-1155463).  Multiple myeloma xenograft models that coexpressed BCL-XL or MCL-1 with BCL-2 were also resistant to venetoclax.  Resistance to venetoclax was mitigated by cotreatment with bortezomib in xenografts that coexpressed BCL-2 and MCL-1 due to upregulation of NOXA, a proapoptotic factor that neutralizes MCL-1.  In contrast, xenografts that expressed BCL-XL, MCL-1, and BCL-2 were more sensitive to the combination of bortezomib with a BCL-XL selective inhibitor (A-1331852) but not with venetoclax cotreatment when compared with monotherapies.  IHC of multiple myeloma patient bone marrow biopsies and aspirates (n = 95) revealed high levels of BCL-2 and BCL-XL in 62% and 43% of evaluable samples, resp., while 34% were characterized as BCL-2High/BCL-XLLow.  In addn. to MCL-1, our data suggest that BCL-XL may also be a potential resistance factor to venetoclax monotherapy and in combination with bortezomib.  Mol Cancer Ther; 15(5); 1132-44. cpr2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnLq1WNK__LVg90H21EOLACvtfcHk0ljS0aleBA2TIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt12ktLY%253D&md5=a389568a0b933da01801e9beea9bf4a9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0730%26sid%3Dliteratum%253Aachs%26aulast%3DPunnoose%26aufirst%3DE.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DBelmont%26aufirst%3DL.%2BD.%26aulast%3DTan%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DMitten%26aufirst%3DM.%26aulast%3DIngalla%26aufirst%3DE.%26aulast%3DDarbonne%26aufirst%3DW.%2BC.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DOeh%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DMaiga%26aufirst%3DS.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DAmiot%26aufirst%3DM.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DSampath%26aufirst%3DD.%26atitle%3DExpression%2520profile%2520of%2520BCL-2%252C%2520BCL-XL%2520and%2520MCL-1%2520predicts%2520pharmacological%2520response%2520to%2520the%2520BCL-2%2520selective%2520antagonist%2520venetoclax%2520in%2520multiple%2520myeloma%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D1132%26epage%3D1144%26doi%3D10.1158%2F1535-7163.MCT-15-0730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Thijssen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geest, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Oers, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kater, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldering, E.</span><span> </span><span class="NLM_article-title">Resistance to ABT-199 inducted by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">e302</span><span class="NLM_x">â</span> <span class="NLM_lpage">e306</span><span class="refDoi">Â DOI: 10.3324/haematol.2015.124560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.3324%2Fhaematol.2015.124560" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=e302-e306&author=R.+Thijssenauthor=E.+Slingerauthor=K.+Wellerauthor=C.+R.+Geestauthor=T.+Beaumontauthor=M.+H.+van+Oersauthor=A.+P.+Katerauthor=E.+Eldering&title=Resistance+to+ABT-199+inducted+by+microenvironmental+signals+in+chronic+lymphocytic+leukemia+can+be+counteracted+by+CD20+antibodies+or+kinase+inhibitors&doi=10.3324%2Fhaematol.2015.124560"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2015.124560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2015.124560%26sid%3Dliteratum%253Aachs%26aulast%3DThijssen%26aufirst%3DR.%26aulast%3DSlinger%26aufirst%3DE.%26aulast%3DWeller%26aufirst%3DK.%26aulast%3DGeest%26aufirst%3DC.%2BR.%26aulast%3DBeaumont%26aufirst%3DT.%26aulast%3Dvan%2BOers%26aufirst%3DM.%2BH.%26aulast%3DKater%26aufirst%3DA.%2BP.%26aulast%3DEldering%26aufirst%3DE.%26atitle%3DResistance%2520to%2520ABT-199%2520inducted%2520by%2520microenvironmental%2520signals%2520in%2520chronic%2520lymphocytic%2520leukemia%2520can%2520be%2520counteracted%2520by%2520CD20%2520antibodies%2520or%2520kinase%2520inhibitors%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3De302%26epage%3De306%26doi%3D10.3324%2Fhaematol.2015.124560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span> </span><span class="NLM_article-title">BCL-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding</span> <span class="citation_source-journal">Br. J. Phamacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">483</span><span class="refDoi">Â DOI: 10.1111/bph.13370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1111%2Fbph.13370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26493374" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=471-483&author=T.+Songauthor=G.+Chaiauthor=Y.+Liuauthor=X.+Yuauthor=Z.+Wangauthor=Z.+Zhang&title=BCL-2+phosphorylation+confers+resistance+on+chronic+lymphocytic+leukaemia+cells+to+the+BH3+mimetics+ABT-737%2C+ABT-263+and+ABT-199+by+impeding+direct+binding&doi=10.1111%2Fbph.13370"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fbph.13370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13370%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChai%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DBCL-2%2520phosphorylation%2520confers%2520resistance%2520on%2520chronic%2520lymphocytic%2520leukaemia%2520cells%2520to%2520the%2520BH3%2520mimetics%2520ABT-737%252C%2520ABT-263%2520and%2520ABT-199%2520by%2520impeding%2520direct%2520binding%26jtitle%3DBr.%2520J.%2520Phamacol.%26date%3D2016%26volume%3D173%26spage%3D471%26epage%3D483%26doi%3D10.1111%2Fbph.13370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fong, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ftouni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papenfuss, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M. A.</span><span> </span><span class="NLM_article-title">BET inhibitor resistance emerges from leukaemia stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">â</span> <span class="NLM_lpage">542</span><span class="refDoi">Â DOI: 10.1038/nature14888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnature14888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26367796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=538-542&author=C.+Y.+Fongauthor=O.+Gilanauthor=E.+Y.+Lamauthor=A.+F.+Rubinauthor=S.+Ftouniauthor=D.+Tylerauthor=K.+Stanleyauthor=D.+Sinhaauthor=P.+Yehauthor=J.+Morisonauthor=G.+Giotopoulosauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+C.+Leeauthor=C.+Carpenterauthor=R.+Gregoryauthor=R.+G.+Ramsayauthor=S.+W.+Laneauthor=O.+Abdel-Wahabauthor=T.+Kouzaridesauthor=R.+W.+Johnstoneauthor=S.+J.+Dawsonauthor=B.+J.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+T.+Papenfussauthor=M.+A.+Dawson&title=BET+inhibitor+resistance+emerges+from+leukaemia+stem+cells&doi=10.1038%2Fnature14888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor resistance emerges from leukaemia stem cells</span></div><div class="casAuthors">Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">538-542</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks.  Early clin. trials have shown promise, esp. in acute myeloid leukemia, and therefore the evaluation of resistance mechanisms is crucial to optimize the clin. efficacy of these drugs.  Here we use primary mouse hematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET.  Resistance to I-BET confers cross-resistance to chem. distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins.  Resistance is not mediated through increased drug efflux or metab., but is shown to emerge from leukemia stem cells both ex vivo and in vivo.  Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription.  We demonstrate that resistance to BET inhibitors, in human and mouse leukemia cells, is in part a consequence of increased Wnt/Î²-catenin signaling, and neg. regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo.  Together, these findings provide new insights into the biol. of acute myeloid leukemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clin. utility of these unique targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Lg1n64SCWrVg90H21EOLACvtfcHk0lgJOk9deiuTVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL&md5=47d1769e077b1c6c92ff52a051368404</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature14888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14888%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DC.%2BY.%26aulast%3DGilan%26aufirst%3DO.%26aulast%3DLam%26aufirst%3DE.%2BY.%26aulast%3DRubin%26aufirst%3DA.%2BF.%26aulast%3DFtouni%26aufirst%3DS.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DStanley%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMorison%26aufirst%3DJ.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DCarpenter%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DR.%26aulast%3DRamsay%26aufirst%3DR.%2BG.%26aulast%3DLane%26aufirst%3DS.%2BW.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DDawson%26aufirst%3DS.%2BJ.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DPapenfuss%26aufirst%3DA.%2BT.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26atitle%3DBET%2520inhibitor%2520resistance%2520emerges%2520from%2520leukaemia%2520stem%2520cells%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D538%26epage%3D542%26doi%3D10.1038%2Fnature14888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Brunelle, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span> </span><span class="NLM_article-title">Control of mitochondrial apoptosis by the Bcl-2 family</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">441</span><span class="refDoi">Â DOI: 10.1242/jcs.031682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1242%2Fjcs.031682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=19193868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Wls7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=437-441&author=J.+K.+Brunelleauthor=A.+Letai&title=Control+of+mitochondrial+apoptosis+by+the+Bcl-2+family&doi=10.1242%2Fjcs.031682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Control of mitochondrial apoptosis by the Bcl-2 family</span></div><div class="casAuthors">Brunelle, Joslyn K.; Letai, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">437-441</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteins of the Bcl-2 family have either pro- or anti-apoptotic activities and regulate the mitochondrial pathway of apoptosis by controlling the permeabilization of the outer mitochondrial membrane, which leads to release of cytochrome c.  The release of cytochrome c leads to activation of caspases, which cleave key cellular proteins.  This leads to many of the morphol. characteristics of apoptosis, including condensed nuclei, DNA laddering, and exposure of phosphatidylserine to the outer leaflet of the plasma membrane.  Here, the authors discuss how proteins of the Bcl-2 family control the crucial event in the commitment to apoptosis, permeabilization of the mitochondrial outer membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV8wHMPqsSlrVg90H21EOLACvtfcHk0lgJOk9deiuTVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Wls7w%253D&md5=8602c8b209d6c1c74fc3712d7fd9acd4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1242%2Fjcs.031682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.031682%26sid%3Dliteratum%253Aachs%26aulast%3DBrunelle%26aufirst%3DJ.%2BK.%26aulast%3DLetai%26aufirst%3DA.%26atitle%3DControl%2520of%2520mitochondrial%2520apoptosis%2520by%2520the%2520Bcl-2%2520family%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2009%26volume%3D122%26spage%3D437%26epage%3D441%26doi%3D10.1242%2Fjcs.031682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romaguera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Q.</span><span> </span><span class="NLM_article-title">Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">â</span> <span class="NLM_lpage">185</span><span class="refDoi">Â DOI: 10.1038/sj.leu.2404959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fsj.leu.2404959" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=179-185&author=M.+Wangauthor=X.+H.+Hanauthor=L.+Zhangauthor=J.+Yangauthor=J.+F.+Qianauthor=Y.+K.+Shiauthor=L.+W.+Kwakauthor=J.+Romagueraauthor=Q.+Yi&title=Bortezomib+is+synergistic+with+rituximab+and+cyclophosphamide+in+inducing+apoptosis+of+mantle+cell+lymphoma+cells+in+vitro+and+in+vivo&doi=10.1038%2Fsj.leu.2404959"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2404959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2404959%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DX.%2BH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DJ.%2BF.%26aulast%3DShi%26aufirst%3DY.%2BK.%26aulast%3DKwak%26aufirst%3DL.%2BW.%26aulast%3DRomaguera%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DQ.%26atitle%3DBortezomib%2520is%2520synergistic%2520with%2520rituximab%2520and%2520cyclophosphamide%2520in%2520inducing%2520apoptosis%2520of%2520mantle%2520cell%2520lymphoma%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D179%26epage%3D185%26doi%3D10.1038%2Fsj.leu.2404959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Trebunova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laputkova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacjakova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verebova, A.</span><span> </span><span class="NLM_article-title">Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">â</span> <span class="NLM_lpage">2854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=22753747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1aks7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2849-2854&author=M.+Trebunovaauthor=G.+Laputkovaauthor=E.+Slabaauthor=K.+Lacjakovaauthor=A.+Verebova&title=Effects+of+docetaxel%2C+doxorubicin+and+cyclophosphamide+on+human+breast+cancer+cell+line+MCF-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7</span></div><div class="casAuthors">Trebunova, Marianna; Liputkova, Galina; Slaba, Eva; Lacjakova, Kamila; Verebova, Aneta</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2849-2854</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Cell viability assays are important tools in oncol. research.  The purpose of this study was to evaluate the effect of docetaxel, doxorubicin and cyclophosphamide on the metabolic activity of MCF-7 breast cancer cell line.  Antiproliferative effect of cytostatics on MCF-7 cells was measured using the std. colorimetric test.  The MCF-7 cell line was exposed to cytostatics for 24 h.  The metabolic activity was evaluated over the 24 h.  According to the statistical anal., the change in the growth rate was significant (p<0.05) for the 120 nM docetaxel and above the 200 nM doxorubicin treatment in comparison with sensitive MCF-7 cells.  When considering drugs in combination (60 nM docetaxel with 200 nM doxorubicin and 60 nM docetaxel with 500 nM doxorubicin) after the addn. of 600 nM cyclophosphamide, we found a statistically significant decrease of metabolic activity of the MCF-7 cell line (p<0.05).  Cyclophosphamide at 600 nM seems to enhance the influence of docetaxel when combined with doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfel-piY1LObVg90H21EOLACvtfcHk0lhpu-MwXM8OYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1aks7nL&md5=8536b5ce6a065a6faf9913ca90e27f86</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrebunova%26aufirst%3DM.%26aulast%3DLaputkova%26aufirst%3DG.%26aulast%3DSlaba%26aufirst%3DE.%26aulast%3DLacjakova%26aufirst%3DK.%26aulast%3DVerebova%26aufirst%3DA.%26atitle%3DEffects%2520of%2520docetaxel%252C%2520doxorubicin%2520and%2520cyclophosphamide%2520on%2520human%2520breast%2520cancer%2520cell%2520line%2520MCF-7%26jtitle%3DAnticancer%2520Res.%26date%3D2012%26volume%3D32%26spage%3D2849%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bosanquet, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosanquet, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorken, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, P. T.</span><span> </span><span class="NLM_article-title">Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide, and chlorambucil but not fludarabine, cladribine, or corticosteroids in B cell chronic lymphocytic leukemia</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">â</span> <span class="NLM_lpage">1044</span><span class="refDoi">Â DOI: 10.1038/sj.leu.2402539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fsj.leu.2402539" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1035-1044&author=A.+G.+Bosanquetauthor=I.+Sturmauthor=T.+Wiederauthor=F.+Essmannauthor=M.+I.+Bosanquetauthor=D.+J.+Headauthor=B.+Dorkenauthor=P.+T.+Daniel&title=Bax+expression+correlates+with+cellular+drug+sensitivity+to+doxorubicin%2C+cyclophosphamide%2C+and+chlorambucil+but+not+fludarabine%2C+cladribine%2C+or+corticosteroids+in+B+cell+chronic+lymphocytic+leukemia&doi=10.1038%2Fsj.leu.2402539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2402539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2402539%26sid%3Dliteratum%253Aachs%26aulast%3DBosanquet%26aufirst%3DA.%2BG.%26aulast%3DSturm%26aufirst%3DI.%26aulast%3DWieder%26aufirst%3DT.%26aulast%3DEssmann%26aufirst%3DF.%26aulast%3DBosanquet%26aufirst%3DM.%2BI.%26aulast%3DHead%26aufirst%3DD.%2BJ.%26aulast%3DDorken%26aufirst%3DB.%26aulast%3DDaniel%26aufirst%3DP.%2BT.%26atitle%3DBax%2520expression%2520correlates%2520with%2520cellular%2520drug%2520sensitivity%2520to%2520doxorubicin%252C%2520cyclophosphamide%252C%2520and%2520chlorambucil%2520but%2520not%2520fludarabine%252C%2520cladribine%252C%2520or%2520corticosteroids%2520in%2520B%2520cell%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D1035%26epage%3D1044%26doi%3D10.1038%2Fsj.leu.2402539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kalac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amengual, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshan, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulahannan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leshchenko, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temkin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, O. A.</span><span> </span><span class="NLM_article-title">HDAC inhibitors and decitabine are highly synergistic and associated with unique gene expression and epigenetic profiles in models of DLBCL</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">5506</span><span class="NLM_x">â</span> <span class="NLM_lpage">5516</span><span class="refDoi">Â DOI: 10.1182/blood-2011-02-336891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1182%2Fblood-2011-02-336891" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=5506-5516&author=M.+Kalacauthor=L.+Scottoauthor=E.+Marchiauthor=J.+Amengualauthor=V.+E.+Seshanauthor=G.+Bhagatauthor=N.+Ulahannanauthor=V.+V.+Leshchenkoauthor=A.+M.+Temkinauthor=S.+Parekhauthor=B.+Tyckoauthor=O.+A.+O%E2%80%99Connor&title=HDAC+inhibitors+and+decitabine+are+highly+synergistic+and+associated+with+unique+gene+expression+and+epigenetic+profiles+in+models+of+DLBCL&doi=10.1182%2Fblood-2011-02-336891"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-02-336891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-02-336891%26sid%3Dliteratum%253Aachs%26aulast%3DKalac%26aufirst%3DM.%26aulast%3DScotto%26aufirst%3DL.%26aulast%3DMarchi%26aufirst%3DE.%26aulast%3DAmengual%26aufirst%3DJ.%26aulast%3DSeshan%26aufirst%3DV.%2BE.%26aulast%3DBhagat%26aufirst%3DG.%26aulast%3DUlahannan%26aufirst%3DN.%26aulast%3DLeshchenko%26aufirst%3DV.%2BV.%26aulast%3DTemkin%26aufirst%3DA.%2BM.%26aulast%3DParekh%26aufirst%3DS.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26atitle%3DHDAC%2520inhibitors%2520and%2520decitabine%2520are%2520highly%2520synergistic%2520and%2520associated%2520with%2520unique%2520gene%2520expression%2520and%2520epigenetic%2520profiles%2520in%2520models%2520of%2520DLBCL%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D5506%26epage%3D5516%26doi%3D10.1182%2Fblood-2011-02-336891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Brown, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chawla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quijada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassiter, Q. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phanse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnidge, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The consequences of overlapping G-quadruplexes and i-motifs in the platelet-derived growth factor receptor Î² core promoter nuclease hypersensitive element can explain the unexpected effects of mutations and provide opportunities for selective targeting of both structures by small molecules to downregulate gene expression</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">7456</span><span class="refDoi">Â DOI: 10.1021/jacs.6b10028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b10028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSksbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=7456&author=R.+V.+Brownauthor=T.+Wangauthor=R.+Chappetaauthor=G.+Wuauthor=B.+Onelauthor=R.+Chawlaauthor=H.+Quijadaauthor=S.+M.+Campauthor=E.+T.+Chiangauthor=Q.+R.+Lassiterauthor=C.+Leeauthor=S.+Phanseauthor=M.+A.+Turnidgeauthor=P.+Zhaoauthor=J.+G.+N.+Garciaauthor=V.+Gokhaleauthor=D.+Yangauthor=L.+H.+Hurley&title=The+consequences+of+overlapping+G-quadruplexes+and+i-motifs+in+the+platelet-derived+growth+factor+receptor+%CE%B2+core+promoter+nuclease+hypersensitive+element+can+explain+the+unexpected+effects+of+mutations+and+provide+opportunities+for+selective+targeting+of+both+structures+by+small+molecules+to+downregulate+gene+expression&doi=10.1021%2Fjacs.6b10028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor Î² Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting of Both Structures by Small Molecules To Downregulate Gene Expression</span></div><div class="casAuthors">Brown, Robert V.; Wang, Ting; Chappeta, Venkateshwar Reddy; Wu, Guanhui; Onel, Buket; Chawla, Reena; Quijada, Hector; Camp, Sara M.; Chiang, Eddie T.; Lassiter, Quinea R.; Lee, Carmen; Phanse, Shivani; Turnidge, Megan A.; Zhou, Ping; Garcia, Joe G. N.; Gokhale, Vijay; Yang, Danzhou; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7456-7475</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The platelet-derived growth factor receptor Î² (PDGFR-Î²) signaling pathway is a validated and important target for the treatment of certain malignant and nonmalignant pathologies.  We previously identified a G-quadruplex-forming nuclease hypersensitive element (NHE) in the human PDGFR-Î² promoter that putatively forms four overlapping G-quadruplexes.  Therefore, we further investigated the structures and biol. roles of the G-quadruplexes and i-motifs in the PDGFR-Î² NHE with the ultimate goal of demonstrating an alternate and effective strategy for molecularly targeting the PDGFR-Î² pathway.  Significantly, we show that the primary G-quadruplex receptor for repression of PDGFR-Î² is the 3'-end G-quadruplex, which has a GGA sequence at the 3'-end.  Mutation studies using luciferase reporter plasmids highlight a novel set of G-quadruplex point mutations, some of which seem to provide conflicting results on effects on gene expression, prompting further investigation into the effect of these mutations on the i-motif-forming strand.  Herein we characterize the formation of an equil. between at least two different i-motifs from the cytosine-rich (C-rich) sequence of the PDGFR-Î² NHE.  The apparently conflicting mutation results can be rationalized if we take into account the single base point mutation made in a crit. cytosine run in the PDGFR-Î² NHE that dramatically affects the equil. of i-motifs formed from this sequence.  We identified a group of ellipticines that targets the G-quadruplexes in the PDGFR-Î² promoter, and from this series of compds., we selected the ellipticine analog GSA1129, which selectively targets the 3'-end G-quadruplex, to shift the dynamic equil. in the full-length sequence to favor this structure.  We also identified a benzothiophene-2-carboxamide (NSC309874) as a PDGFR-Î² i-motif-interactive compd.  In vitro, GSA1129 and NSC309874 downregulate PDGFR-Î² promoter activity and transcript in the neuroblastoma cell line SK-N-SH at subcytotoxic cell concns.  GSA1129 also inhibits PDGFR-Î²-driven cell proliferation and migration.  With an established preclin. murine model of acute lung injury, we demonstrate that GSA1129 attenuates endotoxin-mediated acute lung inflammation.  Our studies underscore the importance of considering the effects of point mutations on structure formation from the G- and C-rich sequences and provide further evidence for the involvement of both strands and assocd. structures in the control of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhaMLX8v_xSrVg90H21EOLACvtfcHk0ljcBY6JQikADQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSksbY%253D&md5=816bce244950c04356a09f731e430c54</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b10028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b10028%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BV.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChappeta%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DOnel%26aufirst%3DB.%26aulast%3DChawla%26aufirst%3DR.%26aulast%3DQuijada%26aufirst%3DH.%26aulast%3DCamp%26aufirst%3DS.%2BM.%26aulast%3DChiang%26aufirst%3DE.%2BT.%26aulast%3DLassiter%26aufirst%3DQ.%2BR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPhanse%26aufirst%3DS.%26aulast%3DTurnidge%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520consequences%2520of%2520overlapping%2520G-quadruplexes%2520and%2520i-motifs%2520in%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520%25CE%25B2%2520core%2520promoter%2520nuclease%2520hypersensitive%2520element%2520can%2520explain%2520the%2520unexpected%2520effects%2520of%2520mutations%2520and%2520provide%2520opportunities%2520for%2520selective%2520targeting%2520of%2520both%2520structures%2520by%2520small%2520molecules%2520to%2520downregulate%2520gene%2520expression%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D7456%26doi%3D10.1021%2Fjacs.6b10028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, W. P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekulic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">A pharmacological chaperone molecule induces cancer cell death by restoring tertiary DNA structures in mutant hTERT promoters</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">13673</span><span class="NLM_x">â</span> <span class="NLM_lpage">13692</span><span class="refDoi">Â DOI: 10.1021/jacs.6b07598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b07598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFamsrnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=13673-13692&author=H.-J.+Kangauthor=Y.+Cuiauthor=H.+Yinauthor=A.+Scheidauthor=W.+P.+D.+Hendricksauthor=J.+Schmidtauthor=A.+Sekulicauthor=D.+Kongauthor=J.+M.+Trentauthor=V.+Gokhaleauthor=H.+Maoauthor=L.+H.+Hurley&title=A+pharmacological+chaperone+molecule+induces+cancer+cell+death+by+restoring+tertiary+DNA+structures+in+mutant+hTERT+promoters&doi=10.1021%2Fjacs.6b07598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters</span></div><div class="casAuthors">Kang, Hyun-Jin; Cui, Yunxi; Yin, Holly; Scheid, Amy; Hendricks, William P. D.; Schmidt, Jessica; Sekulic, Aleksandar; Kong, Deming; Trent, Jeffrey M.; Gokhale, Vijay; Mao, Hanbin; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13673-13692</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of human telomerase reverse transcriptase (hTERT) is necessary for limitless replication in tumorigenesis.  Whereas hTERT is transcriptionally silenced in normal cells, most tumor cells reactivate hTERT expression by alleviating transcriptional repression through diverse genetic and epigenetic mechanisms.  Transcription-activating hTERT promoter mutations have been found to occur at high frequencies in multiple cancer types.  These mutations have been shown to form new transcription factor binding sites that drive hTERT expression, but this model cannot fully account for differences in wild-type and mutant promoter activation and has not yet enabled a selective therapeutic strategy.  Here the authors demonstrate a novel mechanism by which promoter mutations activate hTERT transcription, which also sheds light on a unique therapeutic opportunity.  Promoter mutations occur in a core promoter region that forms tertiary structures consisting of a pair of G-quadruplexes involved in transcriptional silencing.  The authors show that promoter mutations exert a detrimental effect on the folding of one of these G-quadruplexes, resulting in a nonfunctional silencer element that alleviates transcriptional repression.  The authors have also identified a small drug-like pharmacol. chaperone (pharmacoperone) mol., GTC365, that acts at an early step in the G-quadruplex folding pathway to redirect mutant promoter G-quadruplex misfolding, partially reinstate the correct folding pathway, and reduce hTERT activity through transcriptional repression.  This transcription-mediated repression effects cancer cell death through multiple routes including both induction of apoptosis through inhibition of hTERT's role in regulating apoptosis-related proteins and inducing senescence by decreasing telomerase activity and telomere length.  The authors demonstrate the selective therapeutic potential of this strategy in melanoma cells that overexpress hTERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUXprvNdY5oLVg90H21EOLACvtfcHk0ljcBY6JQikADQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFamsrnP&md5=043ffcf8b2f19a9884e9e7b6bdca6a42</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b07598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b07598%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DH.-J.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DScheid%26aufirst%3DA.%26aulast%3DHendricks%26aufirst%3DW.%2BP.%2BD.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DSekulic%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DTrent%26aufirst%3DJ.%2BM.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DA%2520pharmacological%2520chaperone%2520molecule%2520induces%2520cancer%2520cell%2520death%2520by%2520restoring%2520tertiary%2520DNA%2520structures%2520in%2520mutant%2520hTERT%2520promoters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D13673%26epage%3D13692%26doi%3D10.1021%2Fjacs.6b07598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span> </span><span class="NLM_article-title">Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">333</span><span class="refDoi">Â DOI: 10.1038/348331a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2F348331a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=331-333&author=A.+Strasserauthor=A.+W.+Harrisauthor=M.+L.+Bathauthor=S.+Cory&title=Novel+primitive+lymphoid+tumours+induced+in+transgenic+mice+by+cooperation+between+myc+and+bcl-2&doi=10.1038%2F348331a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2F348331a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348331a0%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DA.%2BW.%26aulast%3DBath%26aufirst%3DM.%2BL.%26aulast%3DCory%26aufirst%3DS.%26atitle%3DNovel%2520primitive%2520lymphoid%2520tumours%2520induced%2520in%2520transgenic%2520mice%2520by%2520cooperation%2520between%2520myc%2520and%2520bcl-2%26jtitle%3DNature%26date%3D1990%26volume%3D348%26spage%3D331%26epage%3D333%26doi%3D10.1038%2F348331a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Weinstein, I. B.</span><span> </span><span class="NLM_article-title">Cancer. Addition to oncogenes â the Achilles heal of cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">64</span><span class="refDoi">Â DOI: 10.1126/science.1073096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1126%2Fscience.1073096" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=63-64&author=I.+B.+Weinstein&title=Cancer.+Addition+to+oncogenes+%E2%80%93+the+Achilles+heal+of+cancer&doi=10.1126%2Fscience.1073096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1073096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1073096%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26atitle%3DCancer.%2520Addition%2520to%2520oncogenes%2520%25E2%2580%2593%2520the%2520Achilles%2520heal%2520of%2520cancer%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D63%26epage%3D64%26doi%3D10.1126%2Fscience.1073096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Felsher, D. W.</span><span> </span><span class="NLM_article-title">MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">â</span> <span class="NLM_lpage">604</span><span class="refDoi">Â DOI: 10.1177/1947601910377798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1177%2F1947601910377798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=21037952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyisLfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=597-604&author=D.+W.+Felsher&title=MYC+inactivation+elicits+oncogene+addiction+through+both+tumor+cell-intrinsic+and+host-dependent+mechanisms&doi=10.1177%2F1947601910377798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms</span></div><div class="casAuthors">Felsher, Dean W.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-604</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Tumorigenesis is generally caused by genetic changes that activate oncogenes or inactivate tumor suppressor genes.  The targeted inactivation of oncogenes can be assocd. with tumor regression through the phenomenon of oncogene addiction.  One of the most common oncogenic events in human cancer is the activation of the MYC oncogene.  The inactivation of MYC may be a general and effective therapy for human cancer.  Indeed, it has been exptl. shown that the inactivation of MYC can result in dramatic and sustained tumor regression in lymphoma, leukemia, osteosarcoma, hepatocellular carcinoma, squamous carcinoma, and pancreatic carcinoma through a multitude of mechanisms, including proliferative arrest, terminal differentiation, cellular senescence, induction of apoptosis, and the shutdown of angiogenesis.  Cell-autonomous and cell-dependent mechanisms have both been implicated, and recent results suggest a crit. role for autocrine factors, including thrombospondin-1 and TGF-Î².  Hence, targeting the inactivation of MYC appears to elicit oncogene addiction and, thereby, tumor regression through both tumor cell-intrinsic and host-dependent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquwYFn0Q7HGLVg90H21EOLACvtfcHk0lgcSs0R9wOt6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyisLfI&md5=3f31da945b0ad9461d3b8cba3f54386a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1177%2F1947601910377798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601910377798%26sid%3Dliteratum%253Aachs%26aulast%3DFelsher%26aufirst%3DD.%2BW.%26atitle%3DMYC%2520inactivation%2520elicits%2520oncogene%2520addiction%2520through%2520both%2520tumor%2520cell-intrinsic%2520and%2520host-dependent%2520mechanisms%26jtitle%3DGenes%2520Cancer%26date%3D2010%26volume%3D1%26spage%3D597%26epage%3D604%26doi%3D10.1177%2F1947601910377798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Murphy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junttila, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouyet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnezis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shchors, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Swigart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evan, G. I.</span><span> </span><span class="NLM_article-title">Distinct thresholds govern Mycâs biological output in vivo</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">â</span> <span class="NLM_lpage">457</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2008.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2Fj.ccr.2008.10.018" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=447-457&author=D.+J.+Murphyauthor=M.+R.+Junttilaauthor=L.+Pouyetauthor=A.+Karnezisauthor=K.+Shchorsauthor=D.+A.+Buiauthor=L.+Brown-Swigartauthor=L.+Johnsonauthor=G.+I.+Evan&title=Distinct+thresholds+govern+Myc%E2%80%99s+biological+output+in+vivo&doi=10.1016%2Fj.ccr.2008.10.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26aulast%3DJunttila%26aufirst%3DM.%2BR.%26aulast%3DPouyet%26aufirst%3DL.%26aulast%3DKarnezis%26aufirst%3DA.%26aulast%3DShchors%26aufirst%3DK.%26aulast%3DBui%26aufirst%3DD.%2BA.%26aulast%3DBrown-Swigart%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DEvan%26aufirst%3DG.%2BI.%26atitle%3DDistinct%2520thresholds%2520govern%2520Myc%25E2%2580%2599s%2520biological%2520output%2520in%2520vivo%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D447%26epage%3D457%26doi%3D10.1016%2Fj.ccr.2008.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Eischen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, J. L.</span><span> </span><span class="NLM_article-title">Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2658</span><span class="NLM_x">â</span> <span class="NLM_lpage">2669</span><span class="refDoi">Â DOI: 10.1101/gad.13.20.2658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1101%2Fgad.13.20.2658" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=2658-2669&author=C.+M.+Eischenauthor=J.+D.+Weberauthor=M.+F.+Rousselauthor=C.+J.+Sherrauthor=J.+L.+Cleveland&title=Disruption+of+the+ARF-Mdm2-p53+tumor+suppressor+pathway+in+Myc-induced+lymphomagenesis&doi=10.1101%2Fgad.13.20.2658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.20.2658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.20.2658%26sid%3Dliteratum%253Aachs%26aulast%3DEischen%26aufirst%3DC.%2BM.%26aulast%3DWeber%26aufirst%3DJ.%2BD.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26atitle%3DDisruption%2520of%2520the%2520ARF-Mdm2-p53%2520tumor%2520suppressor%2520pathway%2520in%2520Myc-induced%2520lymphomagenesis%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D2658%26epage%3D2669%26doi%3D10.1101%2Fgad.13.20.2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Zindy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eischen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamijo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, M. F.</span><span> </span><span class="NLM_article-title">Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2424</span><span class="NLM_x">â</span> <span class="NLM_lpage">2433</span><span class="refDoi">Â DOI: 10.1101/gad.12.15.2424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1101%2Fgad.12.15.2424" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2424-2433&author=F.+Zindyauthor=C.+M.+Eischenauthor=D.+H.+Randleauthor=T.+Kamijoauthor=J.+L.+Clevelandauthor=C.+J.+Sherrauthor=M.+F.+Roussel&title=Myc+signaling+via+the+ARF+tumor+suppressor+regulates+p53-dependent+apoptosis+and+immortalization&doi=10.1101%2Fgad.12.15.2424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.15.2424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.15.2424%26sid%3Dliteratum%253Aachs%26aulast%3DZindy%26aufirst%3DF.%26aulast%3DEischen%26aufirst%3DC.%2BM.%26aulast%3DRandle%26aufirst%3DD.%2BH.%26aulast%3DKamijo%26aufirst%3DT.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26atitle%3DMyc%2520signaling%2520via%2520the%2520ARF%2520tumor%2520suppressor%2520regulates%2520p53-dependent%2520apoptosis%2520and%2520immortalization%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2424%26epage%3D2433%26doi%3D10.1101%2Fgad.12.15.2424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">McMahon, S. B.</span><span> </span><span class="NLM_article-title">MYC and the control of apoptosis</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">a014407</span><span class="refDoi">Â DOI: 10.1101/cshperspect.a014407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1101%2Fcshperspect.a014407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=24985130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yltrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=a014407&author=S.+B.+McMahon&title=MYC+and+the+control+of+apoptosis&doi=10.1101%2Fcshperspect.a014407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MYC and the control of apoptosis</span></div><div class="casAuthors">McMahon, Steven B.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a014407/1-a014407/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  MYC expression is tightly correlated with cell-cycle progression in normal tissues, whereas unchecked MYC expression is among the most prominent hallmarks of the hyperproliferation assocd. with most forms of cancer.  At first glance it might seem counterintuitive that MYC is also among the most robust agents of programmed cell death (apoptosis) in mammalian cells.  However it is clearly beneficial for a multicellular organism to have a mechanism for triggering death in cells that express potentially oncogenic levels of MYC.  Decades of intense study have begun to provide an understanding of the mechanisms that regulate MYC's seemingly split personality.  Key features of MYC-induced apoptosis will be discussed here along with examples of how our understanding of this pathway might be exploited for the therapeutic benefit of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-2J30dsIPKLVg90H21EOLACvtfcHk0lgcSs0R9wOt6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yltrzP&md5=68ef64c834d2ab2e06ae6a0bb5ab61d4</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a014407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a014407%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26atitle%3DMYC%2520and%2520the%2520control%2520of%2520apoptosis%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2014%26volume%3D4%26spage%3Da014407%26doi%3D10.1101%2Fcshperspect.a014407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Valentino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubbs, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunhoeber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimsza, L.</span><span> </span><span class="NLM_article-title">Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">â</span> <span class="NLM_lpage">254</span><span class="refDoi">Â DOI: 10.1309/AJCP2Z0TAGMUYJEB</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1309%2FAJCP2Z0TAGMUYJEB" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=23355209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A280%3ADC%252BC3szivFOrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2013&pages=242-254&author=C.+Valentinoauthor=S.+Kendrickauthor=N.+Johnsonauthor=R.+Gascoyneauthor=W.+C.+Chanauthor=D.+D.+Weisenburgerauthor=R.+Brazielauthor=J.+Cookauthor=R.+R.+Tubbsauthor=E.+Campoauthor=A.+Rosenwaldauthor=G.+Ottauthor=J.+Delabieauthor=E.+Jaffeauthor=W.+Zhangauthor=P.+Brunhoeberauthor=H.+Nittaauthor=T.+Groganauthor=L.+Rimsza&title=Colorimetric+in+situ+hybridization+identifies+MYC+gene+signal+clusters+correlating+with+increased+copy+number%2C+mRNA%2C+and+protein+in+diffuse+large+B-cell+lymphoma&doi=10.1309%2FAJCP2Z0TAGMUYJEB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma</span></div><div class="casAuthors">Valentino Carlo; Kendrick Samantha; Johnson Nathalie; Gascoyne Randy; Chan Wing C; Weisenburger Dennis; Braziel Rita; Cook James R; Tubbs Raymond; Campo Elias; Rosenwald Andreas; Ott German; Delabie Jan; Jaffe Elaine; Zhang Wenjun; Brunhoeber Patrick; Nitta Hiro; Grogan Tom; Rimsza Lisa</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Abnormalities of the MYC oncogene on chromosome 8 are characteristic of Burkitt lymphoma and other aggressive B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL).  We recently described a colorimetric in situ hybridization (CISH) method for detecting extra copies of the MYC gene in DLBCL and the frequent occurrence of excess copies of discrete MYC signals in the context of diploidy or polyploidy of chromosome 8, which correlated with increased mRNA signals.  We further observed enlarged MYC signals, which were counted as a single gene copy but, by their dimension and unusual shape, likely consisted of "clusters" of MYC genes.  In this study, we sought to further characterize these clusters of MYC signals by determining whether the presence of these correlated with other genetic features, mRNA levels, protein, and overall survival.  We found that MYC clusters correlated with an abnormal MYC locus and with increased mRNA.  MYC mRNA correlated with protein levels, and both increased mRNA and protein correlated with poorer overall survival.  MYC clusters were seen in both the germinal center and activated B-cell subtypes of DLBCL.  Clusters of MYC signals may be an underappreciated, but clinically important, feature of aggressive B-cell lymphomas with potential prognostic and therapeutic relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRq-qBcTAIZH7JzI8owOhpDfW6udTcc2eYqqX3CiLnJArntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szivFOrtw%253D%253D&md5=19d2d55307fd76b049ff7639b2e703de</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1309%2FAJCP2Z0TAGMUYJEB&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FAJCP2Z0TAGMUYJEB%26sid%3Dliteratum%253Aachs%26aulast%3DValentino%26aufirst%3DC.%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DN.%26aulast%3DGascoyne%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DBraziel%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DJaffe%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBrunhoeber%26aufirst%3DP.%26aulast%3DNitta%26aufirst%3DH.%26aulast%3DGrogan%26aufirst%3DT.%26aulast%3DRimsza%26aufirst%3DL.%26atitle%3DColorimetric%2520in%2520situ%2520hybridization%2520identifies%2520MYC%2520gene%2520signal%2520clusters%2520correlating%2520with%2520increased%2520copy%2520number%252C%2520mRNA%252C%2520and%2520protein%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2013%26volume%3D139%26spage%3D242%26epage%3D254%26doi%3D10.1309%2FAJCP2Z0TAGMUYJEB" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sveva Pelliccia, Jussara Amato, Domenica Capasso, Sonia Di Gaetano, Alberto Massarotti, Marialuisa Piccolo, Carlo Irace, Gian Cesare Tron, Bruno Pagano, Antonio Randazzo, Ettore Novellino, <span class="NLM_string-name hlFld-ContribAuthor">Mariateresa Giustiniano</span>. </span><span class="cited-content_cbyCitation_article-title">Bio-Inspired Dual-Selective BCL-2/c-MYC G-Quadruplex Binders: Design, Synthesis, and Anticancer Activity of Drug-like Imidazo[2,1-i]purine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2035-2050. <a href="https://doi.org/10.1021/acs.jmedchem.9b00262" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBio-Inspired%252BDual-Selective%252BBCL-2%25252Fc-MYC%252BG-Quadruplex%252BBinders%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BAnticancer%252BActivity%252Bof%252BDrug-like%252BImidazo%25255B2%25252C1-i%25255Dpurine%252BDerivatives%26aulast%3DPelliccia%26aufirst%3DSveva%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D08022019%26date%3D10072019%26date%3D26062019%26volume%3D63%26issue%3D5%26spage%3D2035%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daria V.  Andreeva</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Tikhomirov</span>, <span class="hlFld-ContribAuthor ">Andrey E.  Shchekotikhin</span>. </span><span class="cited-content_cbyCitation_article-title">Ligands of G-quadruplex nucleic acids. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2021,</strong> <em>90 </em>
                                    (1)
                                     , 1-38. <a href="https://doi.org/10.1070/RCR4968" title="DOI URL">https://doi.org/10.1070/RCR4968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4968%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DLigands%252Bof%252BG-quadruplex%252Bnucleic%252Bacids%26aulast%3DAndreeva%26aufirst%3DDaria%2BV.%26date%3D2021%26volume%3D90%26issue%3D1%26spage%3D1%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Zhi  Xu</span>, <span class="hlFld-ContribAuthor ">Piroon  Jenjaroenpun</span>, <span class="hlFld-ContribAuthor ">Thidathip  Wongsurawat</span>, <span class="hlFld-ContribAuthor ">Stephanie D  Byrum</span>, <span class="hlFld-ContribAuthor ">Volodymyr  Shponka</span>, <span class="hlFld-ContribAuthor ">David  Tannahill</span>, <span class="hlFld-ContribAuthor ">Elizabeth A  Chavez</span>, <span class="hlFld-ContribAuthor ">Stacy S  Hung</span>, <span class="hlFld-ContribAuthor ">Christian  Steidl</span>, <span class="hlFld-ContribAuthor ">Shankar  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Lisa M  Rimsza</span>, <span class="hlFld-ContribAuthor ">Samantha  Kendrick</span>. </span><span class="cited-content_cbyCitation_article-title">Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphoma. </span><span class="cited-content_cbyCitation_journal-name">NAR Cancer</span><span> <strong>2020,</strong> <em>2 </em>
                                    (4)
                                     <a href="https://doi.org/10.1093/narcan/zcaa029" title="DOI URL">https://doi.org/10.1093/narcan/zcaa029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/narcan/zcaa029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnarcan%2Fzcaa029%26sid%3Dliteratum%253Aachs%26jtitle%3DNAR%2520Cancer%26atitle%3DActivation-induced%252Bcytidine%252Bdeaminase%252Blocalizes%252Bto%252BG-quadruplex%252Bmotifs%252Bat%252Bmutation%252Bhotspots%252Bin%252Blymphoma%26aulast%3DXu%26aufirst%3DYing-Zhi%26date%3D2020%26date%3D2020%26volume%3D2%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam  Eckburg</span>, <span class="hlFld-ContribAuthor ">Joshua  Dein</span>, <span class="hlFld-ContribAuthor ">Joseph  Berei</span>, <span class="hlFld-ContribAuthor ">Zachary  Schrank</span>, <span class="hlFld-ContribAuthor ">Neelu  Puri</span>. </span><span class="cited-content_cbyCitation_article-title">Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     , 2337. <a href="https://doi.org/10.3390/cancers12092337" title="DOI URL">https://doi.org/10.3390/cancers12092337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12092337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12092337%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DOligonucleotides%252Band%252BmicroRNAs%252BTargeting%252BTelomerase%252BSubunits%252Bin%252BCancer%252BTherapy%26aulast%3DEckburg%26aufirst%3DAdam%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D9%26spage%3D2337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre  Devaux</span>, <span class="hlFld-ContribAuthor ">Laureen  Bonnat</span>, <span class="hlFld-ContribAuthor ">Thomas  Lavergne</span>, <span class="hlFld-ContribAuthor ">Eric  Defrancq</span>. </span><span class="cited-content_cbyCitation_article-title">Access to a stabilized
              i
              -motif DNA structure through four successive ligation reactions on a cyclopeptide scaffold. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (32)
                                     , 6394-6406. <a href="https://doi.org/10.1039/D0OB01311K" title="DOI URL">https://doi.org/10.1039/D0OB01311K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01311K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01311K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAccess%252Bto%252Ba%252Bstabilized%252Bi%252B-motif%252BDNA%252Bstructure%252Bthrough%252Bfour%252Bsuccessive%252Bligation%252Breactions%252Bon%252Ba%252Bcyclopeptide%252Bscaffold%26aulast%3DDevaux%26aufirst%3DAlexandre%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D32%26spage%3D6394%26epage%3D6406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinwei  Duan</span>, <span class="hlFld-ContribAuthor ">Xing  Wang</span>, <span class="hlFld-ContribAuthor ">Megan E.  Kizer</span>. </span><span class="cited-content_cbyCitation_article-title">Biotechnological and Therapeutic Applications of Natural Nucleic Acid Structural Motifs. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2020,</strong> <em>378 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-0290-z" title="DOI URL">https://doi.org/10.1007/s41061-020-0290-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-0290-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-0290-z%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DBiotechnological%252Band%252BTherapeutic%252BApplications%252Bof%252BNatural%252BNucleic%252BAcid%252BStructural%252BMotifs%26aulast%3DDuan%26aufirst%3DJinwei%26date%3D2020%26date%3D2020%26volume%3D378%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Montoya</span>, <span class="hlFld-ContribAuthor ">Megan A.  Turnidge</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Wai</span>, <span class="hlFld-ContribAuthor ">Apurvi R.  Patel</span>, <span class="hlFld-ContribAuthor ">David W.  Lee</span>, <span class="hlFld-ContribAuthor ">Vijay  Gokhale</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Hurley</span>, <span class="hlFld-ContribAuthor ">Robert J.  Arceci</span>, <span class="hlFld-ContribAuthor ">Cynthia  Wetmore</span>, <span class="hlFld-ContribAuthor ">David O.  Azorsa</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2019,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-019-6464-9" title="DOI URL">https://doi.org/10.1186/s12885-019-6464-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-019-6464-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-019-6464-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DIn%252Bvitro%252Bactivity%252Bof%252Ba%252BG-quadruplex-stabilizing%252Bsmall%252Bmolecule%252Bthat%252Bsynergizes%252Bwith%252BNavitoclax%252Bto%252Binduce%252Bcytotoxicity%252Bin%252Bacute%252Bmyeloid%252Bleukemia%252Bcells%26aulast%3DMontoya%26aufirst%3DJustin%2BJ.%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Taladriz-Sender</span>, <span class="hlFld-ContribAuthor ">Emma  Campbell</span>, <span class="hlFld-ContribAuthor ">Glenn A.  Burley</span>. </span><span class="cited-content_cbyCitation_article-title">Splice-switching small molecules: A new therapeutic approach to modulate gene expression. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2019,</strong> <em>167 </em>, 134-142. <a href="https://doi.org/10.1016/j.ymeth.2019.06.011" title="DOI URL">https://doi.org/10.1016/j.ymeth.2019.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2019.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2019.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DSplice-switching%252Bsmall%252Bmolecules%25253A%252BA%252Bnew%252Btherapeutic%252Bapproach%252Bto%252Bmodulate%252Bgene%252Bexpression%26aulast%3DTaladriz-Sender%26aufirst%3DAndrea%26date%3D2019%26volume%3D167%26spage%3D134%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Min  Wei</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Shu-Long  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Bi-Qun  Zou</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Yao</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of telomerase activity and SK-OV-3/DDP cell apoptosis by rhodium(III) and iron(III) complexes with 4â²-(3-thiophenecarboxaldehyde)-2,2â²:6â²,2â³-terpyridine. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Communications</span><span> <strong>2019,</strong> <em>102 </em>, 180-184. <a href="https://doi.org/10.1016/j.inoche.2019.02.030" title="DOI URL">https://doi.org/10.1016/j.inoche.2019.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.inoche.2019.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.inoche.2019.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Communications%26atitle%3DInhibition%252Bof%252Btelomerase%252Bactivity%252Band%252BSK-OV-3%25252FDDP%252Bcell%252Bapoptosis%252Bby%252Brhodium%252528III%252529%252Band%252Biron%252528III%252529%252Bcomplexes%252Bwith%252B4%2525E2%252580%2525B2-%2525283-thiophenecarboxaldehyde%252529-2%25252C2%2525E2%252580%2525B2%25253A6%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B3-terpyridine%26aulast%3DWei%26aufirst%3DQing-Min%26date%3D2019%26volume%3D102%26spage%3D180%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Debnath</span>, <span class="hlFld-ContribAuthor ">Khushnood  Fatma</span>, <span class="hlFld-ContribAuthor ">Jyotirmayee  Dash</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Regulation of DNA iâMotifs for Nanobiotechnology and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (10)
                                     , 2968-2983. <a href="https://doi.org/10.1002/ange.201813288" title="DOI URL">https://doi.org/10.1002/ange.201813288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201813288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201813288%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DChemical%252BRegulation%252Bof%252BDNA%252Bi%2525E2%252580%252590Motifs%252Bfor%252BNanobiotechnology%252Band%252BTherapeutics%26aulast%3DDebnath%26aufirst%3DManish%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D10%26spage%3D2968%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Debnath</span>, <span class="hlFld-ContribAuthor ">Khushnood  Fatma</span>, <span class="hlFld-ContribAuthor ">Jyotirmayee  Dash</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Regulation of DNA iâMotifs for Nanobiotechnology and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (10)
                                     , 2942-2957. <a href="https://doi.org/10.1002/anie.201813288" title="DOI URL">https://doi.org/10.1002/anie.201813288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201813288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201813288%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DChemical%252BRegulation%252Bof%252BDNA%252Bi%2525E2%252580%252590Motifs%252Bfor%252BNanobiotechnology%252Band%252BTherapeutics%26aulast%3DDebnath%26aufirst%3DManish%26date%3D2019%26volume%3D58%26issue%3D10%26spage%3D2942%26epage%3D2957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tea  Umek</span>, <span class="hlFld-ContribAuthor ">Karin  Sollander</span>, <span class="hlFld-ContribAuthor ">Helen  Bergquist</span>, <span class="hlFld-ContribAuthor ">Jesper  Wengel</span>, <span class="hlFld-ContribAuthor ">Karin E.  Lundin</span>, <span class="hlFld-ContribAuthor ">C.I. Edvard  Smith</span>, <span class="hlFld-ContribAuthor ">Rula  Zain</span>. </span><span class="cited-content_cbyCitation_article-title">Oligonucleotide Binding to Non-B-DNA in MYC. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5)
                                     , 1000. <a href="https://doi.org/10.3390/molecules24051000" title="DOI URL">https://doi.org/10.3390/molecules24051000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24051000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24051000%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOligonucleotide%252BBinding%252Bto%252BNon-B-DNA%252Bin%252BMYC%26aulast%3DUmek%26aufirst%3DTea%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D5%26spage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah A.  Flusberg</span>, <span class="hlFld-ContribAuthor ">Noreen F.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Victoria  Kutilek</span>, <span class="hlFld-ContribAuthor ">Christine  Andrews</span>, <span class="hlFld-ContribAuthor ">Peter  Saradjian</span>, <span class="hlFld-ContribAuthor ">Chad  Chamberlin</span>, <span class="hlFld-ContribAuthor ">Patrick  Curran</span>, <span class="hlFld-ContribAuthor ">Brooke  Swalm</span>, <span class="hlFld-ContribAuthor ">Sam  Kattar</span>, <span class="hlFld-ContribAuthor ">Graham F.  Smith</span>, <span class="hlFld-ContribAuthor ">Peter  Dandliker</span>, <span class="hlFld-ContribAuthor ">Elliott B.  Nickbarg</span>, <span class="hlFld-ContribAuthor ">Jennifer  OâNeil</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity SelectionâMass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (2)
                                     , 142-157. <a href="https://doi.org/10.1177/2472555218796656" title="DOI URL">https://doi.org/10.1177/2472555218796656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555218796656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555218796656%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DIdentification%252Bof%252BG-Quadruplex-Binding%252BInhibitors%252Bof%252BMyc%252BExpression%252Bthrough%252BAffinity%252BSelection%2525E2%252580%252593Mass%252BSpectrometry%26aulast%3DFlusberg%26aufirst%3DDeborah%2BA.%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D2%26spage%3D142%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sefan  Asamitsu</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Obata</span>, <span class="hlFld-ContribAuthor ">Zutao  Yu</span>, <span class="hlFld-ContribAuthor ">Toshikazu  Bando</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugiyama</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 429. <a href="https://doi.org/10.3390/molecules24030429" title="DOI URL">https://doi.org/10.3390/molecules24030429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24030429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24030429%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BProgress%252Bof%252BTargeted%252BG-Quadruplex-Preferred%252BLigands%252BToward%252BCancer%252BTherapy%26aulast%3DAsamitsu%26aufirst%3DSefan%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fedor  Kouzine</span>, <span class="hlFld-ContribAuthor ">Damian  Wojtowicz</span>, <span class="hlFld-ContribAuthor ">Arito  Yamane</span>, <span class="hlFld-ContribAuthor ">Rafael  Casellas</span>, <span class="hlFld-ContribAuthor ">Teresa M.  Przytycka</span>, <span class="hlFld-ContribAuthor ">David L.  Levens</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Chemical Probing for G-Quadruplex Formation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 369-382. <a href="https://doi.org/10.1007/978-1-4939-9666-7_23" title="DOI URL">https://doi.org/10.1007/978-1-4939-9666-7_23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9666-7_23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9666-7_23%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252BVivo%252BChemical%252BProbing%252Bfor%252BG-Quadruplex%252BFormation%26aulast%3DKouzine%26aufirst%3DFedor%26date%3D2019%26date%3D2019%26spage%3D369%26epage%3D382%26pub%3DSpringer%2520New%2520York%26atitle%3DG-Quadruplex%252BNucleic%252BAcids%26aulast%3DYang%26aufirst%3DDanzhou%26date%3D2019%26volume%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara N.  Journey</span>, <span class="hlFld-ContribAuthor ">Stephanie L.  Alden</span>, <span class="hlFld-ContribAuthor ">Will M.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Megan L.  Peach</span>, <span class="hlFld-ContribAuthor ">Marc C.  Nicklaus</span>, <span class="hlFld-ContribAuthor ">John S.  Schneekloth Jr</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the
              hras
              -1
              Y
              i-motif with small molecules. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 2000-2007. <a href="https://doi.org/10.1039/C8MD00311D" title="DOI URL">https://doi.org/10.1039/C8MD00311D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00311D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00311D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DProbing%252Bthe%252Bhras%252B-1%252BY%252Bi-motif%252Bwith%252Bsmall%252Bmolecules%26aulast%3DJourney%26aufirst%3DSara%2BN.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D12%26spage%3D2000%26epage%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hala  AbouÂ Assi</span>, <span class="hlFld-ContribAuthor ">Miguel  GaravÃ­s</span>, <span class="hlFld-ContribAuthor ">Carlos  GonzÃ¡lez</span>, <span class="hlFld-ContribAuthor ">Masad J  Damha</span>. </span><span class="cited-content_cbyCitation_article-title">i-Motif DNA: structural features and significance to cell biology. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2018,</strong> <em>46 </em>
                                    (16)
                                     , 8038-8056. <a href="https://doi.org/10.1093/nar/gky735" title="DOI URL">https://doi.org/10.1093/nar/gky735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gky735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgky735%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3Di-Motif%252BDNA%25253A%252Bstructural%252Bfeatures%252Band%252Bsignificance%252Bto%252Bcell%252Bbiology%26aulast%3DAbou%25C2%25A0Assi%26aufirst%3DHala%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D16%26spage%3D8038%26epage%3D8056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasish  Dutta</span>, <span class="hlFld-ContribAuthor ">Manish  Debnath</span>, <span class="hlFld-ContribAuthor ">Diana  MÃ¼ller</span>, <span class="hlFld-ContribAuthor ">Rakesh  Paul</span>, <span class="hlFld-ContribAuthor ">Tania  Das</span>, <span class="hlFld-ContribAuthor ">Irene  Bessi</span>, <span class="hlFld-ContribAuthor ">Harald  Schwalbe</span>, <span class="hlFld-ContribAuthor ">Jyotirmayee  Dash</span>. </span><span class="cited-content_cbyCitation_article-title">Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2018,</strong> <em>46 </em>
                                    (11)
                                     , 5355-5365. <a href="https://doi.org/10.1093/nar/gky385" title="DOI URL">https://doi.org/10.1093/nar/gky385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gky385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgky385%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DCell%252Bpenetrating%252Bthiazole%252Bpeptides%252Binhibit%252Bc-MYC%252Bexpression%252Bvia%252Bsite-specific%252Btargeting%252Bof%252Bc-MYC%252BG-quadruplex%26aulast%3DDutta%26aufirst%3DDebasish%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D11%26spage%3D5355%26epage%3D5365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilektra-Chara  Giassa</span>, <span class="hlFld-ContribAuthor ">Jan  Rynes</span>, <span class="hlFld-ContribAuthor ">Tomas  Fessl</span>, <span class="hlFld-ContribAuthor ">Silvie  Foldynova-Trantirkova</span>, <span class="hlFld-ContribAuthor ">Lukas  Trantirek</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the cellular structural biology of nucleic acids. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2018,</strong> <em>592 </em>
                                    (12)
                                     , 1997-2011. <a href="https://doi.org/10.1002/1873-3468.13054" title="DOI URL">https://doi.org/10.1002/1873-3468.13054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1873-3468.13054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1873-3468.13054%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DAdvances%252Bin%252Bthe%252Bcellular%252Bstructural%252Bbiology%252Bof%252Bnucleic%252Bacids%26aulast%3DGiassa%26aufirst%3DIlektra-Chara%26date%3D2018%26date%3D2018%26volume%3D592%26issue%3D12%26spage%3D1997%26epage%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mangesh H.  Kaulage</span>, <span class="hlFld-ContribAuthor ">Santanu  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">K.  Muniyappa</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Characterization of i-Motif Structure in the Human Acetyl-CoA Carboxylaseâ1 Gene Promoters and Their Role in the Regulation of Gene Expression. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2018,</strong> <em>19 </em>
                                    (10)
                                     , 1078-1087. <a href="https://doi.org/10.1002/cbic.201800021" title="DOI URL">https://doi.org/10.1002/cbic.201800021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201800021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201800021%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DStructural%252BCharacterization%252Bof%252Bi-Motif%252BStructure%252Bin%252Bthe%252BHuman%252BAcetyl-CoA%252BCarboxylase%2525E2%252580%2525851%252BGene%252BPromoters%252Band%252BTheir%252BRole%252Bin%252Bthe%252BRegulation%252Bof%252BGene%252BExpression%26aulast%3DKaulage%26aufirst%3DMangesh%2BH.%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D10%26spage%3D1078%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Dzatko</span>, <span class="hlFld-ContribAuthor ">Michaela  Krafcikova</span>, <span class="hlFld-ContribAuthor ">Robert  HÃ¤nsel-Hertsch</span>, <span class="hlFld-ContribAuthor ">Tomas  Fessl</span>, <span class="hlFld-ContribAuthor ">Radovan  Fiala</span>, <span class="hlFld-ContribAuthor ">Tomas  Loja</span>, <span class="hlFld-ContribAuthor ">Daniel  Krafcik</span>, <span class="hlFld-ContribAuthor ">Jean-Louis  Mergny</span>, <span class="hlFld-ContribAuthor ">Silvie  Foldynova-Trantirkova</span>, <span class="hlFld-ContribAuthor ">Lukas  Trantirek</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Stability of DNA i-Motifs in the Nuclei of Living Mammalian Cells. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (8)
                                     , 2187-2191. <a href="https://doi.org/10.1002/ange.201712284" title="DOI URL">https://doi.org/10.1002/ange.201712284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201712284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201712284%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEvaluation%252Bof%252Bthe%252BStability%252Bof%252BDNA%252Bi-Motifs%252Bin%252Bthe%252BNuclei%252Bof%252BLiving%252BMammalian%252BCells%26aulast%3DDzatko%26aufirst%3DSimon%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D8%26spage%3D2187%26epage%3D2191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Dzatko</span>, <span class="hlFld-ContribAuthor ">Michaela  Krafcikova</span>, <span class="hlFld-ContribAuthor ">Robert  HÃ¤nsel-Hertsch</span>, <span class="hlFld-ContribAuthor ">Tomas  Fessl</span>, <span class="hlFld-ContribAuthor ">Radovan  Fiala</span>, <span class="hlFld-ContribAuthor ">Tomas  Loja</span>, <span class="hlFld-ContribAuthor ">Daniel  Krafcik</span>, <span class="hlFld-ContribAuthor ">Jean-Louis  Mergny</span>, <span class="hlFld-ContribAuthor ">Silvie  Foldynova-Trantirkova</span>, <span class="hlFld-ContribAuthor ">Lukas  Trantirek</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Stability of DNA i-Motifs in the Nuclei of Living Mammalian Cells. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (8)
                                     , 2165-2169. <a href="https://doi.org/10.1002/anie.201712284" title="DOI URL">https://doi.org/10.1002/anie.201712284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201712284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201712284%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEvaluation%252Bof%252Bthe%252BStability%252Bof%252BDNA%252Bi-Motifs%252Bin%252Bthe%252BNuclei%252Bof%252BLiving%252BMammalian%252BCells%26aulast%3DDzatko%26aufirst%3DSimon%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D8%26spage%3D2165%26epage%3D2169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Bi-Qun  Zou</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Shu-Long  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Cheng  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptanthrin derivative copper(
              ii
              ) complexes with high antitumor activity by inhibiting telomerase activity, and inducing mitochondria-mediated apoptosis and S-phase arrest in BEL-7402. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (18)
                                     , 15479-15487. <a href="https://doi.org/10.1039/C8NJ03005G" title="DOI URL">https://doi.org/10.1039/C8NJ03005G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ03005G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ03005G%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DTryptanthrin%252Bderivative%252Bcopper%252528%252Bii%252B%252529%252Bcomplexes%252Bwith%252Bhigh%252Bantitumor%252Bactivity%252Bby%252Binhibiting%252Btelomerase%252Bactivity%25252C%252Band%252Binducing%252Bmitochondria-mediated%252Bapoptosis%252Band%252BS-phase%252Barrest%252Bin%252BBEL-7402%26aulast%3DQin%26aufirst%3DQi-Pin%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D18%26spage%3D15479%26epage%3D15487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Testa</span>, <span class="hlFld-ContribAuthor ">Pietro  DâAddabbo</span>, <span class="hlFld-ContribAuthor ">Ersilia  Fornetti</span>, <span class="hlFld-ContribAuthor ">Roberta  Belli</span>, <span class="hlFld-ContribAuthor ">Claudia  Fuoco</span>, <span class="hlFld-ContribAuthor ">Sergio  Bernardini</span>, <span class="hlFld-ContribAuthor ">Stefano  Cannata</span>, <span class="hlFld-ContribAuthor ">Domenico  Frezza</span>, <span class="hlFld-ContribAuthor ">Cesare  Gargioli</span>. </span><span class="cited-content_cbyCitation_article-title">Myoblast Myogenic Differentiation but Not Fusion Process Is Inhibited via MyoD Tetraplex Interaction. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2018,</strong> <em>2018 </em>, 1-8. <a href="https://doi.org/10.1155/2018/7640272" title="DOI URL">https://doi.org/10.1155/2018/7640272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/7640272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F7640272%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DMyoblast%252BMyogenic%252BDifferentiation%252Bbut%252BNot%252BFusion%252BProcess%252BIs%252BInhibited%252Bvia%252BMyoD%252BTetraplex%252BInteraction%26aulast%3DTesta%26aufirst%3DStefano%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Ding</span>, <span class="hlFld-ContribAuthor ">Tao  Xu</span>, <span class="hlFld-ContribAuthor ">Chang-yao  Li</span>, <span class="hlFld-ContribAuthor ">Dan-dan  Zhou</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">HZ-6d targeted HERC5 to regulate p53 ISGylation in human hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2017,</strong> <em>334 </em>, 180-191. <a href="https://doi.org/10.1016/j.taap.2017.09.011" title="DOI URL">https://doi.org/10.1016/j.taap.2017.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2017.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2017.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DHZ-6d%252Btargeted%252BHERC5%252Bto%252Bregulate%252Bp53%252BISGylation%252Bin%252Bhuman%252Bhepatocellular%252Bcarcinoma%26aulast%3DWang%26aufirst%3DYang%26date%3D2017%26volume%3D334%26spage%3D180%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed model for targeting the DNA secondary structure formation within the <i>MYC</i> and <i>BCL2</i> gene promoter regions with <b>05</b> and <b>76</b>. (A) The <i>MYC</i> promoter region consists of a G-rich element that forms a G-quadruplex structure from three stacked G-tetrads composed of four G-Hoogsteen base pairs.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> (B) The C-rich sequence upstream of the <i>BCL2</i> promoter region is capable of adopting an i-motif structure with three and one-half sets of two intercalated hemiprotonated C<sup>+</sup>âC base pairs.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (C) During transcription NM23-H2 can unfold the <i>MYC</i> G-quadruplex, resulting in single-stranded DNA to which CNBP can bind and activate <i>MYC</i> transcription. (D) The nuclear protein hnRNP LL can initiate conformational changes in the <i>BCL2</i> i-motif, leading to transcription activation. (E) Binding of <b>05</b> stabilizes the <i>MYC</i> G-quadruplex, resulting in transcription repression.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> (F) <b>76</b> sequesters the flexible hairpin form of this dynamic element and inhibits transcription.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>MYC</i> targeting with <b>05</b> in DLBCL in vitro and in vivo models. (A) <i>MYC</i> mRNA (left panel) and protein (right panel) expression in DLBCL cell lines as detected by qPCR and Western blot. (B) Effect of 24 h treatment with <b>05</b> on <i>MYC</i> mRNA and protein expression. (C) Tumor burden of mice treated with CPA alone or cotreated with <b>05</b> as measured by tumor volume. Arrows indicate the 5 days of drug administration. <i>MYC</i> mRNA expression is relative to TBP and compared to levels in either the HT or untreated cells. Western blots are representative, with actin as a loading control and DMSO used as vehicle/diluent control. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.0001 for triplicate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>BCL2</i> targeting with <b>76</b> in DLBCL cell lines. (A) <i>BCL2</i> mRNA (left panel) and protein (right panel) expression in DLBCL cell lines as detected by qPCR and Western blot. (B) Effect of 24 h treatment with <b>76</b> on <i>BCL2</i> mRNA and protein expression. <i>BCL2</i> mRNA expression is relative to TBP and compared to levels in either the HT or untreated cells. Western blots are representative, with actin as a loading control and DMSO used as vehicle control. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.0001 for triplicate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dual-targeting of <i>BCL2</i> and <i>MYC</i> increases the efficacy of CPA in DLBCL cell lines. (A) Percent cell viability determined by an MTS cytotoxicity assay following 96 h treatment with CPA alone, with <b>76</b> or <b>05</b>, and with both <b>76</b> and <b>05</b>. CPA concentration for the combination treatments were 5 mM for SUDHL4 and VAL and 10 mM for HT and U2932 cells. Significance considered at <i>P</i> â¤ 0.006 for CPA only comparisons to the nine possible combination treatments and <i>P</i> â¤ 0.03 for the CPA+<b>76</b> or CPA+<b>05</b> compared to the triple combination. (B) Percent caspase-3 activity following 24 h treatment with 1.25 mM CPA alone or in combination with <b>76</b> and/or <b>05</b>. Significance considered at <i>P</i> â¤ 0.02 for CPA only comparisons to the three possible combination treatments. Data represent three replicates, with the exception of HT and SUDHL4 in panel B, which represent four replicates. Comparisons were conducted using the Studentâs <i>t</i> test with the Å Ã­dÃ¡kâBonferroni multiple test correction applied. *<i>P</i> < 0.05 and **<i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/medium/jm-2017-00298v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Simultaneous <i>BCL2</i> and <i>MYC</i> repression sensitizes DLBCL tumor cells to CPA and inhibits tumor growth in mice. (A) Tumor burden of U2932 xenograft mice treated with CPA alone, <b>76</b> and <b>05</b>, or CPA with <b>76</b> and <b>05</b> as measured by tumor volume (<i>n</i> = 5â8). Arrows indicate the 5 days of drug administration. (B) Comparison of the area under the curve for the tumor burden of each treatment combination or control (<i>n</i> = 5â8; solid black bars represent alternative treatment combinations for which curves are shown in Figure S6A of the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf" class="ext-link">Supporting Information</a>). (C) qPCR analysis for <i>BCL2</i> (top) or <i>MYC</i> (bottom) mRNA expression relative to TBP compared to levels in diluent-treated tumors (<i>n</i> = 2â3). *<i>P</i> < 0.05 and **<i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00298/20170804/images/large/jm-2017-00298v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00298&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Williamson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghuraman, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cech, T. R.</span><span> </span><span class="NLM_article-title">Monovalent cation-induced structure of telomeric DNA: the G-quartet model</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">â</span> <span class="NLM_lpage">880</span><span class="refDoi">Â DOI: 10.1016/0092-8674(89)90610-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2F0092-8674%2889%2990610-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=2590943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFCgsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1989&pages=871-880&author=J.+R.+Williamsonauthor=M.+K.+Raghuramanauthor=T.+R.+Cech&title=Monovalent+cation-induced+structure+of+telomeric+DNA%3A+the+G-quartet+model&doi=10.1016%2F0092-8674%2889%2990610-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Monovalent cation-induced structure of telomeric DNA:  the G-quartet model</span></div><div class="casAuthors">Williamson, James R.; Raghuraman, M. K.; Cech, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">871-80</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Structures formed by oligonucleotides composed of 2 or 4 repeats of the telomeric sequences from Oxytricha and Tetrahymena were investigated.  The Oxytricha 4-repeat mol. [d(T4G4)4 = Oxy-4] forms structures with increased electrophoretic mobility in nondenaturing gels contg. Na+, K+, or Cs+, but not in gels contg. Li+ or no added salt.  Formation of the folded structure results in protection of a set of dG's from methylation by di-Me sulfate.  Efficient UV-induced crosslinks are obsd. in Oxy-4 and the related sequence from Tetrahymena [d(T2G4)4 = Tet-4], and join thymidines in different repeats.  Models proposed to account for these data involve G-quartets, H-bonded structures formed from 4 guanosines in a square-planar array.  It is proposed that the G-quartet structure must be dealt with in vivo by the telomere replication machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogp-GTQAD5FbVg90H21EOLACvtfcHk0lhWxgNFOUvGLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFCgsLo%253D&md5=6a86541fc934bcd72b517b75e2dda57b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2889%2990610-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252889%252990610-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%2BR.%26aulast%3DRaghuraman%26aufirst%3DM.%2BK.%26aulast%3DCech%26aufirst%3DT.%2BR.%26atitle%3DMonovalent%2520cation-induced%2520structure%2520of%2520telomeric%2520DNA%253A%2520the%2520G-quartet%2520model%26jtitle%3DCell%26date%3D1989%26volume%3D59%26spage%3D871%26epage%3D880%26doi%3D10.1016%2F0092-8674%2889%2990610-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Leroy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueron, M.</span><span> </span><span class="NLM_article-title">Acid multimers of oligodeoxycytidine strands: stoichiometry, base-pair characterization, and proton exchange properties</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">6019</span><span class="NLM_x">â</span> <span class="NLM_lpage">6031</span><span class="refDoi">Â DOI: 10.1021/bi00074a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00074a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADyaK3sXkvV2itr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=6019-6031&author=J.+L.+Leroyauthor=K.+Gehringauthor=A.+Kettaniauthor=M.+Gueron&title=Acid+multimers+of+oligodeoxycytidine+strands%3A+stoichiometry%2C+base-pair+characterization%2C+and+proton+exchange+properties&doi=10.1021%2Fbi00074a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Acid multimers of oligodeoxycytidine strands: Stoichiometry, base-pair characterization, and proton exchange properties</span></div><div class="casAuthors">Leroy, Jean Louis; Gehring, Kalle; Kettani, Abdelali; Gueron, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6019-31</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The structure recently proposed for the acid form of the oligonucleotide 5'-d(TC5) is a four-strand tetrad in which two parallel-stranded, base-paired duplexes are intimately assocd., with their hemiprotonated CÂ·C+ base pairs face-to-face and fully intercalated, in a so-called i-motif (K. Gehring et al., 1993).  The amino and imino proton spectra were used to establish the structure and symmetry of the base pairs, properties which are a primary element in the resoln. of the acid form described above.  The amino proton spectrum gives the best lower limit (8 Ã 104 s-1) on the rate of the imino proton jumping process which is responsible for the base-pair symmetry.  The stoichiometry of the acid form of other deoxycytidine sequences is studied by gel filtration chromatog. and in one case by an NMR equil. titrn.  In all cases, i.e., d(C12), d(T2C8T2), d(C4TC4), d(TC5), d(C5), d(C4), d(TC4), d(TC3T), and d(TC3), the acid form elutes as a tetramer.  A single-strand component is also present in some cases.  But no dimer is obsd., except for some samples prepd. by quenching from high temps.  The characteristic H1'-H' interresidue NOESY cross-peaks of the d(TC5) structure (K. Gerhring et al., 1992) are also found in all the tetramers where they have been searched for, i.e., those of d(T2C8T2), d(C4TC4), d(TC3T), and d(TC3) (not shown), suggesting that these tetramers also are built on the i-motif and that such structures may be formed generally by strands contg. a stretch of as little as three deoxycytidines.  From the NMR titrn. of d(TC3), a free energy of -7.6 kJ/mol per cytidine base pair was derived for the formation of the tetramer from single strands.  The free energy released by packing a base pair into the i-motif is comparable to that released in forming the base pair itself.  Imino proton exchange is limited by base-pair opening, thanks to efficient intrinsic exchange catalysis: this explains the lack of effect of added catalysts.  The base-pair lifetime is hundreds of times longer than in any DNA duplex, presumably due to the base-pair intercalation geometry.  The variation of the lifetime along the sequence of the d(TC5) tetramer provides support for the recently proposed structure.  The internal amino proton exchanges from the open state of the CÂ·C+ pair, at a rate compatible with a pK of 9 appropriate for C+.  But the external proton exchanges from the closed state, as with a pK of 17!  Comparable pK shifts occur upon transfer of org. acids from an aq. to an org. solvent.  It is also shown that exchange of the internal amino proton is opening-limited, even though it is eight times slower than imino proton exchange.  The lifetime of the open state is at least 1 Î¼s, 100 times longer than in duplexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwdkqnUe73bVg90H21EOLACvtfcHk0lhWxgNFOUvGLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvV2itr0%253D&md5=37cfaa5a5b354831bbe34f06e27defbc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fbi00074a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00074a013%26sid%3Dliteratum%253Aachs%26aulast%3DLeroy%26aufirst%3DJ.%2BL.%26aulast%3DGehring%26aufirst%3DK.%26aulast%3DKettani%26aufirst%3DA.%26aulast%3DGueron%26aufirst%3DM.%26atitle%3DAcid%2520multimers%2520of%2520oligodeoxycytidine%2520strands%253A%2520stoichiometry%252C%2520base-pair%2520characterization%252C%2520and%2520proton%2520exchange%2520properties%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D6019%26epage%3D6031%26doi%3D10.1021%2Fbi00074a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Huppert, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span> </span><span class="NLM_article-title">G-quadruplexes in promoters throughout the human genome</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">â</span> <span class="NLM_lpage">413</span><span class="refDoi">Â DOI: 10.1093/nar/gkl1057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1093%2Fnar%2Fgkl1057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=17169996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=406-413&author=J.+L.+Huppertauthor=S.+Balasubramanian&title=G-quadruplexes+in+promoters+throughout+the+human+genome&doi=10.1093%2Fnar%2Fgkl1057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplexes in promoters throughout the human genome</span></div><div class="casAuthors">Huppert, Julian L.; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Certain G-rich DNA sequences readily form four-stranded structures called G-quadruplexes.  These sequence motifs are located in telomeres as a repeated unit, and elsewhere in the genome, where their function is currently unknown.  It has been proposed that G-quadruplexes may be directly involved in gene regulation at the level of transcription.  In support of this hypothesis, we show that the promoter regions (1 kb upstream of the transcription start site TSS) of genes are significantly enriched in quadruplex motifs relative to the rest of the genome, with >40% of human gene promoters contg. one or more quadruplex motif.  Furthermore, these promoter quadruplexes strongly assoc. with nuclease hypersensitive sites identified throughout the genome via biochem. measurement.  Regions of the human genome that are both nuclease hypersensitive and within promoters show a remarkable (230-fold) enrichment of quadruplex elements, compared to the rest of the genome.  These quadruplex motifs identified in promoter regions also show an interesting structural bias towards more stable forms.  These observations support the proposal that promoter G-quadruplexes are directly involved in the regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaKOSq_qjKrVg90H21EOLACvtfcHk0ljeUsZB_80UZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOls74%253D&md5=626903207653e1c97d568b9b50c093bd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl1057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl1057%26sid%3Dliteratum%253Aachs%26aulast%3DHuppert%26aufirst%3DJ.%2BL.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplexes%2520in%2520promoters%2520throughout%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D406%26epage%3D413%26doi%3D10.1093%2Fnar%2Fgkl1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Eddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maizels, N.</span><span> </span><span class="NLM_article-title">Gene function correlates with potential for G4 DNA formation in the human genome</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3887</span><span class="NLM_x">â</span> <span class="NLM_lpage">3896</span><span class="refDoi">Â DOI: 10.1093/nar/gkl529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1093%2Fnar%2Fgkl529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=16914419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1yis7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=3887-3896&author=J.+Eddyauthor=N.+Maizels&title=Gene+function+correlates+with+potential+for+G4+DNA+formation+in+the+human+genome&doi=10.1093%2Fnar%2Fgkl529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Gene function correlates with potential for G4 DNA formation in the human genome</span></div><div class="casAuthors">Eddy, Johanna; Maizels, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3887-3896</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">G-rich genomic regions can form G4 DNA upon transcription or replication.  We have quantified the potential for G4 DNA formation (G4P) of the 16 654 genes in the human RefSeq database, and then correlated gene function with G4P.  We have found that very low and very high G4P correlates with specific functional classes of genes.  Notably, tumor suppressor genes have very low G4P and proto-oncogenes have very high G4P.  G4P of these genes is evenly distributed between exons and introns, and it does not reflect enrichment for CpG islands or local chromosomal environment.  These results show that genomic structure undergoes selection based on gene function.  Selection based on G4P could promote genomic stability (or instability) of specific classes of genes; or reflect mechanisms for global regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPf7ajy8A2MLVg90H21EOLACvtfcHk0ljeUsZB_80UZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1yis7o%253D&md5=c5da07ec9e667a0fbb1843159e773eb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkl529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkl529%26sid%3Dliteratum%253Aachs%26aulast%3DEddy%26aufirst%3DJ.%26aulast%3DMaizels%26aufirst%3DN.%26atitle%3DGene%2520function%2520correlates%2520with%2520potential%2520for%2520G4%2520DNA%2520formation%2520in%2520the%2520human%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D3887%26epage%3D3896%26doi%3D10.1093%2Fnar%2Fgkl529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span> </span><span class="NLM_article-title">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span><span class="refDoi">Â DOI: 10.1038/nrd3428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnrd3428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=21455236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=261-275&author=S.+Balasubramanianauthor=L.+H.+Hurleyauthor=S.+Neidle&title=Targeting+G-quadruplexes+in+gene+promoters%3A+a+novel+anticancer+strategy%3F&doi=10.1038%2Fnrd3428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span></div><div class="casAuthors">Balasubramanian, Shankar; Hurley, Laurence H.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-275</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-quadruplexes are four-stranded DNA structures that are over-represented in gene promoter regions and are viewed as emerging therapeutic targets in oncol., as transcriptional repression of oncogenes through stabilization of these structures could be a novel anticancer strategy.  Many gene promoter G-quadruplexes have physicochem. properties and structural characteristics that might make them druggable, and their structural diversity suggests that a high degree of selectivity might be possible.  Here, we describe the evidence for G-quadruplexes in gene promoters and discuss their potential as therapeutic targets, as well as progress in the development of strategies to harness this potential through intervention with small-mol. ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk0ePjfQEBk7Vg90H21EOLACvtfcHk0ljeUsZB_80UZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D&md5=b3ea27635da9d1ff72d60228f1ef6d76</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3428%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520G-quadruplexes%2520in%2520gene%2520promoters%253A%2520a%2520novel%2520anticancer%2520strategy%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D261%26epage%3D275%26doi%3D10.1038%2Fnrd3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hansel-Hertsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Antonio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span> </span><span class="NLM_article-title">DNA G-quadruplexes in the human genome: detection, functions, and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">â</span> <span class="NLM_lpage">284</span><span class="refDoi">Â DOI: 10.1038/nrm.2017.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnrm.2017.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=28225080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1agsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=279-284&author=R.+Hansel-Hertschauthor=M.+Di+Antonioauthor=S.+Balasubramanian&title=DNA+G-quadruplexes+in+the+human+genome%3A+detection%2C+functions%2C+and+therapeutic+potential&doi=10.1038%2Fnrm.2017.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential</span></div><div class="casAuthors">Hansel-Hertsch, Robert; Di Antonio, Marco; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">279-284</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Single-stranded guanine-rich DNA sequences can fold into four-stranded DNA structures called G-quadruplexes (G4s) that arise from the self-stacking of two or more guanine quartets.  There has been considerable recent progress in the detection and mapping of G4 structures in the human genome and in biol. relevant contexts.  These advancements, many of which align with predictions made previously in computational studies, provide important new insights into the functions of G4 structures in, for example, the regulation of transcription and genome stability, and uncover their potential relevance for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojysTqYKqZi7Vg90H21EOLACvtfcHk0lg_MFWUbfakSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1agsr0%253D&md5=452d13815a3284a4ca51607d1522fb5f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2017.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2017.3%26sid%3Dliteratum%253Aachs%26aulast%3DHansel-Hertsch%26aufirst%3DR.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DDNA%2520G-quadruplexes%2520in%2520the%2520human%2520genome%253A%2520detection%252C%2520functions%252C%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D18%26spage%3D279%26epage%3D284%26doi%3D10.1038%2Fnrm.2017.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hansel-Hertsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beraldi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensing, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zyner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Antonio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannahill, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span> </span><span class="NLM_article-title">G-quadruplex structures mark human regulatory chromatin</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">â</span> <span class="NLM_lpage">1272</span><span class="refDoi">Â DOI: 10.1038/ng.3662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fng.3662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=27618450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=1267-1272&author=R.+Hansel-Hertschauthor=D.+Beraldiauthor=S.+V.+Lensingauthor=G.+Marsicoauthor=K.+Zynerauthor=A.+Parryauthor=M.+Di+Antonioauthor=J.+Pikeauthor=H.+Kimuraauthor=M.+Naritaauthor=D.+Tannahillauthor=S.+Balasubramanian&title=G-quadruplex+structures+mark+human+regulatory+chromatin&doi=10.1038%2Fng.3662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">G-quadruplex structures mark human regulatory chromatin</span></div><div class="casAuthors">Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Di Antonio, Marco; Pike, Jeremy; Kimura, Hiroshi; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1267-1272</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G-quadruplex (G4) structural motifs have been linked to transcription, replication and genome instability and are implicated in cancer and other diseases.  However, it is crucial to demonstrate the bona fide formation of G4 structures within an endogenous chromatin context.  Herein we address this through the development of G4 ChIP-seq, an antibody-based G4 chromatin immunopptn. and high-throughput sequencing approach.  We find â¼10,000 G4 structures in human chromatin, predominantly in regulatory, nucleosome-depleted regions.  G4 structures are enriched in the promoters and 5' UTRs of highly transcribed genes, particularly in genes related to cancer and in somatic copy no. amplifications, such as MYC.  Strikingly, de novo and enhanced G4 formation are assocd. with increased transcriptional activity, as shown by HDAC inhibitor-induced chromatin relaxation and obsd. in immortalized as compared to normal cellular states.  Our findings show that regulatory, nucleosome-depleted chromatin and elevated transcription shape the endogenous human G4 DNA landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo8vsZd_UZLVg90H21EOLACvtfcHk0lg_MFWUbfakSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSgurvP&md5=898d19559a9ccbc0ff468558a653fc43</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng.3662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3662%26sid%3Dliteratum%253Aachs%26aulast%3DHansel-Hertsch%26aufirst%3DR.%26aulast%3DBeraldi%26aufirst%3DD.%26aulast%3DLensing%26aufirst%3DS.%2BV.%26aulast%3DMarsico%26aufirst%3DG.%26aulast%3DZyner%26aufirst%3DK.%26aulast%3DParry%26aufirst%3DA.%26aulast%3DDi%2BAntonio%26aufirst%3DM.%26aulast%3DPike%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DTannahill%26aufirst%3DD.%26aulast%3DBalasubramanian%26aufirst%3DS.%26atitle%3DG-quadruplex%2520structures%2520mark%2520human%2520regulatory%2520chromatin%26jtitle%3DNat.%2520Genet.%26date%3D2016%26volume%3D48%26spage%3D1267%26epage%3D1272%26doi%3D10.1038%2Fng.3662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The i-motif in the <i>bcl-2</i> P1 promoter forms an unexpectedly stable structure with a unique 8:6:7 loop folding pattern</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">17667</span><span class="NLM_x">â</span> <span class="NLM_lpage">17676</span><span class="refDoi">Â DOI: 10.1021/ja9076292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9076292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17667-17676&author=S.+Kendrickauthor=Y.+Akiyamaauthor=S.+M.+Hechtauthor=L.+H.+Hurley&title=The+i-motif+in+the+bcl-2+P1+promoter+forms+an+unexpectedly+stable+structure+with+a+unique+8%3A6%3A7+loop+folding+pattern&doi=10.1021%2Fja9076292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fja9076292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9076292%26sid%3Dliteratum%253Aachs%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DY.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520i-motif%2520in%2520the%2520bcl-2%2520P1%2520promoter%2520forms%2520an%2520unexpectedly%2520stable%2520structure%2520with%2520a%2520unique%25208%253A6%253A7%2520loop%2520folding%2520pattern%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17667%26epage%3D17676%26doi%3D10.1021%2Fja9076292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11593</span><span class="NLM_x">â</span> <span class="NLM_lpage">11598</span><span class="refDoi">Â DOI: 10.1073/pnas.182256799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1073%2Fpnas.182256799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=12195017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11593-11598&author=A.+Siddiqui-Jainauthor=C.+L.+Grandauthor=D.+J.+Bearssauthor=L.+H.+Hurley&title=Direct+evidence+for+a+G-quadruplex+in+a+promoter+region+and+its+targeting+with+a+small+molecule+to+repress+c-MYC+transcription&doi=10.1073%2Fpnas.182256799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Grand, Cory L.; Bearss, David J.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11593-11598</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The nuclease hypersensitivity element III1 upstream of the P1 promoter of c-MYC controls 85-90% of the transcriptional activation of this gene.  We have demonstrated that the purine-rich strand of the DNA in this region can form two different intramol. G-quadruplex structures, only one of which seems to be biol. relevant.  This biol. relevant structure is the kinetically favored chairform G-quadruplex, which is destabilized when mutated with a single G â A transition, resulting in a 3-fold increase in basal transcriptional activity of the c-MYC promoter.  The cationic porphyrin TMPyP4, which has been shown to stabilize this G-quadruplex structure, is able to suppress further c-MYC transcriptional activation.  These results provide compelling evidence that a specific G-quadruplex structure formed in the c-MYC promoter region functions as a transcriptional repressor element.  Furthermore, we establish the principle that c-MYC transcription can be controlled by ligand-mediated G-quadruplex stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMKd0v3rpM7Vg90H21EOLACvtfcHk0lg_MFWUbfakSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqsL4%253D&md5=5f2767891816e2364405e1a4b37eba48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.182256799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.182256799%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DGrand%26aufirst%3DC.%2BL.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DDirect%2520evidence%2520for%2520a%2520G-quadruplex%2520in%2520a%2520promoter%2520region%2520and%2520its%2520targeting%2520with%2520a%2520small%2520molecule%2520to%2520repress%2520c-MYC%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11593%26epage%3D11598%26doi%3D10.1073%2Fpnas.182256799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Phan, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span> </span><span class="NLM_article-title">Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">8710</span><span class="NLM_x">â</span> <span class="NLM_lpage">8716</span><span class="refDoi">Â DOI: 10.1021/ja048805k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja048805k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFKrsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=8710-8716&author=A.+T.+Phanauthor=Y.+S.+Modiauthor=D.+J.+Patel&title=Propeller-type+parallel-stranded+G-quadruplexes+in+the+human+c-myc+promoter&doi=10.1021%2Fja048805k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Propeller-Type Parallel-Stranded G-Quadruplexes in the Human c-myc Promoter</span></div><div class="casAuthors">Phan, Anh Tuan; Modi, Yasha S.; Patel, Dinshaw J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8710-8716</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nuclease-hypersensitivity element III1 in the c-myc promoter is a good anticancer target since it largely controls transcriptional activation of the important c-myc oncogene.  Recently, the guanine-rich strand of this element has been shown to form an equil. between G-quadruplex structures built from two different sets of G-stretches; two models of intramol. fold-back antiparallel-stranded G-quadruplexes, called "basket" and "chair" forms, were proposed.  Here, the authors show by NMR that two sequences contg. these two sets of G-stretches form intramol. propeller-type parallel-stranded G-quadruplexes in K+-contg. soln.  The two structures involve a core of three stacked G-tetrads formed by four parallel G-stretches with all anti guanines and three double-chain-reversal loops bridging three G-tetrad layers.  The central loop contains two or six residues, while the two other loops contain only one residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6kPTTc-vQbVg90H21EOLACvtfcHk0lidmoj4YS75dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFKrsrs%253D&md5=715526a31f0807bfd3698cb89b5d0861</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fja048805k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja048805k%26sid%3Dliteratum%253Aachs%26aulast%3DPhan%26aufirst%3DA.%2BT.%26aulast%3DModi%26aufirst%3DY.%2BS.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DPropeller-type%2520parallel-stranded%2520G-quadruplexes%2520in%2520the%2520human%2520c-myc%2520promoter%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D8710%26epage%3D8716%26doi%3D10.1021%2Fja048805k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ambrus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span> </span><span class="NLM_article-title">Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2048</span><span class="NLM_x">â</span> <span class="NLM_lpage">2058</span><span class="refDoi">Â DOI: 10.1021/bi048242p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi048242p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFaitQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=2048-2058&author=A.+Ambrusauthor=D.+Chenauthor=J.+Daiauthor=R.+A.+Jonesauthor=D.+Yang&title=Solution+structure+of+the+biologically+relevant+G-quadruplex+element+in+the+human+c-MYC+promoter.+Implications+for+G-quadruplex+stabilization&doi=10.1021%2Fbi048242p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Solution Structure of the Biologically Relevant G-Quadruplex Element in the Human c-MYC Promoter. Implications for G-Quadruplex Stabilization</span></div><div class="casAuthors">Ambrus, Attila; Chen, Ding; Dai, Jixun; Jones, Roger A.; Yang, Danzhou</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2048-2058</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nuclease hypersensitivity element III1 (NHE III1) of the c-MYC promoter strongly controls the transcriptional activity of the c-MYC oncogene.  The purine-rich strand of the NHE III1 element has been shown to be a silencer element for c-MYC transcription upon formation of a G-quadruplex structure.  We have detd. the predominant G-quadruplex structure of this silencer element in potassium soln. by NMR.  The G-quadruplex structure adopts an intramol. parallel-stranded quadruplex conformation with three guanine tetrads and three side loops, including two single-nucleotide side loops and one double-nucleotide side loop, that connect the four guanine strands.  The three side loops are very stable and well-defined.  The 3'-flanking sequence forms a stable fold-back stacking conformation capping the top end of the G-quadruplex structure.  The 5'-flanking A and G bases cap the bottom end of the G-quadruplex, with the adenine stacking very well with the bottom tetrad.  This paper reports the first soln. structure of a G-quadruplex found to form in the promoter region of an oncogene (c-MYC).  This G-quadruplex structure is extremely stable, with a similar melting temp. (>85Â°) to that of the wild-type 27-mer purine-rich NHE III1 sequence of the c-MYC promoter.  This predominant quadruplex structure has been shown to be biol. relevant, and the structural information revealed in this research provides an important basis for the design of new drug candidates that specifically target the c-MYC G-quadruplex structure and modulate gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgsHMKbDZc7Vg90H21EOLACvtfcHk0lidmoj4YS75dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFaitQ%253D%253D&md5=98bed86094bf0d91e5cceb01d1d38304</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi048242p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048242p%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrus%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BA.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DSolution%2520structure%2520of%2520the%2520biologically%2520relevant%2520G-quadruplex%2520element%2520in%2520the%2520human%2520c-MYC%2520promoter.%2520Implications%2520for%2520G-quadruplex%2520stabilization%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D2048%26epage%3D2058%26doi%3D10.1021%2Fbi048242p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuohe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichsel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuillet, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montfort, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III<sub>1</sub></span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">â</span> <span class="NLM_lpage">1377</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-08-1093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1158%2F1535-7163.MCT-08-1093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=19435876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1363-1377&author=T.+S.+Dexheimerauthor=S.+S.+Careyauthor=S.+Zuoheauthor=V.+M.+Gokhaleauthor=X.+Huauthor=L.+B.+Murataauthor=E.+M.+Maesauthor=A.+Weichselauthor=D.+Sunauthor=E.+J.+Meuilletauthor=W.+R.+Montfortauthor=L.+H.+Hurley&title=NM23-H2+may+play+an+indirect+role+in+transcriptional+activation+of+c-myc+gene+expression+but+does+not+cleave+the+nuclease+hypersensitive+element+III1&doi=10.1158%2F1535-7163.MCT-08-1093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1</span></div><div class="casAuthors">Dexheimer, Thomas S.; Carey, Steven S.; Song, Zuohe; Gokhale, Vijay M.; Hu, Xiaohui; Murata, Lauren B.; Maes, Estelle M.; Weichsel, Andrzej; Sun, Daekyu; Meuillet, Emmanuelle J.; Montfort, William R.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1363-1377</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The formation of G-quadruplex structures within the nuclease hypersensitive element (NHE) III1 region of the c-myc promoter and the ability of these structures to repress c-myc transcription have been well established.  However, just how these extremely stable DNA secondary structures are transformed to activate c-myc transcription is still unknown.  NM23-H2/nucleoside disphosphate kinase B has been recognized as an activator of c-myc transcription via interactions with the NHE III1 region of the c-myc gene promoter.  Through the use of RNA interference, we confirmed the transcriptional regulatory role of NM23-H2.  In addn., we find that further purifn. of NM23-H2 results in loss of the previously identified DNA strand cleavage activity, but retention of its DNA binding activity.  NM23-H2 binds to both single-stranded guanine- and cytosine-rich strands of the c-myc NHE III1 and, to a lesser extent, to a random single-stranded DNA template.  However, it does not bind to or cleave the NHE III1 in duplex form.  Significantly, potassium ions and compds. that stabilize the G-quadruplex and i-motif structures have an inhibitory effect on NM23-H2 DNA-binding activity.  Mutation of Arg88 to Ala88 (R88A) reduced both DNA and nucleotide binding but had minimal effect on the NM23-H2 crystal structure.  On the basis of these data and mol. modeling studies, we have proposed a stepwise trapping-out of the NHE III1 region in a single-stranded form, thus allowing single-stranded transcription factors to bind and activate c-myc transcription.  Furthermore, this model provides a rationale for how the stabilization of the G-quadruplex or i-motif structures formed within the c-myc gene promoter region can inhibit NM23-H2 from activating c-myc gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorcY4x6T96eLVg90H21EOLACvtfcHk0lidmoj4YS75dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7o%253D&md5=d167d3f600b446c016db741a571abf13</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1093%26sid%3Dliteratum%253Aachs%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DCarey%26aufirst%3DS.%2BS.%26aulast%3DZuohe%26aufirst%3DS.%26aulast%3DGokhale%26aufirst%3DV.%2BM.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DMurata%26aufirst%3DL.%2BB.%26aulast%3DMaes%26aufirst%3DE.%2BM.%26aulast%3DWeichsel%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26aulast%3DMontfort%26aufirst%3DW.%2BR.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DNM23-H2%2520may%2520play%2520an%2520indirect%2520role%2520in%2520transcriptional%2520activation%2520of%2520c-myc%2520gene%2520expression%2520but%2520does%2520not%2520cleave%2520the%2520nuclease%2520hypersensitive%2520element%2520III1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1363%26epage%3D1377%26doi%3D10.1158%2F1535-7163.MCT-08-1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Brown, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danford, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, T. A.</span><span> </span><span class="NLM_article-title">Demonstration that drug-targeted downregulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">41018</span><span class="NLM_x">â</span> <span class="NLM_lpage">41027</span><span class="refDoi">Â DOI: 10.1074/jbc.M111.274720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1074%2Fjbc.M111.274720" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=41018-41027&author=R.+V.+Brownauthor=V.+Gokhaleauthor=L.+H.+Hurleyauthor=F.+L.+Danfordauthor=T.+A.+Brooks&title=Demonstration+that+drug-targeted+downregulation+of+MYC+in+non-Hodgkins+lymphoma+is+directly+mediated+through+the+promoter+G-quadruplex&doi=10.1074%2Fjbc.M111.274720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.274720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.274720%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BV.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DDanford%26aufirst%3DF.%2BL.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26atitle%3DDemonstration%2520that%2520drug-targeted%2520downregulation%2520of%2520MYC%2520in%2520non-Hodgkins%2520lymphoma%2520is%2520directly%2520mediated%2520through%2520the%2520promoter%2520G-quadruplex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D41018%26epage%3D41027%26doi%3D10.1074%2Fjbc.M111.274720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madathil, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">4161</span><span class="NLM_x">â</span> <span class="NLM_lpage">4171</span><span class="refDoi">Â DOI: 10.1021/ja410934b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja410934b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFOhtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4161-4171&author=S.+Kendrickauthor=H.+J.+Kangauthor=M.+P.+Alamauthor=M.+M.+Madathilauthor=P.+Agrawalauthor=V.+Gokhaleauthor=D.+Yangauthor=S.+M.+Hechtauthor=L.+H.+Hurley&title=The+dynamic+character+of+the+BCL2+promoter+i-motif+provides+a+mechanism+for+modulation+of+gene+expression+by+compounds+that+bind+selectively+to+the+alternative+DNA+hairpin+structure&doi=10.1021%2Fja410934b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure</span></div><div class="casAuthors">Kendrick, Samantha; Kang, Hyun-Jin; Alam, Mohammad P.; Madathil, Manikandadas M.; Agrawal, Prashansa; Gokhale, Vijay; Yang, Danzhou; Hecht, Sidney M.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4161-4171</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is generally accepted that DNA predominantly exists in duplex form in cells.  However, under torsional stress imposed by active transcription, DNA can assume nonduplex structures.  The BCL2 promoter region forms two different secondary DNA structures on opposite strands called the G-quadruplex and the i-motif.  The i-motif is a highly dynamic structure that exists in equil. with a flexible hairpin species.  Here we identify a pregnanol deriv. and a class of piperidine derivs. that differentially modulate gene expression by stabilizing either the i-motif or the flexible hairpin species.  Stabilization of the i-motif structure results in significant upregulation of the BCL2 gene and assocd. protein expression; in contrast, stabilization of the flexible hairpin species lowers BCL2 levels.  The BCL2 levels reduced by the hairpin-binding compd. led to chemosensitization to etoposide in both in vitro and in vivo models.  Furthermore, we show antagonism between the two classes of compds. in soln. and in cells.  For the first time, our results demonstrate the principle of small mol. targeting of i-motif structures in vitro and in vivo to modulate gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvtwX3W1cNTbVg90H21EOLACvtfcHk0liC1MMiuNNMJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFOhtLg%253D&md5=fa217ef832b60ab09959c0ca9eb72983</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja410934b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja410934b%26sid%3Dliteratum%253Aachs%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DAlam%26aufirst%3DM.%2BP.%26aulast%3DMadathil%26aufirst%3DM.%2BM.%26aulast%3DAgrawal%26aufirst%3DP.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520dynamic%2520character%2520of%2520the%2520BCL2%2520promoter%2520i-motif%2520provides%2520a%2520mechanism%2520for%2520modulation%2520of%2520gene%2520expression%2520by%2520compounds%2520that%2520bind%2520selectively%2520to%2520the%2520alternative%2520DNA%2520hairpin%2520structure%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4161%26epage%3D4171%26doi%3D10.1021%2Fja410934b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">4172</span><span class="NLM_x">â</span> <span class="NLM_lpage">4185</span><span class="refDoi">Â DOI: 10.1021/ja4109352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4109352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFOgsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4172-4185&author=H.+J.+Kangauthor=S.+Kendrickauthor=S.+M.+Hechtauthor=L.+H.+Hurley&title=The+transcriptional+complex+between+the+BCL2+i-motif+and+hnRNP+LL+is+a+molecular+switch+for+control+of+gene+expression+that+can+be+modulated+by+small+molecules&doi=10.1021%2Fja4109352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Transcriptional Complex Between the BCL2 i-Motif and hnRNP LL Is a Molecular Switch for Control of Gene Expression That Can Be Modulated by Small Molecules</span></div><div class="casAuthors">Kang, Hyun-Jin; Kendrick, Samantha; Hecht, Sidney M.; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4172-4185</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a companion paper (DOI: 10.021/ja410934b) we demonstrate that the C-rich strand of the cis-regulatory element in the BCL2 promoter element is highly dynamic in nature and can form either an i-motif or a flexible hairpin.  Under physiol. conditions these two secondary DNA structures are found in an equil. mixt., which can be shifted by the addn. of small mols. that trap out either the i-motif (IMC-48) or the flexible hairpin (IMC-76).  In cellular expts. we demonstrate that the addn. of these mols. has opposite effects on BCL2 gene expression and furthermore that these effects are antagonistic.  In this contribution we have identified a transcriptional factor that recognizes and binds to the BCL2 i-motif to activate transcription.  The mol. basis for the recognition of the i-motif by hnRNP LL is detd., and we demonstrate that the protein unfolds the i-motif structure to form a stable single-stranded complex.  In subsequent expts. we show that IMC-48 and IMC-76 have opposite, antagonistic effects on the formation of the hnRNP LL-i-motif complex as well as on the transcription factor occupancy at the BCL2 promoter.  For the first time we propose that the i-motif acts as a mol. switch that controls gene expression and that small mols. that target the dynamic equil. of the i-motif and the flexible hairpin can differentially modulate gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCm1zTboqYrVg90H21EOLACvtfcHk0liC1MMiuNNMJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFOgsLs%253D&md5=6da68941b5392461c7fd2491d538c287</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja4109352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4109352%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520transcriptional%2520complex%2520between%2520the%2520BCL2%2520i-motif%2520and%2520hnRNP%2520LL%2520is%2520a%2520molecular%2520switch%2520for%2520control%2520of%2520gene%2520expression%2520that%2520can%2520be%2520modulated%2520by%2520small%2520molecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4172%26epage%3D4185%26doi%3D10.1021%2Fja4109352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Green, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu-Monette, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadeberg, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourits-Andersen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¸ller, M. B.</span><span> </span><span class="NLM_article-title">Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3460</span><span class="NLM_x">â</span> <span class="NLM_lpage">3467</span><span class="refDoi">Â DOI: 10.1200/JCO.2011.41.4342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1200%2FJCO.2011.41.4342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=22665537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSksrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=3460-3467&author=T.+M.+Greenauthor=K.+H.+Youngauthor=C.+Viscoauthor=Z.+Y.+Xu-Monetteauthor=A.+Oraziauthor=R.+S.+Goauthor=O.+Nielsenauthor=O.+V.+Gadebergauthor=T.+Mourits-Andersenauthor=M.+Frederiksenauthor=L.+M.+Pedersenauthor=M.+B.+M%C3%B8ller&title=Immunohistochemical+double-hit+score+is+a+strong+predictor+of+outcome+in+patients+with+diffuse+large+B-cell+lymphoma+treated+with+rituximab+plus+cyclophosphamide%2C+doxorubicin%2C+vincristine%2C+and+prednisone&doi=10.1200%2FJCO.2011.41.4342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cydophosphamide, doxombicin, vincristine, and prednisone</span></div><div class="casAuthors">Green, Tina Marie; Young, Ken H.; Visco, Carlo; Xu-Monette, Zijun Y.; Orazi, Attilio; Go, Ronald S.; Nielsen, Ole; Gadeberg, Ole V.; Mourits-Andersen, Torben; Frederiksen, Mikael; Pedersen, Lars Moeller; Moeller, Michael Boe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3460-3467</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Approx. 5% of diffuse large B-cell lymphomas (DLBCLs) are double-hit lymphomas (DHLs) with translocations of both MYC and BCL2.  DHLs are characterized by poor outcome.  We tested whether DLBCLs with high expression of MYC protein and BCL2 protein share the clin. features and poor prognosis of DHLs.  Patients and Methods: Paraffin-embedded lymphoma samples from 193 patients with de novo DLBCL who were uniformly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) were studied using immunohistochem. for MYC, BCL2, CD10, BCL6, and MUM1/interferon regulatory factor 4, and fluorescent in situ hybridization (FISH) for MYC and BCL2.  Results: FISH anal. identified DHL in 6% of patients, who showed the expected poor overall survival (OS; P = .002).  On the basis of immunohistochem. MYC and BCL2 expression, a double-hit score (DHS) was assigned to all patients with DLBCL.  The DHS-2 group, defined by high expression of both MYC and BCL2 protein, comprised 29% of the patients.  DHS 2 was significantly assocd. with lower complete response rate (P = .004), shorter OS (P < .001), and shorter progression-free survival (PFS; P < .001).  The highly significant correlation with OS and PFS was maintained in multivariate models that controlled for the International Prognostic Index and the cell-of-origin subtype (OS, P < .001; PFS, P < .001).  DHS was validated in an independent cohort of 116 patients who were treated with R-CHOP.  Conclusion The immunohistochem. DHS defined a large subset of DLBCLs with double-hit biol. and was strongly assocd. with poor outcome in patients treated with R-CHOP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTVpHFuf5h2rVg90H21EOLACvtfcHk0lijlfm9_RTChA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSksrfJ&md5=16187bdcf5721376a943c7242916c8e2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.41.4342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.41.4342%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DT.%2BM.%26aulast%3DYoung%26aufirst%3DK.%2BH.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DXu-Monette%26aufirst%3DZ.%2BY.%26aulast%3DOrazi%26aufirst%3DA.%26aulast%3DGo%26aufirst%3DR.%2BS.%26aulast%3DNielsen%26aufirst%3DO.%26aulast%3DGadeberg%26aufirst%3DO.%2BV.%26aulast%3DMourits-Andersen%26aufirst%3DT.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DPedersen%26aufirst%3DL.%2BM.%26aulast%3DM%25C3%25B8ller%26aufirst%3DM.%2BB.%26atitle%3DImmunohistochemical%2520double-hit%2520score%2520is%2520a%2520strong%2520predictor%2520of%2520outcome%2520in%2520patients%2520with%2520diffuse%2520large%2520B-cell%2520lymphoma%2520treated%2520with%2520rituximab%2520plus%2520cyclophosphamide%252C%2520doxorubicin%252C%2520vincristine%252C%2520and%2520prednisone%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26spage%3D3460%26epage%3D3467%26doi%3D10.1200%2FJCO.2011.41.4342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Johnson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Neriah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehn, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimsza, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunhoeber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braziel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubbs, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holcroft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span> </span><span class="NLM_article-title">Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3452</span><span class="NLM_x">â</span> <span class="NLM_lpage">3459</span><span class="refDoi">Â DOI: 10.1200/JCO.2011.41.0985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1200%2FJCO.2011.41.0985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=22851565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSksrfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=3452-3459&author=N.+A.+Johnsonauthor=G.+W.+Slackauthor=K.+J.+Savageauthor=J.+M.+Connorsauthor=S.+Ben-Neriahauthor=S.+Rogicauthor=D.+W.+Scottauthor=K.+L.+Tanauthor=C.+Steidlauthor=L.+H.+Sehnauthor=W.+C.+Chanauthor=J.+Iqbalauthor=P.+N.+Meyerauthor=G.+Lenzauthor=G.+Wrightauthor=L.+M.+Rimszaauthor=C.+Valentinoauthor=P.+Brunhoeberauthor=T.+M.+Groganauthor=R.+M.+Brazielauthor=J.+R.+Cookauthor=R.+R.+Tubbsauthor=D.+D.+Weisenburgerauthor=E.+Campoauthor=A.+Rosenwaldauthor=G.+Ottauthor=J.+Delabieauthor=C.+Holcroftauthor=E.+S.+Jaffeauthor=L.+M.+Staudtauthor=R.+D.+Gascoyne&title=Concurrent+expression+of+MYC+and+BCL2+in+diffuse+large+B-cell+lymphoma+treated+with+rituximab+plus+cyclophosphamide%2C+doxorubicin%2C+vincristine%2C+and+prednisone&doi=10.1200%2FJCO.2011.41.0985"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone</span></div><div class="casAuthors">Johnson, Nathalie A.; Slack, Graham W.; Savage, Kerry J.; Connors, Joseph M.; Ben-Neriah, Susana; Rogic, Sanja; Scott, David W.; Tan, King L.; Steidl, Christian; Sehn, Laurie H.; Chan, Wing C.; Iqbal, Javeed; Meyer, Paul N.; Lenz, Georg; Wright, George; Rimsza, Lisa M.; Valentino, Carlo; Brunhoeber, Patrick; Grogan, Thomas M.; Braziel, Rita M.; Cook, James R.; Tubbs, Raymond R.; Weisenburger, Dennis D.; Campo, Elias; Rosenwald, Andreas; Ott, German; Delabie, Jan; Holcroft, Christina; Jaffe, Elaine S.; Staudt, Louis M.; Gascoyne, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3452-3459</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Diffuse large B-cell lymphoma (DLBCL) is curable in 60% of patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).  MYC translocations, with or without BCL2 translocations, have been assocd. with inferior survival in DLBCL.  We investigated whether expression of MYC protein, with or without BCL2 protein expression, could risk-stratify patients at diagnosis.  Patients and Methods We detd. the correlation between presence of MYC and BCL2 proteins by immunohistochem. (IHC) with survival in two independent cohorts of patients with DLBCL treated with R-CHOP.  We further detd. if MYC protein expression correlated with high MYC mRNA and/or presence of MYC translocation.  Results: In the training cohort (n = 167), MYC and BCL2 proteins were detected in 29% and 44% of patients, resp.  Concurrent expression (MYC pos./BCL2 pos.) was present in 21% of patients.  MYC protein correlated with presence of high MYC mRNA and MYC translocation (both P < .001), but the latter was less frequent (both 11%).  MYC protein expression was only assocd. with inferior overall and progression-free survival when BCL2 protein was coexpressed (P < .001).  Importantly, the poor prognostic effect of MYC pos./BCL2 pos. was validated in an independent cohort of 140 patients with DLBCL and remained significant (P < .05) after adjusting for presence of high-risk features in a multivariable model that included elevated international prognostic index score, activated B-cell mol. subtype, and presence of concurrent MYC and BCL2 translocations.  Conclusion: Assessment of MYC and BCL2 expression by IHC represents a robust, rapid, and inexpensive approach to risk-stratify patients with DLBCL at diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQqYAo5rAoXLVg90H21EOLACvtfcHk0lijlfm9_RTChA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSksrfI&md5=1aa99c2dc3506531c1273d170f0cce56</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.41.0985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.41.0985%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DSlack%26aufirst%3DG.%2BW.%26aulast%3DSavage%26aufirst%3DK.%2BJ.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DBen-Neriah%26aufirst%3DS.%26aulast%3DRogic%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DD.%2BW.%26aulast%3DTan%26aufirst%3DK.%2BL.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DP.%2BN.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DValentino%26aufirst%3DC.%26aulast%3DBrunhoeber%26aufirst%3DP.%26aulast%3DGrogan%26aufirst%3DT.%2BM.%26aulast%3DBraziel%26aufirst%3DR.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BR.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DHolcroft%26aufirst%3DC.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26atitle%3DConcurrent%2520expression%2520of%2520MYC%2520and%2520BCL2%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%2520treated%2520with%2520rituximab%2520plus%2520cyclophosphamide%252C%2520doxorubicin%252C%2520vincristine%252C%2520and%2520prednisone%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26spage%3D3452%26epage%3D3459%26doi%3D10.1200%2FJCO.2011.41.0985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu-Monette, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzankov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanyam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes-Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybkaer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsi, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Krieken, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreri, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Variakojis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piris, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¸ller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. H.</span><span> </span><span class="NLM_article-title">MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from the International DLBCL Rituximab-CHOP Consortium Program</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">4021</span><span class="NLM_x">â</span> <span class="NLM_lpage">4031</span><span class="refDoi">Â DOI: 10.1182/blood-2012-10-460063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1182%2Fblood-2012-10-460063" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2013&pages=4021-4031&author=S.+Huauthor=Z.+Y.+Xu-Monetteauthor=A.+Tzankovauthor=T.+Greenauthor=L.+Wuauthor=A.+Balasubramanyamauthor=W.+M.+Liuauthor=C.+Viscoauthor=Y.+Liauthor=R.+N.+Mirandaauthor=S.+Montes-Morenoauthor=K.+Dybkaerauthor=A.+Chiuauthor=A.+Oraziauthor=Y.+Zuauthor=G.+Bhagatauthor=K.+L.+Richardsauthor=E.+D.+Hsiauthor=W.+W.+Choiauthor=X.+Zhaoauthor=J.+H.+van+Kriekenauthor=Q.+Huangauthor=J.+Huhauthor=W.+Aiauthor=M.+Ponzoniauthor=A.+J.+Ferreriauthor=F.+Zhouauthor=G.+W.+Slackauthor=R.+D.+Gascoyneauthor=M.+Tuauthor=D.+Variakojisauthor=W.+Chenauthor=R.+S.+Goauthor=M.+A.+Pirisauthor=M.+B.+M%C3%B8llerauthor=L.+J.+Medeirosauthor=K.+H.+Young&title=MYC%2FBCL2+protein+coexpression+contributes+to+the+inferior+survival+of+activated+B-cell+subtype+of+diffuse+large+B-cell+lymphoma+and+demonstrates+high-risk+gene+expression+signatures%3A+a+report+from+the+International+DLBCL+Rituximab-CHOP+Consortium+Program&doi=10.1182%2Fblood-2012-10-460063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-10-460063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-10-460063%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DXu-Monette%26aufirst%3DZ.%2BY.%26aulast%3DTzankov%26aufirst%3DA.%26aulast%3DGreen%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBalasubramanyam%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%2BM.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMiranda%26aufirst%3DR.%2BN.%26aulast%3DMontes-Moreno%26aufirst%3DS.%26aulast%3DDybkaer%26aufirst%3DK.%26aulast%3DChiu%26aufirst%3DA.%26aulast%3DOrazi%26aufirst%3DA.%26aulast%3DZu%26aufirst%3DY.%26aulast%3DBhagat%26aufirst%3DG.%26aulast%3DRichards%26aufirst%3DK.%2BL.%26aulast%3DHsi%26aufirst%3DE.%2BD.%26aulast%3DChoi%26aufirst%3DW.%2BW.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3Dvan%2BKrieken%26aufirst%3DJ.%2BH.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHuh%26aufirst%3DJ.%26aulast%3DAi%26aufirst%3DW.%26aulast%3DPonzoni%26aufirst%3DM.%26aulast%3DFerreri%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DSlack%26aufirst%3DG.%2BW.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVariakojis%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGo%26aufirst%3DR.%2BS.%26aulast%3DPiris%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25B8ller%26aufirst%3DM.%2BB.%26aulast%3DMedeiros%26aufirst%3DL.%2BJ.%26aulast%3DYoung%26aufirst%3DK.%2BH.%26atitle%3DMYC%252FBCL2%2520protein%2520coexpression%2520contributes%2520to%2520the%2520inferior%2520survival%2520of%2520activated%2520B-cell%2520subtype%2520of%2520diffuse%2520large%2520B-cell%2520lymphoma%2520and%2520demonstrates%2520high-risk%2520gene%2520expression%2520signatures%253A%2520a%2520report%2520from%2520the%2520International%2520DLBCL%2520Rituximab-CHOP%2520Consortium%2520Program%26jtitle%3DBlood%26date%3D2013%26volume%3D121%26spage%3D4021%26epage%3D4031%26doi%3D10.1182%2Fblood-2012-10-460063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Perry, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarado-Bernal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehn, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bociek, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armitage, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vose, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span> </span><span class="NLM_article-title">MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">391</span><span class="refDoi">Â DOI: 10.1111/bjh.12763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1111%2Fbjh.12763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=24506200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1Wmuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2014&pages=382-391&author=A.+M.+Perryauthor=Y.+Alvarado-Bernalauthor=J.+A.+Lauriniauthor=L.+M.+Smithauthor=G.+W.+Slackauthor=K.+L.+Tanauthor=L.+H.+Sehnauthor=K.+Fuauthor=P.+Aounauthor=T.+C.+Greinerauthor=W.+C.+Chanauthor=P.+J.+Biermanauthor=R.+G.+Bociekauthor=J.+O.+Armitageauthor=J.+M.+Voseauthor=R.+D.+Gascoyneauthor=D.+D.+Weisenburger&title=MYC+and+BCL2+protein+expression+predicts+survival+in+patients+with+diffuse+large+B-cell+lymphoma+treated+with+rituximab&doi=10.1111%2Fbjh.12763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab</span></div><div class="casAuthors">Perry, Anamarija M.; Alvarado-Bernal, Yuridia; Laurini, Javier A.; Smith, Lynette M.; Slack, Graham W.; Tan, King L.; Sehn, Laurie H.; Fu, Kai; Aoun, Patricia; Greiner, Timothy C.; Chan, Wing C.; Bierman, Philip J.; Bociek, Robert G.; Armitage, James O.; Vose, Julie M.; Gascoyne, Randy D.; Weisenburger, Dennis D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">382-391</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease and "double-hit" DLBCL, with both MYC and BCL2 translocations has a poor prognosis.  In this study, the authors investigated whether MYC and BCL2 protein expression in tissue would predict survival in DLBCL.  The study included 106 cases of de novo DLBCL treated with rituximab and cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) or CHOP-like regimens.  The results were validated on an independent cohort of 205 DLBCL patients.  Patients with low expression of BCL2 (â¤30%) and MYC (â¤50%) had the best prognosis, whereas those with high BCL2 (>30%) and MYC (>50%) had the worst outcome.  In multivariate anal., the combination of the BCL2 and MYC was an independent predictor of overall survival (OS) and event-free survival (EFS) (P = 0Â·015 and P = 0Â·005, resp.).  The risk of death was nine times greater for patients with high BCL2 and MYC compared to those with low expression.  High BCL2 and MYC was a strong predictor of poor OS (P < 0Â·001) and EFS (P = 0Â·0017) in patients with the germinal center B-cell (GCB) type, but not in the non-GCB type.  In DLBCL, high co-expression of MYC and BCL2 was an independent predictor of poor survival, and could be used to stratify patients for risk-adapted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8lt2NpbkldrVg90H21EOLACvtfcHk0ljfk_gU0pIH0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Wmuro%253D&md5=eb376732d51fd5bfa877334f817e1561</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fbjh.12763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjh.12763%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DA.%2BM.%26aulast%3DAlvarado-Bernal%26aufirst%3DY.%26aulast%3DLaurini%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DL.%2BM.%26aulast%3DSlack%26aufirst%3DG.%2BW.%26aulast%3DTan%26aufirst%3DK.%2BL.%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DFu%26aufirst%3DK.%26aulast%3DAoun%26aufirst%3DP.%26aulast%3DGreiner%26aufirst%3DT.%2BC.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DBierman%26aufirst%3DP.%2BJ.%26aulast%3DBociek%26aufirst%3DR.%2BG.%26aulast%3DArmitage%26aufirst%3DJ.%2BO.%26aulast%3DVose%26aufirst%3DJ.%2BM.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26atitle%3DMYC%2520and%2520BCL2%2520protein%2520expression%2520predicts%2520survival%2520in%2520patients%2520with%2520diffuse%2520large%2520B-cell%2520lymphoma%2520treated%2520with%2520rituximab%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2014%26volume%3D165%26spage%3D382%26epage%3D391%26doi%3D10.1111%2Fbjh.12763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kendrick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redd, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muranyi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henricksen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanislaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braziel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubbs, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimsza, L. M.</span><span> </span><span class="NLM_article-title">BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2144</span><span class="NLM_x">â</span> <span class="NLM_lpage">2153</span><span class="refDoi">Â DOI: 10.1016/j.humpath.2014.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2Fj.humpath.2014.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=25090918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7bJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2014&pages=2144-2153&author=S.+L.+Kendrickauthor=L.+Reddauthor=A.+Muranyiauthor=L.+A.+Henricksenauthor=S.+Stanislawauthor=L.+M.+Smithauthor=A.+M.+Perryauthor=K.+Fuauthor=D.+D.+Weisenburgerauthor=A.+Rosenwaldauthor=G.+Ottauthor=R.+D.+Gascoyneauthor=E.+S.+Jaffeauthor=E.+Campoauthor=J.+Delabieauthor=R.+M.+Brazielauthor=J.+R.+Cookauthor=R.+R.+Tubbsauthor=L.+M.+Staudtauthor=W.+C.+Chanauthor=C.+Steidlauthor=T.+M.+Groganauthor=L.+M.+Rimsza&title=BCL2+antibodies+targeted+at+different+epitopes+detect+varying+levels+of+protein+expression+and+correlate+with+frequent+gene+amplification+in+diffuse+large+B-cell+lymphoma&doi=10.1016%2Fj.humpath.2014.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma</span></div><div class="casAuthors">Kendrick, Samantha L.; Redd, Lucas; Muranyi, Andrea; Henricksen, Leigh A.; Stanislaw, Stacey; Smith, Lynette M.; Perry, Anamarija M.; Fu, Kai; Weisenburger, Dennis D.; Rosenwald, Andreas; Ott, German; Gascoyne, Randy D.; Jaffe, Elaine S.; Campo, Elias; Delabie, Jan; Braziel, Rita M.; Cook, James R.; Tubbs, Raymond R.; Staudt, Louis M.; Chan, Wing Chung; Steidl, Christian; Grogan, Thomas M.; Rimsza, Lisa M.</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2144-2153</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Patients with aggressive, BCL2 protein-pos. (+) diffuse large B-cell lymphoma (DLBCL) often experience rapid disease progression that is refractory to std. therapy.  However, there is potential for false-neg. staining of BCL2 using the std. monoclonal mouse 124 antibody that hinders the identification of these high-risk DLBCL patients.  Herein, we compare 2 alternative rabbit monoclonal antibodies (E17 and SP66) to the 124 clone in staining for BCL2 in formalin-fixed, paraffin-embedded DLBCL tissues.  Overall, in 2 independent DLBCL cohorts, E17 and SP66 detected BCL2 expression more frequently than 124.  In the context of MYC expression, cases identified as BCL2 (+) with SP66 demonstrated the strongest correlation with worse overall survival.  The 124 clone failed to detect BCL2 expression in the majority of translocation (+), amplification (+), and activated B-cell DLBCL cases in which high levels of BCL2 protein are expected.  Using dual in situ hybridization as a new tool to detect BCL2 translocation and amplification, we obsd. similar results as previously reported for fluorescence in situ hybridization for translocation but a higher amplification frequency, indicating that BCL2 amplification may be underreported in DLBCL.  Among the discrepant cases, phosphorylation of BCL2 at T69 and/or S70 was more common than in the concordant cases and may contribute to the 124 false negatives, in addn. to previously assocd. mutations within the epitope region.  The accurate detection of BCL2 expression is important in the prognosis and treatment of DLBCL particularly with new anti-BCL2 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpemJhnV44VObVg90H21EOLACvtfcHk0ljfk_gU0pIH0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7bJ&md5=dabf4951dd936eb6dc295a11ce89b716</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2014.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2014.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DKendrick%26aufirst%3DS.%2BL.%26aulast%3DRedd%26aufirst%3DL.%26aulast%3DMuranyi%26aufirst%3DA.%26aulast%3DHenricksen%26aufirst%3DL.%2BA.%26aulast%3DStanislaw%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DL.%2BM.%26aulast%3DPerry%26aufirst%3DA.%2BM.%26aulast%3DFu%26aufirst%3DK.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DBraziel%26aufirst%3DR.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BR.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DGrogan%26aufirst%3DT.%2BM.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26atitle%3DBCL2%2520antibodies%2520targeted%2520at%2520different%2520epitopes%2520detect%2520varying%2520levels%2520of%2520protein%2520expression%2520and%2520correlate%2520with%2520frequent%2520gene%2520amplification%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%26jtitle%3DHum.%2520Pathol.%26date%3D2014%26volume%3D45%26spage%3D2144%26epage%3D2153%26doi%3D10.1016%2Fj.humpath.2014.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Delmore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastritis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilpatrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a therapeutic strategy to target c-Myc</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">â</span> <span class="NLM_lpage">917</span><span class="refDoi">Â DOI: 10.1016/j.cell.2011.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2Fj.cell.2011.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=21889194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=904-917&author=J.+E.+Delmoreauthor=G.+C.+Issaauthor=M.+E.+Lemieuxauthor=P.+B.+Rahlauthor=J.+Shiauthor=H.+M.+Jacobsauthor=E.+Kastritisauthor=T.+Gilpatrickauthor=R.+M.+Paranalauthor=J.+Qiauthor=M.+Chesiauthor=A.+C.+Schinzelauthor=M.+R.+McKeownauthor=T.+P.+Heffernanauthor=C.+R.+Vakocauthor=P.+L.+Bergsagelauthor=I.+M.+Ghobrialauthor=P.+G.+Richardsonauthor=R.+A.+Youngauthor=W.+C.+Hahnauthor=K.+C.+Andersonauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=C.+S.+Mitsiades&title=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc&doi=10.1016%2Fj.cell.2011.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc</span></div><div class="casAuthors">Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Jun-Wei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904-917</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist.  Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation.  Using a selective small-mol. bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc.  BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes.  In exptl. models of multiple myeloma, a Myc-dependent hematol. malignancy, JQ1 produces a potent antiproliferative effect assocd. with cell-cycle arrest and cellular senescence.  Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathol. activation of c-Myc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevD1QHKmOhLVg90H21EOLACvtfcHk0lgUjMz69LBVZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF&md5=013674b8224214a9a1c8f0b75583a5a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelmore%26aufirst%3DJ.%2BE.%26aulast%3DIssa%26aufirst%3DG.%2BC.%26aulast%3DLemieux%26aufirst%3DM.%2BE.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DH.%2BM.%26aulast%3DKastritis%26aufirst%3DE.%26aulast%3DGilpatrick%26aufirst%3DT.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520to%2520target%2520c-Myc%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D904%26epage%3D917%26doi%3D10.1016%2Fj.cell.2011.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boghaert, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catron, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enschede, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaw, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecker, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humerickhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">â</span> <span class="NLM_lpage">208</span><span class="refDoi">Â DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0lgUjMz69LBVZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davids, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puvvada, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerecitano, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipps, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gressick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitner Enschede, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humerickhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span> </span><span class="NLM_article-title">Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">â</span> <span class="NLM_lpage">322</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1513257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1056%2FNEJMoa1513257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26639348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2murrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2016&pages=311-322&author=A.+W.+Robertsauthor=M.+S.+Davidsauthor=J.+M.+Pagelauthor=B.+S.+Kahlauthor=S.+D.+Puvvadaauthor=J.+F.+Gerecitanoauthor=T.+J.+Kippsauthor=M.+A.+Andersonauthor=J.+R.+Brownauthor=L.+Gressickauthor=S.+Wongauthor=M.+Dunbarauthor=M.+Zhuauthor=M.+B.+Desaiauthor=E.+Cerriauthor=S.+Heitner+Enschedeauthor=R.+A.+Humerickhouseauthor=W.+G.+Wierdaauthor=J.+F.+Seymour&title=Targeting+BCL2+with+venetoclax+in+relapsed+chronic+lymphocytic+leukemia&doi=10.1056%2FNEJMoa1513257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Roberts, Andrew W.; Davids, Matthew S.; Pagel, John M.; Kahl, Brad S.; Puvvada, Soham D.; Gerecitano, John F.; Kipps, Thomas J.; Anderson, Mary Ann; Brown, Jennifer R.; Gressick, Lori; Wong, Shekman; Dunbar, Martin; Zhu, Ming; Desai, Monali B.; Cerri, Elisa; Enschede, Sari Heitner; Humerickhouse, Rod A.; Wierda, William G.; Seymour, John F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-322</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND New treatments have improved outcomes for patients with relapsed chronic lymphocytic leukemia (CLL), but complete remissions remain uncommon.  Venetoclax has a distinct mechanism of action; it targets BCL2, a protein central to the survival of CLL cells.  METHODS We conducted a phase 1 dose-escalation study of daily oral venetoclax in patients with relapsed or refractory CLL or small lymphocytic lymphoma (SLL) to assess safety, pharmacokinetic profile, and efficacy.  In the dose-escalation phase, 56 patients received active treatment in one of eight dose groups that ranged from 150 to 1200 mg per day.  In an expansion cohort, 60 addnl. patients were treated with a weekly stepwise ramp-up in doses as high as 400 mg per day.  RESULTS The majority of the study patients had received multiple previous treatments, and 89% had poor prognostic clin. or genetic features.  Venetoclax was active at all dose levels.  Clin. tumor lysis syndrome occurred in 3 of 56 patients in the dose-escalation cohort, with one death.  After adjustments to the dose-escalation schedule, clin. tumor lysis syndrome did not occur in any of the 60 patients in the expansion cohort.  Other toxic effects included mild diarrhea (in 52% of the patients), upper respiratory tract infection (in 48%), nausea (in 47%), and grade 3 or 4 neutropenia (in 41%).  A max. tolerated dose was not identified.  Among the 116 patients who received venetoclax, 92 (79%) had a response.  Response rates ranged from 71 to 79% among patients in subgroups with an adverse prognosis, including those with resistance to fludarabine, those with chromosome 17p deletions (deletion 17p CLL), and those with unmutated IGHV.  Complete remissions occurred in 20% of the patients, including 5% who had no minimal residual disease on flow cytometry.  The 15-mo progression-free survival est. for the 400-mg dose groups was 69%.  CONCLUSIONS Selective targeting of BCL2 with venetoclax had a manageable safety profile and induced substantial responses in patients with relapsed CLL or SLL, including those with poor prognostic features.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQgYgnKl88rVg90H21EOLACvtfcHk0lgvnmwjs-LD-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2murrP&md5=b371a37b76ee88cfc6ac47ea0eeea0e6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1513257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1513257%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DDavids%26aufirst%3DM.%2BS.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DKahl%26aufirst%3DB.%2BS.%26aulast%3DPuvvada%26aufirst%3DS.%2BD.%26aulast%3DGerecitano%26aufirst%3DJ.%2BF.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DAnderson%26aufirst%3DM.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DGressick%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DDunbar%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DM.%2BB.%26aulast%3DCerri%26aufirst%3DE.%26aulast%3DHeitner%2BEnschede%26aufirst%3DS.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26atitle%3DTargeting%2520BCL2%2520with%2520venetoclax%2520in%2520relapsed%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2016%26volume%3D374%26spage%3D311%26epage%3D322%26doi%3D10.1056%2FNEJMoa1513257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Punnoose, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boghaert, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmont, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingalla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darbonne, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span> </span><span class="NLM_article-title">Expression profile of BCL-2, BCL-XL and MCL-1 predicts pharmacological response to the BCL-2 selective antagonist venetoclax in multiple myeloma models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">â</span> <span class="NLM_lpage">1144</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-15-0730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1158%2F1535-7163.MCT-15-0730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26939706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt12ktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1132-1144&author=E.+Punnooseauthor=J.+D.+Leversonauthor=F.+Pealeauthor=E.+R.+Boghaertauthor=L.+D.+Belmontauthor=N.+Tanauthor=A.+Youngauthor=M.+Mittenauthor=E.+Ingallaauthor=W.+C.+Darbonneauthor=A.+Oleksijewauthor=P.+Tapangauthor=P.+Yueauthor=J.+Oehauthor=L.+Leeauthor=S.+Maigaauthor=W.+J.+Fairbrotherauthor=M.+Amiotauthor=A.+J.+Souersauthor=D.+Sampath&title=Expression+profile+of+BCL-2%2C+BCL-XL+and+MCL-1+predicts+pharmacological+response+to+the+BCL-2+selective+antagonist+venetoclax+in+multiple+myeloma+models&doi=10.1158%2F1535-7163.MCT-15-0730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models</span></div><div class="casAuthors">Punnoose, Elizabeth A.; Leverson, Joel D.; Peale, Franklin; Boghaert, Erwin R.; Belmont, Lisa D.; Tan, Nguyen; Young, Amy; Mitten, Michael; Ingalla, Ellen; Darbonne, Walter C.; Oleksijew, Anatol; Tapang, Paul; Yue, Peng; Oeh, Jason; Lee, Leslie; Maiga, Sophie; Fairbrother, Wayne J.; Amiot, Martine; Souers, Andrew J.; Sampath, Deepak</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1132-1144</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BCL-2 family proteins dictate survival of human multiple myeloma cells, making them attractive drug targets.  Indeed, multiple myeloma cells are sensitive to antagonists that selectively target prosurvival proteins such as BCL-2/BCL-XL (ABT-737 and ABT-263/navitoclax) or BCL-2 only (ABT-199/GDC-0199/venetoclax).  Resistance to these three drugs is mediated by expression of MCL-1.  However, given the selectivity profile of venetoclax it is unclear whether coexpression of BCL-XL also affects antitumor responses to venetoclax in multiple myeloma.  In multiple myeloma cell lines (n = 21), BCL-2 is expressed but sensitivity to venetoclax correlated with high BCL-2 and low BCL-XL or MCL-1 expression.  Multiple myeloma cells that coexpress BCL-2 and BCL-XL were resistant to venetoclax but sensitive to a BCL-XL-selective inhibitor (A-1155463).  Multiple myeloma xenograft models that coexpressed BCL-XL or MCL-1 with BCL-2 were also resistant to venetoclax.  Resistance to venetoclax was mitigated by cotreatment with bortezomib in xenografts that coexpressed BCL-2 and MCL-1 due to upregulation of NOXA, a proapoptotic factor that neutralizes MCL-1.  In contrast, xenografts that expressed BCL-XL, MCL-1, and BCL-2 were more sensitive to the combination of bortezomib with a BCL-XL selective inhibitor (A-1331852) but not with venetoclax cotreatment when compared with monotherapies.  IHC of multiple myeloma patient bone marrow biopsies and aspirates (n = 95) revealed high levels of BCL-2 and BCL-XL in 62% and 43% of evaluable samples, resp., while 34% were characterized as BCL-2High/BCL-XLLow.  In addn. to MCL-1, our data suggest that BCL-XL may also be a potential resistance factor to venetoclax monotherapy and in combination with bortezomib.  Mol Cancer Ther; 15(5); 1132-44. cpr2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnLq1WNK__LVg90H21EOLACvtfcHk0lgvnmwjs-LD-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt12ktLY%253D&md5=a389568a0b933da01801e9beea9bf4a9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0730%26sid%3Dliteratum%253Aachs%26aulast%3DPunnoose%26aufirst%3DE.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DBelmont%26aufirst%3DL.%2BD.%26aulast%3DTan%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DMitten%26aufirst%3DM.%26aulast%3DIngalla%26aufirst%3DE.%26aulast%3DDarbonne%26aufirst%3DW.%2BC.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DOeh%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DMaiga%26aufirst%3DS.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DAmiot%26aufirst%3DM.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DSampath%26aufirst%3DD.%26atitle%3DExpression%2520profile%2520of%2520BCL-2%252C%2520BCL-XL%2520and%2520MCL-1%2520predicts%2520pharmacological%2520response%2520to%2520the%2520BCL-2%2520selective%2520antagonist%2520venetoclax%2520in%2520multiple%2520myeloma%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D1132%26epage%3D1144%26doi%3D10.1158%2F1535-7163.MCT-15-0730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Thijssen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geest, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Oers, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kater, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldering, E.</span><span> </span><span class="NLM_article-title">Resistance to ABT-199 inducted by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">e302</span><span class="NLM_x">â</span> <span class="NLM_lpage">e306</span><span class="refDoi">Â DOI: 10.3324/haematol.2015.124560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.3324%2Fhaematol.2015.124560" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=e302-e306&author=R.+Thijssenauthor=E.+Slingerauthor=K.+Wellerauthor=C.+R.+Geestauthor=T.+Beaumontauthor=M.+H.+van+Oersauthor=A.+P.+Katerauthor=E.+Eldering&title=Resistance+to+ABT-199+inducted+by+microenvironmental+signals+in+chronic+lymphocytic+leukemia+can+be+counteracted+by+CD20+antibodies+or+kinase+inhibitors&doi=10.3324%2Fhaematol.2015.124560"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2015.124560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2015.124560%26sid%3Dliteratum%253Aachs%26aulast%3DThijssen%26aufirst%3DR.%26aulast%3DSlinger%26aufirst%3DE.%26aulast%3DWeller%26aufirst%3DK.%26aulast%3DGeest%26aufirst%3DC.%2BR.%26aulast%3DBeaumont%26aufirst%3DT.%26aulast%3Dvan%2BOers%26aufirst%3DM.%2BH.%26aulast%3DKater%26aufirst%3DA.%2BP.%26aulast%3DEldering%26aufirst%3DE.%26atitle%3DResistance%2520to%2520ABT-199%2520inducted%2520by%2520microenvironmental%2520signals%2520in%2520chronic%2520lymphocytic%2520leukemia%2520can%2520be%2520counteracted%2520by%2520CD20%2520antibodies%2520or%2520kinase%2520inhibitors%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3De302%26epage%3De306%26doi%3D10.3324%2Fhaematol.2015.124560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span> </span><span class="NLM_article-title">BCL-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding</span> <span class="citation_source-journal">Br. J. Phamacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">483</span><span class="refDoi">Â DOI: 10.1111/bph.13370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1111%2Fbph.13370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26493374" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=471-483&author=T.+Songauthor=G.+Chaiauthor=Y.+Liuauthor=X.+Yuauthor=Z.+Wangauthor=Z.+Zhang&title=BCL-2+phosphorylation+confers+resistance+on+chronic+lymphocytic+leukaemia+cells+to+the+BH3+mimetics+ABT-737%2C+ABT-263+and+ABT-199+by+impeding+direct+binding&doi=10.1111%2Fbph.13370"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fbph.13370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13370%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChai%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DBCL-2%2520phosphorylation%2520confers%2520resistance%2520on%2520chronic%2520lymphocytic%2520leukaemia%2520cells%2520to%2520the%2520BH3%2520mimetics%2520ABT-737%252C%2520ABT-263%2520and%2520ABT-199%2520by%2520impeding%2520direct%2520binding%26jtitle%3DBr.%2520J.%2520Phamacol.%26date%3D2016%26volume%3D173%26spage%3D471%26epage%3D483%26doi%3D10.1111%2Fbph.13370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fong, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ftouni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papenfuss, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M. A.</span><span> </span><span class="NLM_article-title">BET inhibitor resistance emerges from leukaemia stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">â</span> <span class="NLM_lpage">542</span><span class="refDoi">Â DOI: 10.1038/nature14888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fnature14888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=26367796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=538-542&author=C.+Y.+Fongauthor=O.+Gilanauthor=E.+Y.+Lamauthor=A.+F.+Rubinauthor=S.+Ftouniauthor=D.+Tylerauthor=K.+Stanleyauthor=D.+Sinhaauthor=P.+Yehauthor=J.+Morisonauthor=G.+Giotopoulosauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+C.+Leeauthor=C.+Carpenterauthor=R.+Gregoryauthor=R.+G.+Ramsayauthor=S.+W.+Laneauthor=O.+Abdel-Wahabauthor=T.+Kouzaridesauthor=R.+W.+Johnstoneauthor=S.+J.+Dawsonauthor=B.+J.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+T.+Papenfussauthor=M.+A.+Dawson&title=BET+inhibitor+resistance+emerges+from+leukaemia+stem+cells&doi=10.1038%2Fnature14888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor resistance emerges from leukaemia stem cells</span></div><div class="casAuthors">Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">538-542</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks.  Early clin. trials have shown promise, esp. in acute myeloid leukemia, and therefore the evaluation of resistance mechanisms is crucial to optimize the clin. efficacy of these drugs.  Here we use primary mouse hematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET.  Resistance to I-BET confers cross-resistance to chem. distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins.  Resistance is not mediated through increased drug efflux or metab., but is shown to emerge from leukemia stem cells both ex vivo and in vivo.  Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription.  We demonstrate that resistance to BET inhibitors, in human and mouse leukemia cells, is in part a consequence of increased Wnt/Î²-catenin signaling, and neg. regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo.  Together, these findings provide new insights into the biol. of acute myeloid leukemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clin. utility of these unique targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Lg1n64SCWrVg90H21EOLACvtfcHk0liWUbDIFyYXrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL&md5=47d1769e077b1c6c92ff52a051368404</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature14888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14888%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DC.%2BY.%26aulast%3DGilan%26aufirst%3DO.%26aulast%3DLam%26aufirst%3DE.%2BY.%26aulast%3DRubin%26aufirst%3DA.%2BF.%26aulast%3DFtouni%26aufirst%3DS.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DStanley%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMorison%26aufirst%3DJ.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DCarpenter%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DR.%26aulast%3DRamsay%26aufirst%3DR.%2BG.%26aulast%3DLane%26aufirst%3DS.%2BW.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DDawson%26aufirst%3DS.%2BJ.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DPapenfuss%26aufirst%3DA.%2BT.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26atitle%3DBET%2520inhibitor%2520resistance%2520emerges%2520from%2520leukaemia%2520stem%2520cells%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D538%26epage%3D542%26doi%3D10.1038%2Fnature14888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Brunelle, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span> </span><span class="NLM_article-title">Control of mitochondrial apoptosis by the Bcl-2 family</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">441</span><span class="refDoi">Â DOI: 10.1242/jcs.031682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1242%2Fjcs.031682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=19193868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Wls7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=437-441&author=J.+K.+Brunelleauthor=A.+Letai&title=Control+of+mitochondrial+apoptosis+by+the+Bcl-2+family&doi=10.1242%2Fjcs.031682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Control of mitochondrial apoptosis by the Bcl-2 family</span></div><div class="casAuthors">Brunelle, Joslyn K.; Letai, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">437-441</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteins of the Bcl-2 family have either pro- or anti-apoptotic activities and regulate the mitochondrial pathway of apoptosis by controlling the permeabilization of the outer mitochondrial membrane, which leads to release of cytochrome c.  The release of cytochrome c leads to activation of caspases, which cleave key cellular proteins.  This leads to many of the morphol. characteristics of apoptosis, including condensed nuclei, DNA laddering, and exposure of phosphatidylserine to the outer leaflet of the plasma membrane.  Here, the authors discuss how proteins of the Bcl-2 family control the crucial event in the commitment to apoptosis, permeabilization of the mitochondrial outer membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV8wHMPqsSlrVg90H21EOLACvtfcHk0liWUbDIFyYXrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Wls7w%253D&md5=8602c8b209d6c1c74fc3712d7fd9acd4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1242%2Fjcs.031682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.031682%26sid%3Dliteratum%253Aachs%26aulast%3DBrunelle%26aufirst%3DJ.%2BK.%26aulast%3DLetai%26aufirst%3DA.%26atitle%3DControl%2520of%2520mitochondrial%2520apoptosis%2520by%2520the%2520Bcl-2%2520family%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2009%26volume%3D122%26spage%3D437%26epage%3D441%26doi%3D10.1242%2Fjcs.031682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romaguera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Q.</span><span> </span><span class="NLM_article-title">Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">â</span> <span class="NLM_lpage">185</span><span class="refDoi">Â DOI: 10.1038/sj.leu.2404959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fsj.leu.2404959" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=179-185&author=M.+Wangauthor=X.+H.+Hanauthor=L.+Zhangauthor=J.+Yangauthor=J.+F.+Qianauthor=Y.+K.+Shiauthor=L.+W.+Kwakauthor=J.+Romagueraauthor=Q.+Yi&title=Bortezomib+is+synergistic+with+rituximab+and+cyclophosphamide+in+inducing+apoptosis+of+mantle+cell+lymphoma+cells+in+vitro+and+in+vivo&doi=10.1038%2Fsj.leu.2404959"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2404959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2404959%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DX.%2BH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DJ.%2BF.%26aulast%3DShi%26aufirst%3DY.%2BK.%26aulast%3DKwak%26aufirst%3DL.%2BW.%26aulast%3DRomaguera%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DQ.%26atitle%3DBortezomib%2520is%2520synergistic%2520with%2520rituximab%2520and%2520cyclophosphamide%2520in%2520inducing%2520apoptosis%2520of%2520mantle%2520cell%2520lymphoma%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D179%26epage%3D185%26doi%3D10.1038%2Fsj.leu.2404959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Trebunova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laputkova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacjakova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verebova, A.</span><span> </span><span class="NLM_article-title">Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">â</span> <span class="NLM_lpage">2854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=22753747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1aks7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2849-2854&author=M.+Trebunovaauthor=G.+Laputkovaauthor=E.+Slabaauthor=K.+Lacjakovaauthor=A.+Verebova&title=Effects+of+docetaxel%2C+doxorubicin+and+cyclophosphamide+on+human+breast+cancer+cell+line+MCF-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7</span></div><div class="casAuthors">Trebunova, Marianna; Liputkova, Galina; Slaba, Eva; Lacjakova, Kamila; Verebova, Aneta</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2849-2854</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Cell viability assays are important tools in oncol. research.  The purpose of this study was to evaluate the effect of docetaxel, doxorubicin and cyclophosphamide on the metabolic activity of MCF-7 breast cancer cell line.  Antiproliferative effect of cytostatics on MCF-7 cells was measured using the std. colorimetric test.  The MCF-7 cell line was exposed to cytostatics for 24 h.  The metabolic activity was evaluated over the 24 h.  According to the statistical anal., the change in the growth rate was significant (p<0.05) for the 120 nM docetaxel and above the 200 nM doxorubicin treatment in comparison with sensitive MCF-7 cells.  When considering drugs in combination (60 nM docetaxel with 200 nM doxorubicin and 60 nM docetaxel with 500 nM doxorubicin) after the addn. of 600 nM cyclophosphamide, we found a statistically significant decrease of metabolic activity of the MCF-7 cell line (p<0.05).  Cyclophosphamide at 600 nM seems to enhance the influence of docetaxel when combined with doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfel-piY1LObVg90H21EOLACvtfcHk0lgD-n7ljoDHNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1aks7nL&md5=8536b5ce6a065a6faf9913ca90e27f86</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrebunova%26aufirst%3DM.%26aulast%3DLaputkova%26aufirst%3DG.%26aulast%3DSlaba%26aufirst%3DE.%26aulast%3DLacjakova%26aufirst%3DK.%26aulast%3DVerebova%26aufirst%3DA.%26atitle%3DEffects%2520of%2520docetaxel%252C%2520doxorubicin%2520and%2520cyclophosphamide%2520on%2520human%2520breast%2520cancer%2520cell%2520line%2520MCF-7%26jtitle%3DAnticancer%2520Res.%26date%3D2012%26volume%3D32%26spage%3D2849%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bosanquet, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosanquet, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorken, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, P. T.</span><span> </span><span class="NLM_article-title">Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide, and chlorambucil but not fludarabine, cladribine, or corticosteroids in B cell chronic lymphocytic leukemia</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">â</span> <span class="NLM_lpage">1044</span><span class="refDoi">Â DOI: 10.1038/sj.leu.2402539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2Fsj.leu.2402539" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1035-1044&author=A.+G.+Bosanquetauthor=I.+Sturmauthor=T.+Wiederauthor=F.+Essmannauthor=M.+I.+Bosanquetauthor=D.+J.+Headauthor=B.+Dorkenauthor=P.+T.+Daniel&title=Bax+expression+correlates+with+cellular+drug+sensitivity+to+doxorubicin%2C+cyclophosphamide%2C+and+chlorambucil+but+not+fludarabine%2C+cladribine%2C+or+corticosteroids+in+B+cell+chronic+lymphocytic+leukemia&doi=10.1038%2Fsj.leu.2402539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2402539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2402539%26sid%3Dliteratum%253Aachs%26aulast%3DBosanquet%26aufirst%3DA.%2BG.%26aulast%3DSturm%26aufirst%3DI.%26aulast%3DWieder%26aufirst%3DT.%26aulast%3DEssmann%26aufirst%3DF.%26aulast%3DBosanquet%26aufirst%3DM.%2BI.%26aulast%3DHead%26aufirst%3DD.%2BJ.%26aulast%3DDorken%26aufirst%3DB.%26aulast%3DDaniel%26aufirst%3DP.%2BT.%26atitle%3DBax%2520expression%2520correlates%2520with%2520cellular%2520drug%2520sensitivity%2520to%2520doxorubicin%252C%2520cyclophosphamide%252C%2520and%2520chlorambucil%2520but%2520not%2520fludarabine%252C%2520cladribine%252C%2520or%2520corticosteroids%2520in%2520B%2520cell%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D1035%26epage%3D1044%26doi%3D10.1038%2Fsj.leu.2402539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kalac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amengual, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshan, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulahannan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leshchenko, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temkin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, O. A.</span><span> </span><span class="NLM_article-title">HDAC inhibitors and decitabine are highly synergistic and associated with unique gene expression and epigenetic profiles in models of DLBCL</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">5506</span><span class="NLM_x">â</span> <span class="NLM_lpage">5516</span><span class="refDoi">Â DOI: 10.1182/blood-2011-02-336891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1182%2Fblood-2011-02-336891" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=5506-5516&author=M.+Kalacauthor=L.+Scottoauthor=E.+Marchiauthor=J.+Amengualauthor=V.+E.+Seshanauthor=G.+Bhagatauthor=N.+Ulahannanauthor=V.+V.+Leshchenkoauthor=A.+M.+Temkinauthor=S.+Parekhauthor=B.+Tyckoauthor=O.+A.+O%E2%80%99Connor&title=HDAC+inhibitors+and+decitabine+are+highly+synergistic+and+associated+with+unique+gene+expression+and+epigenetic+profiles+in+models+of+DLBCL&doi=10.1182%2Fblood-2011-02-336891"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-02-336891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-02-336891%26sid%3Dliteratum%253Aachs%26aulast%3DKalac%26aufirst%3DM.%26aulast%3DScotto%26aufirst%3DL.%26aulast%3DMarchi%26aufirst%3DE.%26aulast%3DAmengual%26aufirst%3DJ.%26aulast%3DSeshan%26aufirst%3DV.%2BE.%26aulast%3DBhagat%26aufirst%3DG.%26aulast%3DUlahannan%26aufirst%3DN.%26aulast%3DLeshchenko%26aufirst%3DV.%2BV.%26aulast%3DTemkin%26aufirst%3DA.%2BM.%26aulast%3DParekh%26aufirst%3DS.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26atitle%3DHDAC%2520inhibitors%2520and%2520decitabine%2520are%2520highly%2520synergistic%2520and%2520associated%2520with%2520unique%2520gene%2520expression%2520and%2520epigenetic%2520profiles%2520in%2520models%2520of%2520DLBCL%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D5506%26epage%3D5516%26doi%3D10.1182%2Fblood-2011-02-336891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Brown, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chawla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quijada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassiter, Q. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phanse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnidge, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">The consequences of overlapping G-quadruplexes and i-motifs in the platelet-derived growth factor receptor Î² core promoter nuclease hypersensitive element can explain the unexpected effects of mutations and provide opportunities for selective targeting of both structures by small molecules to downregulate gene expression</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">7456</span><span class="refDoi">Â DOI: 10.1021/jacs.6b10028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b10028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSksbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=7456&author=R.+V.+Brownauthor=T.+Wangauthor=R.+Chappetaauthor=G.+Wuauthor=B.+Onelauthor=R.+Chawlaauthor=H.+Quijadaauthor=S.+M.+Campauthor=E.+T.+Chiangauthor=Q.+R.+Lassiterauthor=C.+Leeauthor=S.+Phanseauthor=M.+A.+Turnidgeauthor=P.+Zhaoauthor=J.+G.+N.+Garciaauthor=V.+Gokhaleauthor=D.+Yangauthor=L.+H.+Hurley&title=The+consequences+of+overlapping+G-quadruplexes+and+i-motifs+in+the+platelet-derived+growth+factor+receptor+%CE%B2+core+promoter+nuclease+hypersensitive+element+can+explain+the+unexpected+effects+of+mutations+and+provide+opportunities+for+selective+targeting+of+both+structures+by+small+molecules+to+downregulate+gene+expression&doi=10.1021%2Fjacs.6b10028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor Î² Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting of Both Structures by Small Molecules To Downregulate Gene Expression</span></div><div class="casAuthors">Brown, Robert V.; Wang, Ting; Chappeta, Venkateshwar Reddy; Wu, Guanhui; Onel, Buket; Chawla, Reena; Quijada, Hector; Camp, Sara M.; Chiang, Eddie T.; Lassiter, Quinea R.; Lee, Carmen; Phanse, Shivani; Turnidge, Megan A.; Zhou, Ping; Garcia, Joe G. N.; Gokhale, Vijay; Yang, Danzhou; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7456-7475</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The platelet-derived growth factor receptor Î² (PDGFR-Î²) signaling pathway is a validated and important target for the treatment of certain malignant and nonmalignant pathologies.  We previously identified a G-quadruplex-forming nuclease hypersensitive element (NHE) in the human PDGFR-Î² promoter that putatively forms four overlapping G-quadruplexes.  Therefore, we further investigated the structures and biol. roles of the G-quadruplexes and i-motifs in the PDGFR-Î² NHE with the ultimate goal of demonstrating an alternate and effective strategy for molecularly targeting the PDGFR-Î² pathway.  Significantly, we show that the primary G-quadruplex receptor for repression of PDGFR-Î² is the 3'-end G-quadruplex, which has a GGA sequence at the 3'-end.  Mutation studies using luciferase reporter plasmids highlight a novel set of G-quadruplex point mutations, some of which seem to provide conflicting results on effects on gene expression, prompting further investigation into the effect of these mutations on the i-motif-forming strand.  Herein we characterize the formation of an equil. between at least two different i-motifs from the cytosine-rich (C-rich) sequence of the PDGFR-Î² NHE.  The apparently conflicting mutation results can be rationalized if we take into account the single base point mutation made in a crit. cytosine run in the PDGFR-Î² NHE that dramatically affects the equil. of i-motifs formed from this sequence.  We identified a group of ellipticines that targets the G-quadruplexes in the PDGFR-Î² promoter, and from this series of compds., we selected the ellipticine analog GSA1129, which selectively targets the 3'-end G-quadruplex, to shift the dynamic equil. in the full-length sequence to favor this structure.  We also identified a benzothiophene-2-carboxamide (NSC309874) as a PDGFR-Î² i-motif-interactive compd.  In vitro, GSA1129 and NSC309874 downregulate PDGFR-Î² promoter activity and transcript in the neuroblastoma cell line SK-N-SH at subcytotoxic cell concns.  GSA1129 also inhibits PDGFR-Î²-driven cell proliferation and migration.  With an established preclin. murine model of acute lung injury, we demonstrate that GSA1129 attenuates endotoxin-mediated acute lung inflammation.  Our studies underscore the importance of considering the effects of point mutations on structure formation from the G- and C-rich sequences and provide further evidence for the involvement of both strands and assocd. structures in the control of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhaMLX8v_xSrVg90H21EOLACvtfcHk0lhL3RlPOJw4MQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSksbY%253D&md5=816bce244950c04356a09f731e430c54</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b10028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b10028%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BV.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChappeta%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DOnel%26aufirst%3DB.%26aulast%3DChawla%26aufirst%3DR.%26aulast%3DQuijada%26aufirst%3DH.%26aulast%3DCamp%26aufirst%3DS.%2BM.%26aulast%3DChiang%26aufirst%3DE.%2BT.%26aulast%3DLassiter%26aufirst%3DQ.%2BR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPhanse%26aufirst%3DS.%26aulast%3DTurnidge%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DThe%2520consequences%2520of%2520overlapping%2520G-quadruplexes%2520and%2520i-motifs%2520in%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520%25CE%25B2%2520core%2520promoter%2520nuclease%2520hypersensitive%2520element%2520can%2520explain%2520the%2520unexpected%2520effects%2520of%2520mutations%2520and%2520provide%2520opportunities%2520for%2520selective%2520targeting%2520of%2520both%2520structures%2520by%2520small%2520molecules%2520to%2520downregulate%2520gene%2520expression%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D7456%26doi%3D10.1021%2Fjacs.6b10028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, W. P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekulic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, L. H.</span><span> </span><span class="NLM_article-title">A pharmacological chaperone molecule induces cancer cell death by restoring tertiary DNA structures in mutant hTERT promoters</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">13673</span><span class="NLM_x">â</span> <span class="NLM_lpage">13692</span><span class="refDoi">Â DOI: 10.1021/jacs.6b07598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b07598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFamsrnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=13673-13692&author=H.-J.+Kangauthor=Y.+Cuiauthor=H.+Yinauthor=A.+Scheidauthor=W.+P.+D.+Hendricksauthor=J.+Schmidtauthor=A.+Sekulicauthor=D.+Kongauthor=J.+M.+Trentauthor=V.+Gokhaleauthor=H.+Maoauthor=L.+H.+Hurley&title=A+pharmacological+chaperone+molecule+induces+cancer+cell+death+by+restoring+tertiary+DNA+structures+in+mutant+hTERT+promoters&doi=10.1021%2Fjacs.6b07598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters</span></div><div class="casAuthors">Kang, Hyun-Jin; Cui, Yunxi; Yin, Holly; Scheid, Amy; Hendricks, William P. D.; Schmidt, Jessica; Sekulic, Aleksandar; Kong, Deming; Trent, Jeffrey M.; Gokhale, Vijay; Mao, Hanbin; Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13673-13692</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of human telomerase reverse transcriptase (hTERT) is necessary for limitless replication in tumorigenesis.  Whereas hTERT is transcriptionally silenced in normal cells, most tumor cells reactivate hTERT expression by alleviating transcriptional repression through diverse genetic and epigenetic mechanisms.  Transcription-activating hTERT promoter mutations have been found to occur at high frequencies in multiple cancer types.  These mutations have been shown to form new transcription factor binding sites that drive hTERT expression, but this model cannot fully account for differences in wild-type and mutant promoter activation and has not yet enabled a selective therapeutic strategy.  Here the authors demonstrate a novel mechanism by which promoter mutations activate hTERT transcription, which also sheds light on a unique therapeutic opportunity.  Promoter mutations occur in a core promoter region that forms tertiary structures consisting of a pair of G-quadruplexes involved in transcriptional silencing.  The authors show that promoter mutations exert a detrimental effect on the folding of one of these G-quadruplexes, resulting in a nonfunctional silencer element that alleviates transcriptional repression.  The authors have also identified a small drug-like pharmacol. chaperone (pharmacoperone) mol., GTC365, that acts at an early step in the G-quadruplex folding pathway to redirect mutant promoter G-quadruplex misfolding, partially reinstate the correct folding pathway, and reduce hTERT activity through transcriptional repression.  This transcription-mediated repression effects cancer cell death through multiple routes including both induction of apoptosis through inhibition of hTERT's role in regulating apoptosis-related proteins and inducing senescence by decreasing telomerase activity and telomere length.  The authors demonstrate the selective therapeutic potential of this strategy in melanoma cells that overexpress hTERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUXprvNdY5oLVg90H21EOLACvtfcHk0lhL3RlPOJw4MQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFamsrnP&md5=043ffcf8b2f19a9884e9e7b6bdca6a42</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b07598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b07598%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DH.-J.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DScheid%26aufirst%3DA.%26aulast%3DHendricks%26aufirst%3DW.%2BP.%2BD.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DSekulic%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DTrent%26aufirst%3DJ.%2BM.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DA%2520pharmacological%2520chaperone%2520molecule%2520induces%2520cancer%2520cell%2520death%2520by%2520restoring%2520tertiary%2520DNA%2520structures%2520in%2520mutant%2520hTERT%2520promoters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D13673%26epage%3D13692%26doi%3D10.1021%2Fjacs.6b07598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span> </span><span class="NLM_article-title">Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">333</span><span class="refDoi">Â DOI: 10.1038/348331a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1038%2F348331a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=331-333&author=A.+Strasserauthor=A.+W.+Harrisauthor=M.+L.+Bathauthor=S.+Cory&title=Novel+primitive+lymphoid+tumours+induced+in+transgenic+mice+by+cooperation+between+myc+and+bcl-2&doi=10.1038%2F348331a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2F348331a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348331a0%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DA.%2BW.%26aulast%3DBath%26aufirst%3DM.%2BL.%26aulast%3DCory%26aufirst%3DS.%26atitle%3DNovel%2520primitive%2520lymphoid%2520tumours%2520induced%2520in%2520transgenic%2520mice%2520by%2520cooperation%2520between%2520myc%2520and%2520bcl-2%26jtitle%3DNature%26date%3D1990%26volume%3D348%26spage%3D331%26epage%3D333%26doi%3D10.1038%2F348331a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Weinstein, I. B.</span><span> </span><span class="NLM_article-title">Cancer. Addition to oncogenes â the Achilles heal of cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">64</span><span class="refDoi">Â DOI: 10.1126/science.1073096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1126%2Fscience.1073096" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=63-64&author=I.+B.+Weinstein&title=Cancer.+Addition+to+oncogenes+%E2%80%93+the+Achilles+heal+of+cancer&doi=10.1126%2Fscience.1073096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1073096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1073096%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26atitle%3DCancer.%2520Addition%2520to%2520oncogenes%2520%25E2%2580%2593%2520the%2520Achilles%2520heal%2520of%2520cancer%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D63%26epage%3D64%26doi%3D10.1126%2Fscience.1073096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Felsher, D. W.</span><span> </span><span class="NLM_article-title">MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">â</span> <span class="NLM_lpage">604</span><span class="refDoi">Â DOI: 10.1177/1947601910377798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1177%2F1947601910377798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=21037952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyisLfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=597-604&author=D.+W.+Felsher&title=MYC+inactivation+elicits+oncogene+addiction+through+both+tumor+cell-intrinsic+and+host-dependent+mechanisms&doi=10.1177%2F1947601910377798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms</span></div><div class="casAuthors">Felsher, Dean W.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-604</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Tumorigenesis is generally caused by genetic changes that activate oncogenes or inactivate tumor suppressor genes.  The targeted inactivation of oncogenes can be assocd. with tumor regression through the phenomenon of oncogene addiction.  One of the most common oncogenic events in human cancer is the activation of the MYC oncogene.  The inactivation of MYC may be a general and effective therapy for human cancer.  Indeed, it has been exptl. shown that the inactivation of MYC can result in dramatic and sustained tumor regression in lymphoma, leukemia, osteosarcoma, hepatocellular carcinoma, squamous carcinoma, and pancreatic carcinoma through a multitude of mechanisms, including proliferative arrest, terminal differentiation, cellular senescence, induction of apoptosis, and the shutdown of angiogenesis.  Cell-autonomous and cell-dependent mechanisms have both been implicated, and recent results suggest a crit. role for autocrine factors, including thrombospondin-1 and TGF-Î².  Hence, targeting the inactivation of MYC appears to elicit oncogene addiction and, thereby, tumor regression through both tumor cell-intrinsic and host-dependent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquwYFn0Q7HGLVg90H21EOLACvtfcHk0ljR-X-5qYKQaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyisLfI&md5=3f31da945b0ad9461d3b8cba3f54386a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1177%2F1947601910377798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601910377798%26sid%3Dliteratum%253Aachs%26aulast%3DFelsher%26aufirst%3DD.%2BW.%26atitle%3DMYC%2520inactivation%2520elicits%2520oncogene%2520addiction%2520through%2520both%2520tumor%2520cell-intrinsic%2520and%2520host-dependent%2520mechanisms%26jtitle%3DGenes%2520Cancer%26date%3D2010%26volume%3D1%26spage%3D597%26epage%3D604%26doi%3D10.1177%2F1947601910377798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Murphy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junttila, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouyet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnezis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shchors, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Swigart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evan, G. I.</span><span> </span><span class="NLM_article-title">Distinct thresholds govern Mycâs biological output in vivo</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">â</span> <span class="NLM_lpage">457</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2008.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1016%2Fj.ccr.2008.10.018" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=447-457&author=D.+J.+Murphyauthor=M.+R.+Junttilaauthor=L.+Pouyetauthor=A.+Karnezisauthor=K.+Shchorsauthor=D.+A.+Buiauthor=L.+Brown-Swigartauthor=L.+Johnsonauthor=G.+I.+Evan&title=Distinct+thresholds+govern+Myc%E2%80%99s+biological+output+in+vivo&doi=10.1016%2Fj.ccr.2008.10.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26aulast%3DJunttila%26aufirst%3DM.%2BR.%26aulast%3DPouyet%26aufirst%3DL.%26aulast%3DKarnezis%26aufirst%3DA.%26aulast%3DShchors%26aufirst%3DK.%26aulast%3DBui%26aufirst%3DD.%2BA.%26aulast%3DBrown-Swigart%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DEvan%26aufirst%3DG.%2BI.%26atitle%3DDistinct%2520thresholds%2520govern%2520Myc%25E2%2580%2599s%2520biological%2520output%2520in%2520vivo%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D447%26epage%3D457%26doi%3D10.1016%2Fj.ccr.2008.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Eischen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, J. L.</span><span> </span><span class="NLM_article-title">Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2658</span><span class="NLM_x">â</span> <span class="NLM_lpage">2669</span><span class="refDoi">Â DOI: 10.1101/gad.13.20.2658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1101%2Fgad.13.20.2658" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=2658-2669&author=C.+M.+Eischenauthor=J.+D.+Weberauthor=M.+F.+Rousselauthor=C.+J.+Sherrauthor=J.+L.+Cleveland&title=Disruption+of+the+ARF-Mdm2-p53+tumor+suppressor+pathway+in+Myc-induced+lymphomagenesis&doi=10.1101%2Fgad.13.20.2658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.20.2658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.20.2658%26sid%3Dliteratum%253Aachs%26aulast%3DEischen%26aufirst%3DC.%2BM.%26aulast%3DWeber%26aufirst%3DJ.%2BD.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26atitle%3DDisruption%2520of%2520the%2520ARF-Mdm2-p53%2520tumor%2520suppressor%2520pathway%2520in%2520Myc-induced%2520lymphomagenesis%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D2658%26epage%3D2669%26doi%3D10.1101%2Fgad.13.20.2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Zindy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eischen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamijo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, M. F.</span><span> </span><span class="NLM_article-title">Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2424</span><span class="NLM_x">â</span> <span class="NLM_lpage">2433</span><span class="refDoi">Â DOI: 10.1101/gad.12.15.2424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1101%2Fgad.12.15.2424" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2424-2433&author=F.+Zindyauthor=C.+M.+Eischenauthor=D.+H.+Randleauthor=T.+Kamijoauthor=J.+L.+Clevelandauthor=C.+J.+Sherrauthor=M.+F.+Roussel&title=Myc+signaling+via+the+ARF+tumor+suppressor+regulates+p53-dependent+apoptosis+and+immortalization&doi=10.1101%2Fgad.12.15.2424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.15.2424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.15.2424%26sid%3Dliteratum%253Aachs%26aulast%3DZindy%26aufirst%3DF.%26aulast%3DEischen%26aufirst%3DC.%2BM.%26aulast%3DRandle%26aufirst%3DD.%2BH.%26aulast%3DKamijo%26aufirst%3DT.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26atitle%3DMyc%2520signaling%2520via%2520the%2520ARF%2520tumor%2520suppressor%2520regulates%2520p53-dependent%2520apoptosis%2520and%2520immortalization%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2424%26epage%3D2433%26doi%3D10.1101%2Fgad.12.15.2424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">McMahon, S. B.</span><span> </span><span class="NLM_article-title">MYC and the control of apoptosis</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">a014407</span><span class="refDoi">Â DOI: 10.1101/cshperspect.a014407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1101%2Fcshperspect.a014407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=24985130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yltrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=a014407&author=S.+B.+McMahon&title=MYC+and+the+control+of+apoptosis&doi=10.1101%2Fcshperspect.a014407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MYC and the control of apoptosis</span></div><div class="casAuthors">McMahon, Steven B.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a014407/1-a014407/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  MYC expression is tightly correlated with cell-cycle progression in normal tissues, whereas unchecked MYC expression is among the most prominent hallmarks of the hyperproliferation assocd. with most forms of cancer.  At first glance it might seem counterintuitive that MYC is also among the most robust agents of programmed cell death (apoptosis) in mammalian cells.  However it is clearly beneficial for a multicellular organism to have a mechanism for triggering death in cells that express potentially oncogenic levels of MYC.  Decades of intense study have begun to provide an understanding of the mechanisms that regulate MYC's seemingly split personality.  Key features of MYC-induced apoptosis will be discussed here along with examples of how our understanding of this pathway might be exploited for the therapeutic benefit of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-2J30dsIPKLVg90H21EOLACvtfcHk0ljR-X-5qYKQaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yltrzP&md5=68ef64c834d2ab2e06ae6a0bb5ab61d4</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a014407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a014407%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26atitle%3DMYC%2520and%2520the%2520control%2520of%2520apoptosis%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2014%26volume%3D4%26spage%3Da014407%26doi%3D10.1101%2Fcshperspect.a014407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Valentino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenburger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubbs, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunhoeber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimsza, L.</span><span> </span><span class="NLM_article-title">Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">â</span> <span class="NLM_lpage">254</span><span class="refDoi">Â DOI: 10.1309/AJCP2Z0TAGMUYJEB</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=10.1309%2FAJCP2Z0TAGMUYJEB" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=23355209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;key=1%3ACAS%3A280%3ADC%252BC3szivFOrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2013&pages=242-254&author=C.+Valentinoauthor=S.+Kendrickauthor=N.+Johnsonauthor=R.+Gascoyneauthor=W.+C.+Chanauthor=D.+D.+Weisenburgerauthor=R.+Brazielauthor=J.+Cookauthor=R.+R.+Tubbsauthor=E.+Campoauthor=A.+Rosenwaldauthor=G.+Ottauthor=J.+Delabieauthor=E.+Jaffeauthor=W.+Zhangauthor=P.+Brunhoeberauthor=H.+Nittaauthor=T.+Groganauthor=L.+Rimsza&title=Colorimetric+in+situ+hybridization+identifies+MYC+gene+signal+clusters+correlating+with+increased+copy+number%2C+mRNA%2C+and+protein+in+diffuse+large+B-cell+lymphoma&doi=10.1309%2FAJCP2Z0TAGMUYJEB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma</span></div><div class="casAuthors">Valentino Carlo; Kendrick Samantha; Johnson Nathalie; Gascoyne Randy; Chan Wing C; Weisenburger Dennis; Braziel Rita; Cook James R; Tubbs Raymond; Campo Elias; Rosenwald Andreas; Ott German; Delabie Jan; Jaffe Elaine; Zhang Wenjun; Brunhoeber Patrick; Nitta Hiro; Grogan Tom; Rimsza Lisa</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Abnormalities of the MYC oncogene on chromosome 8 are characteristic of Burkitt lymphoma and other aggressive B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL).  We recently described a colorimetric in situ hybridization (CISH) method for detecting extra copies of the MYC gene in DLBCL and the frequent occurrence of excess copies of discrete MYC signals in the context of diploidy or polyploidy of chromosome 8, which correlated with increased mRNA signals.  We further observed enlarged MYC signals, which were counted as a single gene copy but, by their dimension and unusual shape, likely consisted of "clusters" of MYC genes.  In this study, we sought to further characterize these clusters of MYC signals by determining whether the presence of these correlated with other genetic features, mRNA levels, protein, and overall survival.  We found that MYC clusters correlated with an abnormal MYC locus and with increased mRNA.  MYC mRNA correlated with protein levels, and both increased mRNA and protein correlated with poorer overall survival.  MYC clusters were seen in both the germinal center and activated B-cell subtypes of DLBCL.  Clusters of MYC signals may be an underappreciated, but clinically important, feature of aggressive B-cell lymphomas with potential prognostic and therapeutic relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRq-qBcTAIZH7JzI8owOhpDfW6udTcc2eabMC9nZ7LdV7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szivFOrtw%253D%253D&md5=19d2d55307fd76b049ff7639b2e703de</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1309%2FAJCP2Z0TAGMUYJEB&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FAJCP2Z0TAGMUYJEB%26sid%3Dliteratum%253Aachs%26aulast%3DValentino%26aufirst%3DC.%26aulast%3DKendrick%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DN.%26aulast%3DGascoyne%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DBraziel%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DJaffe%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBrunhoeber%26aufirst%3DP.%26aulast%3DNitta%26aufirst%3DH.%26aulast%3DGrogan%26aufirst%3DT.%26aulast%3DRimsza%26aufirst%3DL.%26atitle%3DColorimetric%2520in%2520situ%2520hybridization%2520identifies%2520MYC%2520gene%2520signal%2520clusters%2520correlating%2520with%2520increased%2520copy%2520number%252C%2520mRNA%252C%2520and%2520protein%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2013%26volume%3D139%26spage%3D242%26epage%3D254%26doi%3D10.1309%2FAJCP2Z0TAGMUYJEB" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00298">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14224"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00298">10.1021/acs.jmedchem.7b00298</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures showing in situ hybridization characterization of the DLBCL cells for <i>MYC</i> and <i>BCL2</i> translocations and gene amplification; cell viability MTS curves; qPCR data for <i>MYC</i> expression following 6 h treatment with <b>05</b>; qPCR data for <i>MYC</i> and <i>BCL2</i>; mean mouse weight, survival curves, qPCR, Western blot data from in vivo studies; and purity determination of the compunds and tables summarizing the IC<sub>50</sub> of <b>05</b> and <b>76</b> and STR data for authentication of DLBCL cell lines (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_001.pdf">jm7b00298_si_001.pdf (5.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00298/suppl_file/jm7b00298_si_002.csv">jm7b00298_si_002.csv (0.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00298&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-15%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00298%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00298" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996daf1e811985","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
